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ABSTRACT 
Development of an HPLC-based oligosaccharide synthesizer 
Salvatore G. Pistorio 
Doctor of Philosophy, University of Missouri – St. Louis  
Prof. Alexei V. Demchenko, Advisor 
 
Carbohydrates are the most abundant molecules on Earth. They are involved 
in a wide range of fundamental biological processes: anti-inflammation, immune 
response, joint lubrication, cell growth, antigenic determination. Carbohydrates are also 
held responsible for many damaging cellular processes, such as bacterial and viral 
infections, development of tumors, etc.. Therefore, the development of effective 
methods for the synthesis of complex carbohydrates has become a critical area of 
glycosciences. One challenge that stands out is the stereocontrol in the synthesis of 
glycosidic bonds, the linkage that serves as the only means to connect simple 
monosaccharides into complex oligomeric networks. Beyond this, the lack of a simple 
automated platform, similar to that utilized in the preparation of oligonucleotides and 
oligopeptides, significantly hampers access to oligosaccharides. The work presented 
herein addresses both of these limitations of oligosaccharides synthesis: stereocontrol 
and the lack of automation.  The stereocontrolled formation of very challenging beta-
mannosidic linkages has been achieved using a new reaction called Hydrogen-bond-
mediated Aglycone Delivery (HAD). Automation in Oligosaccharide solid phase 
synthesis has been accomplished using an AgilentTM HPLC, model 1260 Infinity, that 
was adapted to the polymer supported synthesis of oligosaccharides. The utility of the 
HAD reaction and the HPLC-based automated technology has been demonstrated by 
the synthesis of different oligosaccharide sequences in high stereoselectivities and 
yields. 
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1.1   General introduction 
It has been long known that carbohydrates are involved in a wide range of 
fundamental biological processes and are often called “essential molecules of life.”1  
Indeed, our life begins with fertilization, which takes place via a selective 
carbohydrate-protein recognition.2  In addition, carbohydrates help us maintain a 
healthy lifestyle via their active involvement in anti-inflammation, immune response, 
joint lubrication, cell growth, antigenic determination, etc.3  The explosive growth of 
glycosciences in the recent years also brought the understanding of the roles of sugars 
as “molecules of death” due to their sizable contribution to harmful processes. 
Bacterial, parasitic, and viral infections; development and growth of tumors; 
metastasis; tissue rejection; septic shock; congenital disorders are only few to 
mention.4  Elucidating the roles of carbohydrates in pathogenesis of cancer, AIDS, 
pneumonia, septicemia, diabetes, hepatitis, and malaria has been particularly 
stimulating for major efforts in the field of modern glycosciences.5   
It is already appreciated that both chemical and enzymatic syntheses6 could 
lead to natural oligosaccharides of glycoconjugates. These compounds are typically 
needed for studying of their composition,7 conformation,8 interaction with other 
molecules,9 and biological roles.10 Isolation from natural sources offers another viable 
means to obtain sugars. Only the synthetic approach, however, can provide unnatural 
glycomimetics that are often of interest due to their therapeutic4, 11 and/or diagnostic 
potential.12 Manufacturers have shown an interest in producing carbohydrate-based 
pharmaceuticals; however, even with significant progress, controlled chemical 
synthesis of complex carbohydrates remains difficult. Resultantly, the entire area of 
glycosciences remains somewhat underdeveloped, whereas other major classes of 
natural biopolymers, peptides and polynucleotides, can be studied by advanced 
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methods and their synthesis can be automated using commercially available 
synthesizers. Low accessibility and high cost of complex carbohydrates hinders their 
large-scale development, and examples such as heparin analogs,13 oligosaccharide 
antibiotics,14 oligosaccharide and glycoconjugate-based vaccines,15 etc.,5b, c, 16 are still 
rare. 
Practically all complex carbohydrates have an oligomeric sequence wherein 
monosaccharide residues are linked via O-glycosidic linkages. This linkage is 
obtained by a glycosylation reaction that typically involves the nucleophilic 
displacement of a leaving group (LG, Scheme 1.1) on the glycosyl donor by a 
hydroxyl group of the acceptor (ROH) in the presence of an electrophilic promoter or 
activator.17 The remaining functional groups of both components are temporarily 
masked with protecting groups (P). A detailed mechanism has not yet been 
elucidated, although certain conventions and the involvement of the key reaction 
intermediates (A-C, Scheme 1.1) have been established.18 In spite of significant 
recent progress, chemical glycosylation remains challenging due to the requirement to 
achieve complete stereocontrol and to suppress side reactions.17  
 
Scheme 1.1   Chemical glycosylation 
 
 
 
The single-step glycosylation is only one challenge researchers working on 
oligosaccharide synthesis face: often additional protecting and/or leaving group 
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modifications between each glycosylation step are required. Because these 
manipulations become increasingly inefficient with larger oligosaccharides, many 
advanced strategies focus on minimizing the intermediate reaction steps.19 A few 
relevant examples include Fraser-Reid’s armed-disarmed approach,20 Nicolaou’s 
selective activation,21 Danishefsky’s glycal-based assembly,22 Kahne’s one-pot 
synthesis,23 Roy’s24 and Boons’25 active-latent concept, Ogawa’s orthogonal 
strategy,26 Huang’s preactivation concept,27 etc.28  
In light of recent progress made in the areas of glycobiology and glycomics 
the discovery of efficient methods and technologies for the synthesis of complex 
carbohydrates is critical because reliable access to these compounds is becoming truly 
essential for research, development and application in therapeutics and diagnostics. 
This Chapter will discuss recent development of novel technologies for automation of 
oligosaccharide synthesis both on solid phase and in solution. Following numerous 
attempts to streamline oligosaccharide synthesis using predictive or computational 
reactivity assessment performed by the Fraser-Reid, Ley, and Wong groups in the 
1990’s, the first example of the truly automated synthesis is credited to Seeberger and 
co-workers, who reported the first automated synthesizer in 2001. In this application, 
they used a peptide synthesizer ABI 433 that after a few modifications was optimized 
for the synthesis of oligosaccharides.29 From that moment, an automated approach to 
oligosaccharide synthesis became possible, and a new era in carbohydrate research 
has been plotted. Another important milestone is the commercialization of this 
automated platform, Glyconeer 2.1 that is now available via GlycoUniverse. It should 
be mentioned that Activotec has also developed a peptide synthesizer-based 
oligosaccharide synthesizer that is now commercially available. 
  
Salvatore G. Pistorio| UMSL 2016 | Page  5 
 
 
1.2  Automation of the polymer-supported synthesis 
 
Solid-phase synthesis using insoluble polymer supports30 has been widely 
used in the preparation of many organic molecules30-31 including oligopeptides32 and 
oligonucleotides.33 The early example of solid phase peptide synthesis by Merrifield34 
was followed by oligosaccharide synthesis by Fréchet and Schuerch that emerged 
shortly thereafter.35 Since the early attempts, the polymer-supported oligosaccharide 
synthesis has become a viable means for the rapid synthesis of oligosaccharide 
sequences without the necessity of purifying (and characterizing) the intermediates.36 
Another important advantage of oligosaccharide synthesis on solid support is the ease 
of excess reagent removal (usually can be achieved by filtration and rinsing).  
There are two main strategies for solid phase saccharide synthesis that differ 
in the type of the attachment (Scheme 1.2). In strategy A, the glycosyl acceptor unit is 
bound to the solid support either at the anomeric position or other suitable hydroxyl.  
In this case, an excess of the glycosyl donor and promoter are in the solution. In 
approach B, the glycosyl donor unit, linked to the solid support via a suitable 
hydroxyl group, is reacted with the solution phase acceptor. Two-directional 
techniques, combining approaches A and B are also known.37 To improve the 
operational simplicity of the oligosaccharide assembly Seeberger developed an 
automated approach, which is based on strategy A: using a solid phase acceptor and a 
liquid phase donor.29a Since this approach is already well-documented in the 
literature, including a number of review articles,16, 29b, 38 herein only a brief historical 
perspective with a few representative examples and milestones will be discussed.  
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Scheme 1.2.  Glycosylation on polymer support 
 
 
 
 
1.2.1 Peptide synthesizer-based automation of polymer-supported synthesis 
 
The automation was initially accomplished by using a peptide synthesizer 
that had been modified to perform oligosaccharide assembly at low temperature.29a 
Merrifield resin was chosen as the solid support, for its good swelling properties in 
organic solvents commonly used in glycosylation. The design of the linker between 
the sugar and the solid support is of the key importance. In this application, the 
polymer support was equipped with an olefin-type linker due to its high stability in 
both basic and acidic media. Thus, the octenediol-functionalized resin 1.1 was 
glycosylated with trichloroacetimidate donor 1.2 (10-fold excess) in the presence of 
trimethylsilyl trifluoromethanesulfonate (TMSOTf, Scheme 1.3). The use of acetyl 
group at C-2 of glycosyl donor 1.2 was chosen to control the anomeric 
stereoselectivity for the formation of oligosaccharides 1.3, and to be selectively 
deprotected with NaOMe in methanol/dichloromethane to obtain the next generation 
glycosyl acceptor 1.4.  To reduce the formation of side products and truncated 
sequences, both glycosylation and deprotection steps were performed twice. This 
cycle of glycosylation-washing-deprotection was repeated to obtain the desired linear 
oligosaccharide sequence. After that, the linker was removed using Grubbs’ catalyst 
to afford penta-, hepta- and decasaccharides 1.5a-c as pentenyl glycosides. For 
instance, using the automated approach, heptasaccharide 1.5b was obtained in 24 h in 
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42% over-all yield, whereas the manual synthesis was much more laborious (14 days) 
and less efficient (9% over-all yield).39  
 
Scheme 1.3. First automated oligosaccharide synthesis 
 
 
 
 
Working on expanding this promising technology, Seeberger and co-
workers, approached the synthesis of oligosaccharides containing other important 
residues and linkages including aminosugars,40 sialic acids,41 furanosides,42 1,2-cis 
glycosides,43 glycopeptides,44 and branched oligosaccharide sequences.29a  Codee et 
al. reported the synthesis of β-mannosides45 using essentially the same automation 
platform. The acquired knowledge was applied to a very effective synthesis of Globo-
H hexasaccharide. This oligosaccharide is expressed on surfaces of different types of 
cancer cells, and this represents a key target for the development of anti-cancer 
vaccines and therapeutics.15c, 16, 46 The appreciation of the biological significance of 
Globo-H stimulated the interest in the synthetic community and the antigen has been 
synthesized by different methods,27c, 37b, 43, 47  
This effort culminated in the automated synthesis by Seeberger, which was 
the first attempt to conquer the challenge on 1,2-cis glycosidic bond formation using 
automated approach.43 Careful refinement of reaction conditions allowed 1,2-cis 
galactosylation in dichloromethane-ether and Globo-H sequence was assembled as 
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depicted in Scheme 1.4. First, glycosyl phosphate donor 1.6 was linked to the resin 
1.1 via glycosylation using TMSOTf (repeated once) as the promoter, followed by 
deprotection of the Fmoc substituent with piperidine (repeated twice) to provide 
polymer-bound acceptor. In this synthesis, Fmoc group was chosen as a protecting 
group, for its high stability in acid and easy cleavage in presence of mildly basic 
amines. In addition, after cleavage Fmoc provides dibenzofluorene adduct that can be 
used to monitor the efficiency of deprotection via quantitative colorimetric assay.48 
The general synthetic protocol consists of repetitive cycles of glycosylation using 
either glycosyl phosphate (1.6-1.9) or glycosyl N-phenyl trifluoroacetimidate donors 
(1.10 and 1.11) followed by the deprotection with piperidine. The final product 1.12 
was obtained under an atmosphere of ethylene in the presence of Grubbs’ catalyst49 in 
an overall yield of 30%.  
 
 
Scheme 1.4.  Automated synthesis of Globo H hexasaccharide 
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1.2.2 Dedicated oligosaccharide synthesizer for the automation of polymer-
supported synthesis  
 
More recently, Seeberger and co-workers introduced “the first fully 
automated solid-phase oligosaccharides synthesizer”.50 The new automated 
synthesizer was developed by combining the following equipment: syringe pumps, 
solenoid valves, a cryostat with the temperature controlling system capable of 
maintaining the reaction temperature between -50 oC and 90 oC, and a fraction 
collector (Scheme 1.5). The reaction vessel is equipped with the porous glass filter 
that allows for delivering the inert gas to maintain anhydrous reaction conditions. The 
gas is also used for rapid removal of the solution phase reagents and solvents. The 
glycosylation and deprotection protocol can be set using a computer program. This 
allows for the full automation of reactions, temperature control, cleavage, and the 
collection of the released oligosaccharide product.  
To illustrate the versatility of this new synthesizer Seeberger and co-workers 
performed the synthesis of a few oligosaccharides, included a high mannose type 
branched glucan 1.18 as depicted in Scheme 1.5. To ensure the feasibility of the 
complete automation, a new type of linker 1.13 stable under the most common 
glycosylation and protecting group removal conditions was introduced. The synthesis 
of pentasaccharide 1.18 began with the assembly of the chitobiose portion using two 
glycosylation-deprotection cycles with glycosyl donor 1.14. A challenging β-
mannosidic linkage was then obtained with donor 1.15, equipped with 2-
(hydroxycarbonyl)benzyl leaving group developed by Kim.51 Subsequently, the 
treatment with TBAF and selective opening of benzylidene acetal gave 3,6-diol. The 
latter was then subjected to bis-mannosylation using donor 1.16 to obtain the final 
branched sequence. Cleavage from the solid support was affected in the presence of 
MeONa to afford precursor 1.17 (α/β = 1/3). The undesired α-linked anomer formed 
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as the by-product during the β-mannosylation step was separated off by preparative 
HPLC, and the resulting diastereomerically pure compound was deprotected by 
hydrogenation to afford the target pentasaccharide 1.18 in 3.5% yield overall.  
 
Scheme 1.5.  Automated synthesis of branched oligomannan 1.18 using second 
generation synthesizer 
 
 
 
 
Very recently, making use of essentially the same technology, Seeberger and 
co-workers obtained a α-(16)-linked linear oligosaccharide sequence containing 30 
mannose residues.52  To undergo this impressive synthesis, a modified Merrifield 
resin 1.19 equipped with the photocleavable p-nitrophenyl linker was repeatedly 
glycosylated with phosphate donor 1.20 in the presence of TMSOTf (Scheme 1.6). 
The capping of the unreacted hydroxyls in 1.21 was affected by acetylation with 
Ac2O in the presence of pyridine. The deprotection of 6-O-Fmoc substituent was then 
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affected with piperidine to afford glycosyl acceptor of the next generation 1.22. 
Benzoyl protecting groups were used at other positions to ensure high stability, 
stereoselectivity, and yields throughout the synthesis. Upon execution of 29 
glycosylation cycles with the interim capping-deprotection steps, the resulting 29-mer 
was then glycosylated with donor 1.23. The latter is equipped with the spacer moiety 
to allow for a very effective cap-and-tag purification technique.53 Thus, upon release 
from the polymer support using UV light, the resulting 30-mer 1.24 was conjugated to 
magnetic beads via the amino group of the terminal mannose unit equipped with an ε-
aminocaproic ester spacer.  
 
Scheme 1.6.  Automated synthesis of the linear 30-mer oligomannan using 
second generation synthesizer. 
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This approach allowed for magnetic separation of the tagged oligosaccharide 
1.26 followed by simple washing with dichloromethane and methanol.  Subsequent 
release from the magnetic beads and concomitant debenzoylation with sodium 
methoxide in methanol followed by hydrogenation to remove Cbz group led to the 
fully uprotected 30-mer manno-oligosaccharide 1.27. Resultantly, the longest 
oligosaccharide sequence ever made by chemical synthesis was obtained in a total 
yield of 1%, which accounts for 96% average yield per synthetic step.   
 
1.2.3 HPLC-based automation of polymer-supported synthesis  
 
Demchenko, Stine and their co-workers developed a new experimental set-
up based on an unmodified HPLC instrument. In brief, an Omnifit chromatography 
column was packed with the pre-swelled polymer resin TentaGel-NH2. The column 
was then connected to the HPLC system consisting of a reciprocating pump 
containing three chambers, a variable UV range detector, and a computer with 
standard HPLC-operating software installed (Scheme 1.7).54 The column was packed 
with the glycosyl acceptor loaded on resin, purged with the solvent and then two 
separate solutions containing glycosyl donor and promoter were delivered 
concomitantly. After a relatively short reaction time, typically 30-60 min, the system 
was purged (washed) with solvent. At this time, the resin is loaded with the 
disaccharide derivative, and the oligosaccharide elongation can be continued via 
alternating deprotection-glycosylation steps. Although the versatility of the HPLC-
assisted method is still to be demonstrated, the synthesis of linear pentasaccharide 
1.30 has already been accomplished (Scheme 1.7). For the synthesis of this molecule, 
TentaGel-NH2 resin loaded glycosyl acceptor 1.29 was packed into the Omnifit 
column (alternatively, the loading could be performed using the HPLC-based set up). 
The elongation of the glucan sequence was then performed using glycosyl donor 1.28 
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equipped with 2-O-benzoyl group to ensure the stereoselectivity control and 6-O-
Fmoc as the selectively removable temporary substituent. Two reagent bottles, one 
with a solution of donor 1.28 and one with a solution of promoter (TMSOTf) were 
then used to deliver the solutions to the column via dedicated pumps. After 1 h, the 
two pumps were stopped and the system was purged with dichloromethane using a 
separate pump. Subsequently, a solution of piperidine in DMF was delivered to 
perform Fmoc-deprotection with a typical reaction time of 5 min, after which the 
system was purged with dichloromethane. The cycle (glycosylation-washing-
deprotection-washing) was repeated until the desired oligosaccharide was assembled. 
The latter was then cleaved off from the polymer support by using a recirculating 
solution of NaOMe in methanol-dichloromethane. Resultantly, pentasaccharide 1.30 
was isolated in 62% yield with an important reduction in time with respect to the 
same pentasaccharide obtained using a manual approach (7 hours vs. 7 days).  
 
Scheme 1.7.  HPLC-assisted automated oligosaccharide synthesis 
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It was also demonstrated that all steps of the HPLC-assisted synthesis could 
be monitored using a standard HPLC detection system set to record changes in the 
UV absorbance of the solution eluting off the column.54  A solution of reagents can be 
recirculated to reduce the amount of reagents and to ensure complete conversion at 
each reaction step. This experimental set up offers the following advantages in 
comparison to that of conventional (manual) oligosaccharide synthesis on polymer 
supports: faster reaction times, real-time reaction monitoring using an HPLC 
detection system, and all steps and sequences can be automated using the standard 
HPLC-managing computer software. Novel O-benzoxazolyl (OBox) imidates were 
found promising glycosyl donors for HPLC-based applications.55 
 
1.3   Other platforms for the automated synthesis 
 
In spite of remarkable progress, the solid phase technique still suffers from 
significant limitations: large reagent excess, limited use of molecular sieves, large 
volume of waste solvent, cumbersome analysis of intermediates, lower 
stereoselectivity, loss and poisoning of resin, reagent trapping, etc.  In addition, the 
necessity to carefully select (match) reaction components, linkers, resins, activators, 
solvents, temperature, etc. have also become apparent and required thorough 
refinement.  This section will discuss major efforts to automate the synthesis of 
oligosaccharides either in solution with or without using soluble tags or with the use 
of alternative solid supports.  
 
1.3.1 Automation of the one-pot oligosaccharide synthesis in solution 
 
Oligosaccharide synthesis using the principle of chemoselectivity introduced 
by Fraser-Reid has been used in a variety of ways and found broad application in 
synthesis.20, 56 With the discovery of multiple reactivity levels ranging from the 
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superdisarmed to the superarmed building blocks and systems,28c, 57 the versatility of 
the chemoselective approach to oligosaccharide synthesis was enhanced. Wong and 
co-workers devised a mathematical approach, assigning relative reactivity values 
(RRVs) to a wide library of building blocks that were then used for oligosaccharide 
assembly in one-pot.58  The determination of RRVs was made in standardized 
reaction conditions, tolyl thioglycoside donors in the presence of an NIS/TfOH 
promoter system.  The cumulative reactivity data was then compiled into a predictive 
computer program called Optimer.58  Following these studies, a well-rounded 
technology for one-pot oligosaccharide synthesis based on RRVs emerged.  A 
relevant example is shown in Scheme 1.8 (synthesis of 1.35) wherein sequential 
activation of building blocks 1.31, 1.32, and 1.33 was based on their relative 
reactivity, which was found to be 17000/162.8/13.1, respectively.58 In this context, the 
reactivity difference between similarly protected sugars of different series has to be 
also taken into consideration. For example, the reactivity ratio between per-
benzylated S-(p-methylphenyl) glycosides of L-fuco, D-galacto, and D-gluco series 
was found to be 27.1/6.4/1 respectively.58 This approach has been used to obtain 
various oligosaccharides and glycoconjugates of biological significance and 
medicinal relevance.59 Similar reactivity scales have also been devised by Fraser-
Reid,60 Ley,61 and others.56 
 
Scheme 1.8.  Programmable oligosaccharide synthesis assisted  
by the predictive computer program Optimer.  
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Takahashi and co-workers probed a number of automation platforms for the 
solution-based one-pot oligosaccharide synthesis.62 In a majority of applications, 
selective activation of different leaving groups, another common approach to 
expeditious oligosaccharide synthesis,19, 28b was executed. For instance, a parallel 
synthesis instrument Quest 210 by Argonaut Technologies, was applied to the 
automated one-pot synthesis of linear and branched oligosaccharides shown in 
Scheme 1.9a and 1.9b.63 Thus, for the synthesis of trisaccharide 1.39, glycosyl 
bromide donor 1.36 was selectively activated for reaction with thioglycoside acceptor 
1.37 in the presence of AgOTf as promoter. The anomeric thiophenyl leaving group 
of the disaccharide intermediate was then directly activated by the addition of 
NIS/TfOH and acceptor 1.38 to provide linear trisaccharide 1.39 in 79% yield over 
two steps. Scheme 1.9b illustrates the formation of the branched trisaccharide 1.43, 
which was obtained by two-step sequential glycosylation of diol 1.41. First, the 
primary hydroxyl of acceptor 1.41 was glycosylated with bromide 1.40 in the 
presence of AgOTf. Subsequent addition of thiophenyl donor 1.42 and NIS/TfOH 
promoter system resulted in the glycosylation of the remaining secondary hydroxyl to 
afford trisaccharide 1.43 in 89% yield over two steps.  
In an effort to obtain more complex oligosaccharide sequences, Takahashi 
adapted another instrument, L-COS by Moritex, which was used to make a dimeric 
Lex 1.48 and its analogues. Using this instrument, Takahashi et al. achieved 
automation of stirring, temperature control, and rate of reagent addition for each 
glycosylation and deprotection step shown in Scheme 1.9c.62, 64 The synthesis began 
by the coupling of fluoride donor 1.45 with diol acceptor 1.44 in the presence of 
AgOTf as the promoter. This reactions proceeded regioselectively at the C-4 position, 
and the resulting pentasaccharide equipped with the anomeric thiophenyl leaving 
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group was used as the glycosyl donor for the coupling with glycosyl acceptor 1.46, 
which was added along with NIS/TfOH to affect the activation. Finally, the remaining 
3’-OH of the resulting hexasaccharide intermediate was fucosylated by the addition of 
donor 1.47 and NIS/TfOH. Resultantly, the desired heptasaccharide 1.48 was 
obtained in eight hours in 24% yield (average 79% yield per step). The automated 
synthesizer could be combined with Combi Flash automated column chromatograph, 
which was used for purification of the resulting oligosaccharides.  
 
Scheme 1.9 Automation of one-pot synthesis using parallel synthesizers  
Quest-210 (a and b) and Moritex L-cos (c). 
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1.3.2 Automation of the fluorous tag-supported synthesis  
 
Fluorous tag-supported synthesis has emerged as a new and attractive 
strategy for obtaining oligosaccharides with good prospects for automation. 
Apparently, fluorous protecting groups (groups incorporating a fluorinated alkyl 
chain) allow for the separation of fluorinated species (typically glycosyl acceptors) 
from non-fluorinated species (glycosyl donors) by simple partitioning between 
perfluorohexanes and methanol (or toluene).65  
Solution-based microreactors, developed in the late 1990’s, have been 
adapted to fluorous tag-supported synthesis of oligosaccharides by Seeberger and co-
workers.66 A five-port silicon microfluidic reactor was utilized for the synthesis of 
homotetramer 1.52. For this purpose, glycosyl phosphate donor 1.48 was first 
glycosidated with a fluorous linker 1.49 in the presence of TMSOTf.66 To accomplish 
the glycosylation reaction in a microfluidic device, three separate solutions in 
dichloromethane were prepared: glycosyl acceptor, phosphate donor, and the activator 
(TMSOTf). Using three syringe pumps, the solutions of acceptor, donor, and 
promoter were connected via inlets 1, 2 and 3, respectively (Scheme 1.10). By 
diffusion-controlled sampling, each solution is then delivered into the mixing zone 
and the concentration of each component is controlled by the concentration inside the 
syringe and by the flow rate of each stream. After mixing, the reaction then takes 
place inside the reaction zone. The reaction can be monitored using different types of 
instruments connected at the outlet of the microreactor, including UV-vis, IR, or mass 
spectrometer. The glycosylation step was then followed by the removal of the Fmoc 
group with piperidine and TBAF (used to remove 6-O-TMS formed as a result of 
competing silylation) to afford fluorous glycosyl acceptor 1.50. The latter was then 
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glycosylated with glycosyl donor 1.48 and the deprotection-glycosylation sequence 
was repeated until the desired tetrasaccharide 1.51 had been assembled.  
 
Scheme 1.10  Fluorous tag-supported synthesis in the microreactor. 
 
 
 
The tetrasaccharide was then cleaved from the fluorous support by the 
treatment with second-generation Grubbs’ catalyst to provide tetrasaccharide 1.52. 
The reaction times for glycosylations were 20 sec for the formation of the 
disaccharide, and 60 sec each for the tri- and tetrasaccharides.  The yields for the 
reactions after purification were 97, 90, and 95% for di-, tri-, and tetrasaccharides, 
respectively. The benefits of using microfluidic reactors in oligosaccharide synthesis 
include ease of scale up, the ability to readily optimize reaction conditions and control 
the reaction outcome by varying the flow rate and amounts of reagents, improved 
safety, a greater control of the reaction temperature, the compatibility with various 
analytical techniques and automation platforms. Inherent microfluidic system 
Supplementary Material for Chemical Communications 
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Supplementary Figure 2. Schematic of diffusion-controlled 
mixing of glycosyl donor, acceptor and activator laminae in 
the mixing zone. 
 
 
Scheme 1
Scheme 2
 
Supplementary Figure 3. Representative HPLC scans from 
Schemes 1 and 2. 
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drawback include: possible longer times if a low flow-rate is required and the 
incompatibility with solids. 
 
Scheme 1.11 Pohl automated synthesis using fluorous tag approach. 
 
 
 
 
Jaipuri and Pohl also used the fluorous tag-assisted glycosylation strategy for 
developing their own automation platform using the fluorous solid-phase extraction 
protocol (Scheme 1.11).67 Their approach involved the use of a fluorous tag attached 
glycosidically to glycosyl acceptor 1.54, which was glycosylated using excess of 
trichloroacetimidate donor 1.53 in the presence of TMSOTf. The resultant 
disaccharide 1.55 was separated using an automated three-step fluorous solid phase 
extraction protocol. First, the mixture containing organic and fluorous components are 
loaded on a separation column. All fluorine-free molecules elute off the column using 
20% solution of water in methanol. After that, fluorous molecules that are retained on 
the column can be released using a fluorophilic wash, such as methanol or THF. This 
procedure can be automated using commercially available equipment that is able to 
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create a positive pressure or vacuum. Subsequently, disaccharide 1.55 was subjected 
to the two-step deprotection of TBS (with TBAF) and Lev groups (with hydrazine) to 
afford triol 1.56. The latter was then glycosylated with excess trichloroacetimidate 
donor 1.57 to afford pentasaccharide 1.58 in a high yield of 92%.  
 
1.3.3 STICS: Surface-Tethered Iterative Carbohydrate Synthesis  
 
In attempt to address major drawbacks of the polymer-supported synthesis, 
predominantly swelling, reagent trapping, and poisoning, Demchenko and Stine 
introduced the Surface-Tethered Iterative Carbohydrate Synthesis (STICS), a novel 
approach to oligosaccharide synthesis using nanoporous gold (NPG) as a solid 
support.68 NPG is a high-surface area, sponge-like nanomaterial. It can be utilized as a 
set of NPG plates (8 x 8 x 0.2 mm) assembled in a stacked Teflon mini reactor as 
shown in Scheme 1.12. The glycosyl acceptor can be anchored to NPG using thiolated 
linkers and the oligosaccharide assembly is accomplished via alternating 
glycosylation, washing, deprotection and drying steps as depicted in Scheme 1.12. 
Thus, 6-O-TBDPS-protected S-benzoxazolyl (SBox) glycosyl donor 1.60 was 
coupled to the lipoic acid anchored acceptor 1.59 in the presence of MeOTf. Then, 
after a quick rinse, the tethered disaccharide intermediate was treated with Bu4NF to 
deprotect the silyl group to afford the second-generation glycosyl acceptor. The latter 
was dried and reacted with SBox donor 1.61, and the resulting trisaccharide was 
released by the treatment with NaOMe in MeOH. Finally, for the purification and 
characterization purpose, the trisaccharide was benzoylated to afford compound 1.63 
in 52% overall. The pictures in Scheme 1.12 are SEM images of NPG plates with two 
different bar scales (2.5 µm and 200 nm). 
Over-all, the STICS approach offers a promising new platform for 
oligosaccharide synthesis. NPG surface only requires wetting; upon reaction, the 
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access reagent is simply rinsed off; reagent trapping/resin poisoning is not an issue 
with NPG because it does not trap any reagent and can be regenerated to bare surface 
by electrochemical methods if necessary, and gold is fully recoverable. The 
limitations of the STICS approach are similar to other standard drawbacks of the 
polymer-supported synthesis and include: difficulty of monitoring the reaction and 
analyzing intermediates, longer reaction times than those for reactions in solution and 
the requirement to use large (5-10 fold) excess of reagents.  
 
Scheme 1.12  STICS: Surface-Tethered Iterative Carbohydrate Synthesis 
 
 
 
 
To address some of these drawbacks, the subsequent study made use of the HPLC-
assisted automated technology for oligosaccharide synthesis.69 The HPLC pump was 
used to force the circulation of the donor inside the column and the NPG chips placed 
in the Omnifit column (Scheme 1.13). Also investigated was the role of the spacer in 
the lipoic acid anchoring systems.  Using this strategy in combination with a long 
chain spacer between the acceptor and lipoic acid anchor it was possible to increase 
the disaccharide yield from 60% to 90%.69 
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Scheme 1.13  HPLC-assisted surface-tethered  
iterative carbohydrate synthesis 
 
 
 
 
1.3.4 Solution phase-based automation using electrochemical activation of 
thioglycosides 
 
Electrochemical activation
 
of calcogenoglycosides has been known for 
years.70 Very recently, Nokami and co-workers introduced an automated 
oligosaccharide synthesis based on the electrochemical activation of thioglycosides 
via the corresponding glycosyl triflates.71 The automated synthesizer was specifically 
developed for this application, and the synthesis of a series of β-(16)-linked glycans 
consisting of multiple N-acetylglucosamine units has been accomplished. As depicted 
in Scheme 1.14, aryl thioglycoside donor 1.64 was preactivated via the corresponding 
glycosyl triflate 1.65 by electrochemical oxidation at -80 oC and 1.0 F/mol at 1.73 
Volt for 40 min. The temperature was then increased to -50-60 oC and glycosyl 
acceptor 1.66 equipped with the S-aryl leaving group is added resulting in the 
formation of disaccharide 1.67 in 30 min. Essentially the same two-step preactivation-
glycosylation sequence could be repeated multiple times to afford the desired 
pentasaccharide 1.68 in 9-15% overall yield (62-68%, average yield per cycle) in 10 
h.71  
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Scheme 1.14  Automation of the electrochemical activation of thioglycosides in 
solution. 
 
 
 
 
1.4 Conclusions 
 
To keep pace with the exploding area of glycobiology, it is critical to make 
complex carbohydrates more accessible to the general chemical, biochemical and 
industrial audience. This lofty goal can be achieved only by the development of 
reliable, stereoselective and expeditious methods for glycoside synthesis and 
oligosaccharide assembly that are applicable to both laboratory and industrial-scale 
preparations. Traditional chemical assembly of oligosaccharides in solution involves 
multiple protecting group and/or leaving group manipulations and requires tedious 
purification between each glycosylation steps. Expeditious strategies for 
oligosaccharide assembly in solution require specialist knowledge of all aspects of 
carbohydrate chemistry and fine-tuning of the reaction conditions and reactivity 
levels. Manual polymer-supported synthesis helps to streamline the synthesis and 
purification, and the automated platform developed by Seeberger introduces an idea 
of operational simplicity. Yet, it requires a sophisticated and expensive synthesizer.  
Recent developments of automation with the use of inexpensive laboratory 
equipment including syringe pumps, HPLC components, microreactors, and parallel 
synthesizers offer a promise of simple automation using commonly available and 
relatively inexpensive equipment. The modular character of many new wave 
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synthesizers allows for endless opportunities to implement attachments, reagent 
delivery modes, detecting systems, accessories, and software packages. Some 
automation platforms allow for real-time reaction monitoring, which, in turn, helps 
reduce the reaction time and the amount of reagents needed. Further development of 
existing and new platform for the automated synthesis remains a significant area of 
research. While most automated platforms remain underdeveloped, solution-based 
manual (standard) synthesis will still remain as an important (major) tool to obtain 
complex oligosaccharides or particularly challenging sequences. 
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CHAPTER 2 
 
Hydrogen bond-mediated aglycone 
delivery: focus on β-mannosylation 
 
 
 
 
 
 
2.1 General Introduction 
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The vast majority of complex carbohydrates consists of monosaccharide 
residues connected via O-glycosidic linkages.1 Uncontrolled chemical O-
glycosylations often lead to low yields and/or mixtures of anomers. The goal of 
stereocontrolling glycosylation has been a major inspiration and driving force of 
progress in the field. The synthesis of 1,2-cis glycosides, which cannot be assisted by 
conventional neighboring acyl group participation,2 is more challenging. Many factors 
affect the stereoselectivity of glycosylation, but none can guarantee complete 1,2-cis 
stereoselectivity.3 Therefore, all individual factors and combinations thereof are 
typically considered when glycosylations are attempted.  
Amongst a variety of unconventional protecting groups that have been 
introduced in recent years to control the stereoselectivity of glycosylations,4 the 
neighboring 2-O-picolinyl group formally participates in glycosylation and provides 
1,2-trans products stereoselectively as a result of the anti attack by the glycosyl 
acceptor.5 Remarkably, when placed at remote positions (C-3, C-4, and C-6), 
picolinyl and similar picoloyl substituents also provide high selectivity, but act via a 
different mode. All glycosylations proceed with stereoselectivity consistent with syn 
attack, because the remote picolinyl moiety acts as an H-bond acceptor for the 
incoming nucleophile (Scheme 2.1).6 Therefore, since this remote protecting group 
assistance is not directly correlated with the orientation of the substituent at C-2, this 
approach should in principle be suitable for the assisted synthesis of either 1,2-cis or 
1,2-trans-linked glycosides. 
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Scheme 2.1. 6-O-Picoloyl-assisted β-D-glycosylation 
 
For instance, as illustrated in Scheme 2.2, glycosidation of the 6-picoloyl 
(Pico) glucosyl donor 2.1a with acceptor 2.2 in the presence of 
dimethyl(methylthio)sulfonium triflate (DMTST)7 afforded disaccharide 2.3a in 92% 
yield and complete β-selectivity.6 A similar DMTST-promoted glycosylation with 
mannosyl donor 2.1b was significantly less stereoselective (α/β = 1/4.5) and afforded 
the corresponding disaccharide 2.3b in 86% yield.6  
Scheme 2.2. Synthesis of β-glucosides vs. β-mannosides 
 
Further screening of the reaction conditions showed that the NIS/TfOH 
promoter system provides a better environment for β-mannosylation with donor 2.1b. 
Under these reaction conditions, disaccharide 2.3b was obtained in 87% yield and 
enhanced β-selectivity (α/β = 1/9.5, Table 2.1, entry 1).6 The synthesis of β-
mannosides has been regarded as one of the greatest challenges of glycochemistry.8 
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Some promising methods have been established by Crich9 and others,10 but these are 
typically limited to specific types of glycosyl donor and require extreme reaction 
conditions or indirect methods11 to ensure that reactions proceed highly 
stereoselectively. Building upon promising preliminary results, herein we present our 
systematic study of H-bond mediated aglycone delivery reaction as applied to β-
mannosylation. 
 
2.2   Results and Discussion 
As the starting comparison point, known per-O-benzylated glycosyl donor 
2.1c12 was coupled with glycosyl acceptor 2.2 in the presence of DMTST or 
NIS/TfOH under high dilution reaction conditions that became the standard for O-
picoloylated glycosyl donors: 5.0 mM concentration in 1,2-dichloroethane. 
Previously, we conducted all reactions at -30  42 oC.6 Herein we determined no 
significant temperature dependence and conducted all reactions at rt. Thus, a 
glycosylation reaction between donor 2.1c and acceptor 2.213 gave the corresponding 
disaccharide 2.3c14 in good yield, but no selectivity was observed in the case of either 
promoter (Table 2.1, entry 2).  Similarly, glycosidation of 6-O-benzoyl donor 2.1d15 
provided disaccharide 2.3d with no stereoselection (entry 3). Since D-mannose has 
two remote substituents projecting above the pyranose ring (O-3 and O-6) we were 
curious to compare 6-O-picoloyl donor 2.1b with its 3-O-picoloyl counterpart 2.1e. 
Encouragingly, donor 2.1e gave excellent yields (89-92%) and high β-
stereoselectivity (α/β = 1/7-8, entry 4). Further screening of protecting groups 
included the 3,6-di-O-picoloyl donor 2.1f, the 4,6-O-benzylidene donor 2.1g, and the 
4,6-di-O-benzoyl donor 2.1h. Among this 3-O-picoloyl donor series, the best results 
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were achieved with donor 2.1h, which afforded the corresponding disaccharide 2.3h 
in good yield and with high stereoselectivity (α/β > 1/12, entry 7). 
Table 2.1.  Comparative investigation of mannosyl donors 2.1b-2.1h 
 
entry donor promoter, time 
product (yield, α/β 
ratio) 
16 
2.1b  
DMTST, 4 h 
NIS/TfOH, 2.5 h 
2.3b (86%, 1/4.5) 
2.3b (87%, 1/9.5) 
2 
2.1c  
DMTST, 72 h 
NIS/TfOH, 72 h 
2.3c (65%, 1/1.4) 
2.3c (67%, 1/1.0) 
3 
2.1d  
DMTST, 24 h 
NIS/TfOH, 24 h 
2.3d (68%, 1/1.0) 
2.3d (70%, 1/1.0) 
4 
2.1e  
DMTST, 30 min 
NIS/TfOH, 20 min 
2.3e (92%, 1/7.0) 
2.3e (89%, 1/8.0) 
5 
2.1f  
DMTST, 50 min 
NIS/TfOH, 3 h 
2.3f (72%, 1/10.0) 
2.3f (86%, 1/8.7) 
6 
2.1g 
DMTST, 40 min 
NIS/TfOH, 40 min 
2.3g (73%, 1/5.7) 
2.3g (73%, 1/6.5) 
7 
2.1h  
DMTST, 1.5 h 
NIS/TfOH, 1 h 
2.3h (86%, 1/12.1) 
2.3h (72%, 1/12.3) 
 
Having identified the most promising glycosyl donor 2.1h of the ethyl 
thioglycoside series, we conducted further studies with similarly protected p-tolyl and 
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phenyl thioglycoside series, 2.4 and 2.5, respectively. In addition to studying the 
effect of the anomeric leaving groups, this in-depth study involved screening 
promoters (DMTST and NIS/TfOH), concentration (1-50 mM), and temperature (rt 
and -30 oC). Although all experiments summarized in Table 2.2 proceeded with high 
selectivity (α/β > 1/5), the most beneficial conditions for β-mannosylation of acceptor 
2.2 include: glycosyl donor 2.5 (5 mM in 1,2-dichloromethane) activated with 
DMTST at rt. Resultantly, disaccharide 2.3h was obtained in excellent yield and 
stereoselectivity (91%, α/β = 1/18.5, entry 5). 
Table 2.2.  Investigation of S-tolyl 2.4 and S-phenyl 2.5 glycosyl donors 
 
entry donor (conc.) conditions time 
yield, α/β ratio 
of 2.3h 
1 2.4 (5 mM) DMTST, rt 2 h 50 min 89%, 1/9.5 
2 2.4 (5 mM) NIS/TfOH, rt 12 h 86%, 1/9.5 
3 2.5 (50 mM) DMTST, rt 7 h 73%, 1/5.0 
4 2.5 (50 mM) NIS/TfOH, rt 1h 10 min 97%, 1/8.8 
5 2.5 (5 mM) DMTST, rt 2 h 50 min 91%, 1/18.5 
6 2.5 (5 mM) NIS/TfOH, rt 12 h 96%, 1/7.2 
7 2.5 (5 mM) DMTST, -30 oC 5 h 87%, 1/17.6 
8 2.5 (1 mM) DMTST, rt 2 h 80%, 1/14.0 
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Following this, we decided to investigate whether these mannosyl donors 
would also be suitable for stereoselective couplings with the secondary glycosyl 
acceptors 3.6, 2.8, and 2.14. Concerning glycosyl donors of the ethyl thioglycoside 
series, the best results for glycosylation of primary glycosyl acceptor 2.2 were 
obtained with 2.1e, 2.1f, and 2.1h (see Table 2.1). Unfortunately, when applied to 
glycosylations of secondary acceptors 6 and 2.8,19 none of these donors performed up 
to our expectations (Table 2.3, entries 1-4). Although the corresponding disaccharides 
2.7 and 2.9-2.11 were obtained in respectable yields of 72-87%, stereoselectivity was 
much lower (α/β = 1/2.9-5.2, Table 2.3) in comparison to that achieved with the 
primary acceptor 2.2. 
In contrast, the glycosyl donor 2.1g, which was not very effective with the 
primary acceptor 2.2, showed respectable results in coupling reactions with the 
secondary glycosyl acceptors. Thus, coupling of the donor 2.1g with the 4-OH 
acceptor 2.6 afforded disaccharide 2.12 in good yields 71-83% and commendable β-
stereoselectivity (α/β ~ 1/10, entry 5). Similar results were obtained in glycosylations 
of the acceptors 2.8 and 2.14, which led to the formation of disaccharides 2.13 and 
2.15, respectively, in 71-88% yield with high stereoselectivity (α/β = 1/6-10, entries 6 
and 7). Similarly protected S-tolyl 2.16 and S-phenyl 2.17 donors provided 
disaccharide 2.12 with even higher yields (80-96%) albeit with lower stereoselectivity 
(α/β = 1/5.4-8, entries 8 and 9) in comparison to that obtained with their S-ethyl 
counterpart 2.1g. 
Having investigated the synthesis of both primary and secondary β-
mannosides, we felt well equipped to evaluate an oligosaccharide synthesis, to probe 
the protecting/leaving group combinations and conditions. For this purpose, we 
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obtained disaccharide 2.3h (91%, α/β = 1/18.5) using best conditions for  primary  
glycosyl  accep- 
Table 2.3.  Glycosylation of secondary glycosyl acceptors 2.6, 2.8, and 2.14 
 
entry donor acceptor promoter, time product 
yield, α/β 
ratio  
1 
 
2.1e 
 
2.6 
NIS/TfOH, 30 
min 
2.7  
80%, 1/2.9 
2 2.1e 
 
2.8 
NIS/TfOH, 30 
min 
2.9  
78%, 1/4.9 
3 
 
2.1f 
2.6 
DMTST, 2 h 
NIS/TfOH, 3 h 
2.10  
73%, 1/2.9 
87%, 1/2.9 
4 
 
2.1h 
2.6 
DMTST, 1.5 h 
NIS/TfOH, 1.5 h 
2.11  
86%, 1/5.2 
72%, 1/3.5 
5 
 
2.1g 
2.6 
DMTST, 40 min 
NIS/TfOH, 2 h 
2.12
 
71%, 1/10.0 
83%, 1/9.8 
6 2.1g 2.8 DMTST, 1.5 h 
2.13 
78%, 1/7.3 
7 2.1g 
 
2.14 
DMTST, 2 h 
NIS/TfOH, 2 h 
2.15 
71%, 1/6.0 
88%, 1/10 
8 
 
2.16 
2.6 
DMTST, 24 h 
NIS/TfOH, 2 hb 
2.12 
80%, 1/5.4 
96%, 1/8.0 
9 
 
2.17 
2.6 
DMTST, 2.5 h 
NIS/TfOH, 12 hc 
2.12 
86%, 1/5.5 
89%, 1/7.4 
a  Unless noted otherwise, performed under standard conditions: 5 mM concentration of donor, 1,2-dichloroethane 
(10 mL), rt; b  Performed at 50 mM concentration of donor, no reaction at 5 mM; c  Performed at 50 mM concentration 
of donor, lower stereoselectivity obtained at 5 mM
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tor 2.2: S-phenyl donor 2.5 activated with DMTST at rt. The β-linked disaccharide was 
separated and subjected to selective removal of 3’-O-picoloyl group, which was 
selectively affected in the presence of copper(II) acetate to give the 3’-OH derivative 2.18 
(Scheme 2.3). The latter was glycosylated with donor 2.1g, which was found the most 
suitable for glycosylation of secondary hydroxyls. This coupling was promoted in the 
presence of NIS and TfOH and resulted in the formation of trisaccharide 2.19 in 76% 
yield and, to our delight, with complete β-stereoselectivity (α/β > 1/25). 
 
Scheme 2.3.  The synthesis of trisaccharide 2.19 
 
 
 
2.3 Conclusions 
We have discovered that a remote 3-O-picoloyl group can effectively mediate β-
mannosylation reactions with high facial syn selectivity for attack of the glycosyl 
acceptor. The applicability of this approach was demonstrated for the synthesis of an 
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oligosaccharide containing both primary and secondary β-mannosidic linkages. Further 
application of this new stereoselective glycosylation reaction to other targets and systems 
is currently underway in our laboratory. 
 
2.4   Experimental 
2.4.1   General methods 
Column chromatography was performed on silica gel 60 (70-230 mesh), reactions were 
monitored by TLC on Kieselgel 60 F254. The compounds were detected by examination 
under UV light and by charring with 10% sulfuric acid in methanol. Solvents were 
removed under reduced pressure at <40 °C. CH2Cl2 and ClCH2CH2Cl (1,2-DCE) were 
distilled from CaH2 directly prior to application. Pyridine was dried by refluxing with 
CaH2 and then distilled and stored over molecular sieves (3 Å). Molecular sieves (3 Å or 
4 Å), used for reactions, were crushed and activated in vacuo at 390 °C during 8 h in the 
first instance and then for 2-3 h at 390 °C directly prior to application. Optical rotations 
were measured at ‘Jasco P-1020’ polarimeter. Unless noted otherwise, 1H n.m.r. spectra 
were recorded in CDCl3 at 300 MHz, 
13C n.m.r. spectra were recorded in CDCl3 at 75 or 
150 MHz. Two-dimensional heteronuclear J-resolved spectra (HETERO2D) were 
recorded in CDCl3 at 600 MHz. 
 
2.4.2   Synthesis of Glycosyl S-Et donors series 
Ethyl 2,3,4-tri-O-benzyl-6-O-picolinyl-1-thio-β-D-glucopyranoside (2.1a). The title 
compound was synthesized according to the reported procedure and its analytical data 
was essentially the same as reported previously.6 
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Ethyl 2,3,4-tri-O-benzyl-6-O-picoloyl-1-thio-α-D-mannopyranoside (2.1b). The title 
compound was synthesized according to the reported procedure and its analytical data 
was essentially the same as reported previously.6  
Ethyl 2,3,4,6-tetra-O-benzyl-1-thio-α-D-mannopyranoside (2.1c). The title compound 
was synthesized according to the reported procedure and its analytical data was 
essentially the same as reported previously.12 
 
Ethyl 6-O-benzoyl-2,3,4-tri-O-benzyl-1-thio-α-D-mannopyranoside (2.1d). The title 
compound was synthesized according to the reported procedure and its analytical data 
was essentially the same as reported previously.15  
 
Ethyl 2,4,6-tri-O-benzyl-3-O-picoloyl-1-thio-α-D-mannopyranoside (2.1e). Picolinic 
acid (136 mg, 1.11 mmol), N,N'-dicyclohexylcarbodiimide (DCC, 343 mg, 1.66 mmol), 
and 4-dimethylaminopyridine (DMAP, 2.0 mg, 0.17 mmol) were added to a solution of 
ethyl 2,4,6-tri-O-benzyl-1-thio-α-D-mannopyranoside16 (2.S1, 350 mg, 0.856 mmol) in 
CH2Cl2 (12 mL), and the resulting mixture was stirred under argon for 25 min at rt. The 
reaction mixture was diluted with CH2Cl2 (~50 mL), the solid was filtered off, and the 
filtrate was washed with cold water (10 mL), sat. aq. NaHCO3 (10 mL), and water (2 x 10 
mL). The organic phase was separated, dried with magnesium sulfate, and concentrated 
in vacuo. The residue was purified by column chromatography on silica gel (ethyl 
acetate-hexane gradient elution) to give the title compound as an amorphous powder in 
90% yield (462 mg, 0.277 mmol). Analytical data for 2.1e: Rf = 0.52 (ethyl 
acetate/hexane, 1/1, v/v); [α]D22 +66.9 (c = 1.0, CHCl3); 1H n.m.r. (300 MHz): δ, 1.33 (t, 
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3H, J = 7.4 Hz, SCH2CH3), 2.69 (q, 2H, SCH2CH3), 3.78 (dd, J5,6a = 10.9 Hz, H-6a), 3.93 
(dd, J5,6b = 10.9 Hz, H-6b), 4.17 (dd, 1H, J2,3
 = 1.8 Hz, H-2), 4.34-4.44 (m, 2H, H-4, 5), 
4.54-4.86 (m, 6H, 3 x CH2Ph), 5.51 (d, 1H, J1,2
 = 1.7 Hz, H-1), 5.54 (d, 1H, J2,3 = 3.3 Hz, 
H-3), 7.12-7.53 (m, 17H, aromatic), 7.82-8.05 (m, 1H, aromatic), 8.04 (d, 1H, J = 7.8 Hz, 
aromatic), 8.82-8.83 (m, 1H, aromatic) ppm; 13C n.m.r. (75 MHz): δ, 14.9, 25.2, 68.9, 
71.7, 72.3, 73.4, 73.5, 74.8, 75.6, 81.7, 125.2, 126.8, 127.5, 127.6, 127.7 (x2), 127.8 (x2), 
127.9 (x3), 128.0 (x2), 128.2 (x3), 128.3 (x2), 136.8, 137.7, 138.1, 138.2, 147.8, 150.0, 
164.2 ppm; HR-FAB MS [M+H]+ calcd for C35H37O6NS 600.2420, found 600.2428 
 
Ethyl 2-O-benzyl-4,6-O-benzylidene-3-O-picoloyl-1-thio-α-D-mannopyranoside 
(2.1g). Picolinic acid (168 mg, 1.36 mmol), DCC (0.31 g, 1.5 mmol), and DMAP (25 mg, 
0.2 mmol) were added to a solution of ethyl 2-O-benzyl-4,6-O-benzylidene-1-thio-α-D-
mannopyranoside17 (2.S2, 0.47 g, 1.0 mmol) in CH2Cl2 (15 mL) and the resulting mixture 
was stirred under argon for 40 min at rt. The reaction mixture was diluted with CH2Cl2 
(~100 mL) and the solid was filtered off. The filtrate was washed with cold water (10 
mL), sat. aq. NaHCO3 (10 mL), and water (2 x 10 mL). The organic phase was separated, 
dried with magnesium sulfate, and concentrated in vacuo. The residue was purified by 
column chromatography on silica gel (ethyl acetate-hexane gradient elution) to give the 
title compound as an amorphous powder in 90% yield (450 mg, 0.88 mmol). Analytical 
data for 2.1g: Rf = 0.55 (ethyl acetate/hexane, 1/1, v/v); [α]D23 +17.7 (c = 1.0, CHCl3); 1H 
n.m.r. (300 MHz): δ, 1.31 (t, 3H, J = 7.4 Hz, SCH2CH3), 2.66 (q, 2H, SCH2CH3), 3.96 (t, 
1H, J2,3 = 10.2 Hz, H-2), 4.22-4.32 (m, 2H, H-6a, 6b), 4.39-4.56 (m, 2H, H-4, 5), 4.70 
(dd, 2H, 2J  = 12.0 Hz, CH2Ph), 5.44 (s, 1H, H-1), 5.65 (dd, 1H J3,4 = 10.1 Hz, H-3), 5.65 
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(s, 1H, >CHPh), 7.18-7.47 (m, 11H, aromatic), 7.76-7.81 (m, 1H, aromatic), 8.08 (m, 1H, 
J = 7.7 Hz, aromatic), 8.79 (m, 1H, J = 4.2 Hz, aromatic) ppm; 13C n.m.r. (75 MHz): δ, 
14.9, 25.4, 53.6, 64.6, 68.6, 72.1, 73.1, 76.4, 83.0, 101.8, 125.5, 126.3 (x2), 127.0, 128.0, 
128.1 (x3) 128.2 (x3), 128.4 (x3), 129.0, 136.9, 137.3, 137.4 ppm; HR FAB MS [M+H+] 
calcd for C28H30NO6S 508.1763, found 508.1786. 
 
Ethyl 2,4-di-O-benzyl-3,6-di-O-picoloyl-1-thio-α-D-mannopyranoside (2.1f). 
Copper(II) trifluoromethanesulfate (8.0 mg, 0.02 mmol) was added to a solution of α-
2.1g (100 mg, 0.2 mmol) in 1M BH3-THF (1.0 mL) and the resulting mixture was stirred 
under argon for 2 h at rt. The reaction mixture was cooled to 0 ºC and quenched with 
triethylamine (0.5 mL) until pH = 7. MeOH (1.5 mL) was added dropwise and the 
volatiles were removed in vacuo. The residue was purified by column chromatography on 
silica gel (acetone-toluene gradient elution) to give ethyl 2,4-di-O-benzyl-3-O-picoloyl-1-
thio-α-D-mannopyranoside (2.S3) as white amorphous solid in 77% yield (78 mg, 0.15 
mmol). Analytical data for 2.S3: Rf = 0.54 (acetone/toluene, 1/9, v/v); [α]D22 +168.3 (c = 
1.0, CHCl3); 
1H n.m.r. (300 MHz): δ, 1.27 (t, 3H, J = 7.4 Hz, SCH2CH3), 2.58 (q, 2H, 
SCH2CH3), 3.56-3.70 (m, 4H, H-2, 4, 5, 6a), 3.81-3.86 (m, 2H, H-4, 6b), 4.50 (dd, 2H, 
2J 
= 11.7 Hz, CH2Ph), 4.62 (dd, 2H, 
2J = 11.2 Hz, CH2Ph), 5.23 (s, 1H, H-1), 7.28-7.40 (m, 
11H, aromatic), 7.81 (d, 1H, J = 7.9 Hz, aromatic), 7.93-7.95 (m, 1H, aromatic), 8.70 (d, 
1H, J = 5.5 Hz, aromatic) ppm; 13C n.m.r. (75 MHz): δ, 14.8, 25.1, 62.2, 71.6, 72.3, 72.5, 
74.9, 79.9, 81.2, 127.8, 127,9 (x4), 128.1 (x4), 128.2, 128.5 (x3), 128.7 (x4), 137.5, 138.9 
ppm; HR FAB MS [M+H+] calcd for C28H32NO6S 510.1950, found 510.1972.  
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Picolinic acid (60 mg, 0.494 mmol), 3-(ethyliminomethyleneamino)-N,N-
dimethylpropan-1-amine (EDC, 0.176 g, 0.6 mmol), and DMAP (9.2 mg, 0.076 mmol) 
were added to a solution of 2.S3 (0.13 g, 0.25 mmol) in CH2Cl2 (16 mL) and the resulting 
mixture was stirred under argon for 40 min at rt. The reaction mixture was diluted with 
CH2Cl2 (~50 mL) and was washed with cold water (5 mL), sat. aq. NaHCO3 (5 mL), and 
water (5 mL). The organic phase was separated, dried with magnesium sulfate, and 
concentrated in vacuo. The residue was purified by column chromatography on silica gel 
(ethyl acetate-hexane gradient elution) to give the title compound white amorphous solid 
in 85% yield (0.135 g, 0.22 mmol). Analytical data for 2.1g: Rf = 0.25 (ethyl 
acetate/hexane, 1/1, v/v); [α]D23 +38.4 (c = 1.0, CHCl3); 1H n.m.r. (300 MHz): δ, 1.24 (t, 
3H, J = 7.4 Hz, SCH2CH3), 2.64 (q, 2H, SCH2CH3), 4.17 (dd, 1H, J2,3 = 3.1 Hz, H-2), 
4.38 (t, 1H, J3,4 = 9.2 Hz, H-4), 4.53-4.47 (m, 1H, H-5), 4.56-4.89 (m, 3H, H-6a, 6b, 
1/2 
CH2Ph), 4.87 (d, 1H, J  = 11 Hz, 
1/2 CH2Ph), 5.44 (d, 1H, J1,2 = 5.4 Hz, H-1), 5.54 (dd, 
1H, J3,4 = 9.2 Hz, H-3), 7.10-8.06 (m, 16H, aromatic), 8.75-8.79 (m, 2H, aromatic)  ppm; 
13C n.m.r. (75 MHz): δ, 14.9, 25.2, 64.3, 70.0, 72.3, 73.1, 74.8, 75.8, 81.7, 125.2, 125.3, 
126.8, 127.0, 127.72 127.75 (x2), 127.8 (x2), 128.1 (x2), 128.2 (x2), 128.3 (x2), 136.8, 
136.9, 137.6, 137.7, 147.7, 147.8, 150, 150.1, 164.3, 164.6 ppm; HR FAB MS [M+H+] 
calcd for C34H35N2O7S 615.2165, found 615.2164. 
 
Ethyl 4,6-di-O-benzoyl-2-O-benzyl-3-O-picoloyl-1-thio-α-D-mannopyranoside (2.1h). 
Water (400 μL) and trifluoroacetic acid (TFA)/CH2Cl2 (1.8 mL, 1/9, v/v) were added to a 
stirring mixture of 2.1g (1.8 g, 3.5 mmol) in CH2Cl2 (40 mL) and the resulting mixture 
was stirred for 1 h at rt. After that, the reaction mixture was neutralized with Et3N (~4 
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mL), and diluted with CH2Cl2 (~200 mL) and washed with cold water (20 mL), sat. aq. 
NaHCO3 (20 mL), and cold water (3 x 20 mL). The organic phase was separated, dried 
with magnesium sulfate, and concentrated in vacuo. The residue was purified by column 
chromatography on silica gel (methanol-CH2Cl2 gradient elution) to afford ethyl 2-O-
benzyl-3-O-picoloyl-1-thio-α-D-mannopyranoside (2.S4) as a white amorphous solid in 
87% yield (1.29 g, 3.18 mmol). Analytical data for 2.S4: Rf = 0.47 (methanol/CH2Cl2, 
D
22 +148.9 (c = 1.0, CHCl3); 
1H n.m.r. (300 MHz): δ, 1.28 (t, 3H, J = 7.4 
Hz, SCH2CH3), 2.63 (q, 2H, SCH2CH3), 2.90 (t, 1H, J = 12.4 Hz, OH), 3.93-3.96 (m, 2H, 
H-6a, 6b), 4.09-4.18 (m, 3H, H-2, 5, OH), 4.42-4.50 (m, 1H, H-4), 4.60 (dd, 2H, 2J  = 
12.4 Hz, CH2Ph), 5.27 (dd, 1H, J3,4 = 10.0 Hz, H-3), 5.39 (s, 1H, H-1), 7.08-7.82 (m, 7H, 
aromatic), 7.99 (d, 1H, J = 7.9 Hz, aromatic), 8.75 (m, 1H, aromatic) ppm; 13C n.m.r. (75 
MHz): δ, 14.9, 25.4, 62.7, 66.3, 72.7, 72.8, 82.1, 125.5, 125.7, 127.3, 127.9, 128.2 (x2), 
128.4 (x2), 129.2, 137.2, 137.8, 147.7, 149.9, 164.9 ppm; HR FAB MS [M+H+] calcd for 
C21H26NO6S 420.1481, found 420.1475. 
Benzoyl chloride (0.41 mL, 4.8 mmol) and DMAP (14 mg, 0.12 mmol) were added to a 
solution of 2.S4 (0.50 g, 1.2 mmol) in anhydrous pyridine (5.0 mL) and the resulting 
mixture was stirred under argon for 15 min at 0 °C. After that, the reaction mixture was 
allowed to warm to rt and stirred for 12 h. The reaction mixture was then cooled to 0 ˚C, 
quenched with MeOH (~0.5 mL), and concentrated in vacuo. The residue was diluted 
with CH2Cl2 (~50 mL) and washed with H2O (10 mL), sat. aq. NaHCO3 (2 x 10 mL), and 
H2O (2 x 10 mL). The organic phase was separated, dried over MgSO4, and concentrated 
in vacuo. The residue was purified by column chromatography on silica gel (acetone-
toluene gradient elution) to afford the title compound white amorphous solid in 93% 
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yield (0.70 g, 1.11 mmol). Analytical data for 2.1h: Rf = 0.76 (acetone-toluene, 2/3, v/v); 
[α]D22 +97.4 (c = 1.0, CHCl3); 1H n.m.r. (300 MHz): δ, 1.29 (t, 3H, J = 7.4 Hz, 
SCH2CH3), 2.67 (q, 2H, SCH2CH3), 4.29 (dd, 1H, J2,3 = 1.7 Hz, H-2), 4.55-4.73 (m, 4H, 
H-6a, 6b, CH2Ph), 4.81 (m, 1H, H-5), 5.58 (s, 1H, H-1), 5.82 (dd, 1H, J3,4 = 10.0 Hz, H-
3), 6.21 (t, 1H, J3,4 = 10.0 Hz, H- 4), 7.13-7.48 (m, 12H, aromatic), 7.55-7.62 (m, 1H, 
aromatic), 797-8.09 (m, 5H, aromatic), 8.64 (d, 1H, aromatic) ppm; 13C n.m.r. (75 MHz): 
δ, 51.6, 63.0, 67.3, 68.8, 72.2, 72.6, 81.6, 124.9, 127.3, 127.4, 127.8 (x2), 127.9 (x3), 
128.1 (x2), 128.6 (x2), 128.7, 129.1, 129.3, 129.4, 129.5, 132.5, 132.6, 133.0, 136.6, 
137.2, 137.3, 146.7, 149.7, 163.5, 165.1, 165.7 ppm; HR FAB MS [M+H+] calcd for 
C35H34NO8S 628.2005, found 628.2008. 
 
2.4.3   Synthesis of Glycosyl S-Tolyl donor series  
p-Tolyl 2-O-benzyl-4,6-O-benzylidene-3-O-picoloyl-1-thio-α-D-mannopyranoside 
(2.16). Picolinic acid (470 mg, 3,84 mmol), DCC (0.91 mg, 4.42 mmol), and DMAP (72 
mg, 0.59 mmol) were added to a solution of p-tolyl 2-O-benzyl-4,6-O-benzylidene-1-
thio-α-D-mannopyranoside18 (2.S5, 1.4 g, 2.95 mmol) in CH2Cl2 (45 mL) and the 
resulting mixture was stirred under argon for 40 min at rt. The reaction mixture was 
diluted with CH2Cl2 (~200 mL) and the solid was filtered off. The filtrate was washed 
with cold water (15 mL), sat. aq. NaHCO3 (15 mL), and water (2 x 15 mL), dried with 
magnesium sulfate, and concentrated in vacuo. The residue was purified by column 
chromatography on silica gel (ethyl acetate-hexane gradient elution) to give the title 
compound as white amorphous solid in 93% yield (1.55 g, 2.72 mmol). Analytical data 
for 2.16: Rf = 0.46 (ethyl acetate/hexane, 2/3, v/v); [α]D23 +93.3 (c = 1.0, CHCl3); 1H 
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n.m.r. (300 MHz): δ, 2.39 (s, 3H, CH3), 3.94 (m, 1H, J5,6a = 9.5 Hz, H-6a), 4.30 (m, 1H, 
J5,6b = 4.1 Hz, H-6b), 4.77 (dd, 1H, J1,2 = 1.3 Hz, H-2), 4.50-4.61 (m, 3H, H-4, 5, 
1/2 
CH2Ph), 4.72 (d, 1H, 
2J = 12.1 Hz, 1/2 CH2Ph), 5.55 (d, 1H, J1,2 = 1.3 Hz, H-1), 5.64-5.69 
(m, 2H, >CHPh, H-3), 7.14-7.27 (m, 5H, aromatic), 7.28-7.50 (m, 11H, aromatic), 7.82-
7.87 (m, 1H, aromatic), 8.10-8.13 (m, 1H, aromatic), 8.82-8.84 (m, 1H, aromatic) ppm; 
13C n.m.r. (75 MHz): δ, 21.2, 65.4, 68.5, 71.8, 72.9, 76.1, 86.77, 101.8, 125.5, 126.2 (x2), 
126.9, 127.8, 128.1 (x2), 128.2 (x2), 128.3 (x2), 128.9, 129.6, 130.0 (x2), 132.5 (x2) 
136.8, 137.1 (x2), 137.2, 138.1, 147.7, 150.0, 164.3 ppm; HR FAB MS [M+H+] calcd for 
C33H32NO6S 570.1950, found 570.1957.  
 
p-Tolyl 4,6-O-benzoyl-2-O-benzyl-3-O-picoloyl-1-thio-α-D-mannopyranoside (2.4). 
Water (100 μL) and TFA/CH2Cl2 (1/9, v/v, 0.8 mL) were added to a mixture of 2.16 (0.5 
g, 0.87 mmol) in CH2Cl2 (11 mL) and the resulting mixture was stirred for 1 h at rt. After 
that, the reaction mixture was neutralized with Et3N (~1 mL), diluted with CH2Cl2 (50 
mL) and washed with cold water (5 mL), sat. aq. NaHCO3 (5 mL), and cold water (2 x 5 
mL).  The organic phase was separated, dried with magnesium sulfate, and concentrated 
in vacuo. The residue was purified by column chromatography on silica gel (methanol-
CH2Cl2 gradient elution) to afford p-tolyl 2-O-benzyl-3-O-picoloyl-1-thio-α-D-
mannopyranoside (2.S6) as a white amorphous solid in 93% yield (0.39 g, 0.81 mmol). 
Analytical data for 2.S6: Rf = 0.37 (methanol/CH2Cl2, 1/9, v/v); [α]D23 +47.5 (c = 1.0, 
CHCl3); 
1H n.m.r. (300 MHz): δ, 2.25 (s, 3H, CH3), 3.00 (m, 1H, OH), 3.33 (m, 1H, OH), 
3.75-3.95 (m, 2H, H-6a, 6b), 4.18-4.55 (m, 5H, H-2, 4, 5, CH2Ph), 5.17 (dd, 1H, J3,4 = 9.9 
Hz, H-3), 5.43 (s, 1H, H-1), 6.09-7.39 (m, 10H, aromatic), 7.70 (m, 1H, J = 7.7 Hz, 
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aromatic), 7.92 (d, 1H, J = 7.7 Hz, aromatic), 8.62 (d, 1H, J = 3.8 Hz aromatic), ppm; 13C 
n.m.r. (75 MHz): δ, 21.2, 62.3, 65.4, 72.3, 73.5, 76.3, 86.0, 125.6, 127.3, 127.7, 128.0 
(x3) 128.2 (x3), 130.1, 132.5 (x3), 137.3, 137.4, 137.9, 147.4, 149.4, 164.4 ppm; HR 
FAB MS [M+H+] calcd for C26H28NO6S 482.1623, found 482.1636. 
Benzoyl chloride (0.20 mL, 2.43 mmol) and DMAP (10 mg, 0.081 mmol) were added to 
a solution of 2.S6 (0.39 g, 0.81 mmol) in anhydrous pyridine (5.0 mL) and the resulting 
mixture was stirred under argon for 15 min at 0 °C. After that, the reaction mixture was 
allowed to warm to rt and stirred for 12 h. The reaction mixture was then cooled to 0 ˚C, 
quenched with dry MeOH (0.5 mL), and concentrated in vacuo. The residue was diluted 
with CH2Cl2 (~50 mL) and washed successively with H2O (10 mL), sat. aq. NaHCO3 (2 x 
10 mL), H2O (2 x 10 mL), dried over MgSO4, and concentrated in vacuo. The residue 
was purified by column chromatography on silica gel (acetone-toluene gradient elution) 
to afford the title compound as a white amorphous solid in 87% yield (0.53 g, 0.77 
mmol). Analytical data for 2.4: Rf = 0.77 (acetone-toluene, 2/3, v/v); [α]D23 +97.3 (c = 
1.0, CHCl3); 
1H n.m.r. (300 MHz): δ, 2.32 (s, 3H, SPhCH3), 4.40-4.41 (m, 1H, H-4), 
4.51-4.64 (m, 3H, H-6a, 6b, 
1/2 CH2Ph), 4.75 (d, 1H, 
2J= 12.1 Hz, 1/2 CH2Ph), 4.91 (m, 
1H, H-5), 5.68 (d, 1H, J1,2 = 1.3 Hz, H-1), 5.76 (dd, 1H, J3,4 = 10 Hz, H-3), 6.09 (t, 1H, 
J4,3 = 10 Hz, H-4), 7.04 (d, 2H, J = 7.9 Hz, aromatic), 7.15-7.59 (m, 12H, aromatic), 
7.75-7.78 (m, 2H, aromatic), 7.99-8.08 (m, 7H, aromatic), 8.76 (d, 1H, J = 3.9 Hz, 
aromatic) ppm; 13C n.m.r. (75 MHz): δ, 21.2, 63.6, 67.5, 69.7, 72.6, 72.8, 85.7, 125.5, 
127.1, 127.8 (x2), 127.9 (x2), 128.3 (x2), 128.4 (x2), 129.0, 129.4, 129.6, 129.8 (x2), 
129.9 (x2), 130.0 (x2), 120.1, 132.3 (x2), 132.9, 133.9, 133.4, 137.1, 137.3, 138.1, 147.0, 
Salvatore G. Pistorio| UMSL 2016 | Page  59 
 
150.2, 163.7, 165.5, 166.3 ppm; HR FAB MS [M+H+] calcd for C40H36NO8S 690.2162, 
found 690.2169. 
2.4.4   Synthesis of Glycosyl S-Phenyl donor series  
 
Phenyl 2-O-benzyl-4,6-O-benzylidene-3-O-picoloyl-1-thio-α-D-mannopyranoside 
(2.17). Picolinic acid (168 mg, 1.36 mmol), DCC (0.31 g, 1.5 mmol), and DMAP (25 mg, 
0.20 mmol) were added to a solution of phenyl 2-O-benzyl-4,6-O-benzylidene-1-thio-α-
D-mannopyranoside19 (2.S7, 0.47 g, 1.0 mmol) in CH2Cl2 (15 mL) and the resulting 
mixture was stirred under argon for 40 min at rt. The reaction mixture was diluted with 
CH2Cl2 (~100 mL) and the solid was filtered off. The filtrate was washed with cold water 
(10 mL), sat. aq. NaHCO3 (10 mL), and water (2 x 10 mL). The organic phase was 
separated, dried with magnesium sulfate, and concentrated in vacuo. The residue was 
purified by column chromatography on silica gel (ethyl acetate-hexane gradient elution) 
to give the title compound a white amorphous solid in 89% yield (0.50 g, 0.88 mmol). 
Analytical data for 2.17: Rf = 0.54 (ethyl acetate/hexane, 2/3, v/v); [α]D22 +66.3 (c = 1.0, 
CHCl3); 
1H n.m.r. (300 MHz): δ, 3.95 (m, 1H, J5,6a = 9.9 Hz, H-6a), 4.30 (dd, 1H, J5,6b = 
4.4 Hz, H-6b), 4.38 (dd, 1H, J2,3 = 3.4 Hz, H-2), 4.49-4.62 (m, 3H, H-4, 5, 
1/2 CH2Ph), 
4.73 (d, 1H, 2J = 12.0 Hz, 1/2 CH2Ph), 5.62 (d, 1H, J1,2 = 1.3 Hz, H-1), 5.66 (m, 2H, H-3, 
>CHPh), 7.14-7.53 (m, 16H, aromatic), 7.84-7.85 (m, 1H, aromatic), 8.10-8.13 (m, 1H, 
aromatic), 8.82-8.84 (m, 1H, aromatic) ppm; 13C n.m.r. (75 MHz): δ, 65.5, 68.5, 71.8, 
73.1, 76.2, 77.3, 86.5, 101.8, 125.5, 126.3 (x2), 126.9, 127.8, 127.9, 128.1 (x2), 128.2 
(x2), 128.3 (x2), 129.9, 129.2 (x2), 131.8 (x2), 133.5, 136.8, 127.1, 137.2, 147.7, 150.0, 
164.3 ppm; HR FAB MS [M+H+] calcd for C32H30NO6S 556.1794, found 556.1782. 
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Phenyl 4,6-di-O-benzoyl-2-O-benzyl-3-O-picoloyl-1-thio-α-D-mannopyranoside 
(2.5). Water (100 μL) and TFA/CH2Cl2 (1.0 mL, 1/9, v/v) were added to a mixture of 
2.17 (0.48 g, 0.84 mmol) in CH2Cl2 (10 mL) and the resulting mixture was stirred for 1 h 
at rt. After that, the reaction mixture was neutralized with Et3N (~1 mL), diluted with 
CH2Cl2 (~50 mL) and washed with cold water (5 mL), sat. aq. NaHCO3 (5 mL), and cold 
water (2 x 5 mL). The organic phase was separated, dried with magnesium sulfate, and 
concentrated in vacuo. The residue was purified by column chromatography on silica gel 
(methanol-CH2Cl2 gradient elution) to afford phenyl 2-O-benzyl-3-O-picoloyl-1-thio-α-
D-mannopyranoside (2.S8) as a white amorphous solid in 94% yield (0.31 g, 0.82 mmol). 
Analytical data for 2.S8: Rf = 0.37 (methanol/CH2Cl2, 1/9, v/v); [α]D22 +22.3 (c = 1.0, 
CHCl3); 
1H n.m.r. (300 MHz): δ, 2.99 (s, 1H, OH), 3.95-3.99 (m, 2H, H-6a, 6b), 4.28-
4.34 (m, 2H, H-2, 5), 4.47-4.69 (m, 4H, H-4, OH, CH2Ph), 5.30 (dd, 1H, J3,4 = 9.7 Hz, H-
3), 5.61 (d, 1H, J1,2 = 1.3 Hz, H-1), 7.06-7.53 (m, 11H, aromatic), 7.84-7.87 (m, 1H, 
aromatic), 8.03-8.05 (m, 1H, aromatic), 8.75 (d, 1H, aromatic) ppm; 13C n.m.r. (75 MHz): 
δ, 62.3, 65.7, 72.4, 73.5, 76.4, 76.5, 85.7, 125.5, 127.2, 127.7, 127.8, 128.0 (x2), 128.2 
(x2), 129.1 (x2), 131.9 (x2), 133.8, 137.2, 137.4, 147.4, 149.5, 164.6 ppm; HR FAB MS 
[M+H+] calcd for C25H26NO6S 468.1481, found 468.1476. 
Benzoyl chloride (0.43 mL, 4.95 mmol) and DMAP (26 mg, 0.22 mmol) were added to a 
solution of 2.S8 (0.41 g, 1.10 mmol) in anhydrous pyridine (5.0 mL) and the resulting 
mixture was stirred for 15 min at 0 oC. The reaction mixture was allowed to warm to rt 
and stirred for 24 h. After that, the reaction mixture was cooled to 0 ˚C, quenched with 
dry MeOH (0.5 mL), and concentrated in vacuo. The residue was diluted with CH2Cl2 
(~50 mL) and washed with H2O (5 mL), saturated aq. NaHCO3 (2 x 5 mL), and H2O (2 x 
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5 mL). The organic phase was separated, dried over MgSO4, and concentrated in vacuo. 
The residue was purified by column chromatography on silica gel (acetone-toluene 
gradient elution) to afford the title compound as white amorphous solid in 92% yield 
(0.68 g, 1.00 mmol). Analytical data for 2.5: Rf = 0.6 (acetone/toluene, 2/3, v/v); [α]D23 
+47.6 (c = 1.0, CHCl3); 
1H n.m.r. (300 MHz): δ, 4.42 (m, 1H, H-2), 4.55-4.65 (m, 3H, H-
6a, 6b, 1/2 CH2Ph), 4.77 (d, 1H, 
2J= 12.0 Hz, 1/2 CH2Ph), 4.90 (m, 1H, H-5), 5.72-5.76 (m, 
2H, H-1, 3), 6.09 (dd, 1H, J4,5 = 10.1 Hz, H-4), 7.18-7.56 (m, 16H, aromatic), 7.75-7.79 
(m, 1H, aromatic), 8.08-8.11 (m, 1H, aromatic), 8.08-8.11 (m, 1H, aromatic) 8.75 (d, 1H, 
aromatic) ppm; 13C n.m.r. (75 MHz): δ, 52.0, 63.5, 67.5, 69.8, 72.7, 72.8, 85.4, 125.5, 
127.1, 127.7, 127.8 (x2), 127.9 (x2), 128.3 (x2), 128.4 (x2), 128.5, 129.0, 129.2 (x2), 
129.6, 129.7, 129.8, 130.1, 131.6 (x2), 132.9, 133.0, 133.3, 133.4, 137.1, 137.2, 147.0, 
150.2, 163.7, 165.5, 166.2 ppm; HR-FAB MS [M+H+] calcd for C39H34NO8S 676.2005, 
found 676.2009.  
 
2.4.5 Synthesis of Disaccharides  
Metod A. A general procedure for glycosylation in the presence of DMTST.  A 
mixture of a glycosyl donor (0.50 mmol), glycosyl acceptor (0.45 mmol), and freshly 
activated molecular sieves (4 Å, 200 mg) in (ClCH2)2 (1.0 mL or 10 mL) was stirred 
under argon for 1 h at rt. DMTST7 (0.10 mmol) was added and the resulting mixture was 
stirred at rt for the time specified in Tables 1-3 of the manuscript. Alternative procedure 
involved stirring at -30 ºC as indicated in Tables. Upon completion, the solid was filtered 
off, and the residue was washed sucessively with CH2Cl2. The combined filtrate (~30-40 
mL) was washed with 20% aq. NaHCO3 (10 mL) and water (3 x 10 mL). The organic 
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phase was separated, dried with magnesium sulfate, and concentrated in vacuo. The 
residue was purified by column chromatography on silica gel (ethyl acetate-hexane 
gradient elution). Anomeric ratios (or anomeric purity) were determined by comparison 
of the integral intensities of relevant signals in 1H n.m.r. spectra.  
 
Metod B. A general procedure for glycosylation in the presence of NIS/TfOH.  A 
mixture of a glycosyl donor (0.50 mmol), glycosyl acceptor (0.45 mmol), and freshly 
activated molecular sieves (4 Å, 200 mg) in (ClCH2)2 (1.0 mL or 10 mL) was stirred 
under argon for 1 h at rt. NIS (0.10 mmol) and TfOH (0.02 mmol) were added and the 
resulting mixture stirred at rt for the time specified in Tables 1-3 of the manuscript. 
Alternative procedure involved stirring at -30 ºC as indicated in Tables. Upon 
completion, the solid was filtered off, and the residue was washed sucessively with 
CH2Cl2. The combined filtrate (~30-40 mL) was washed with Na2SO4 (10 mL) and water 
(3 x 10 mL). The organic phase was separated, dried with magnesium sulfate, and 
concentrated in vacuo. The residue was purified by column chromatography on silica gel 
(ethyl acetate - hexane gradient elution). Anomeric ratios (or anomeric purity) were 
determined by comparison of the integral intensities of relevant signals in 1H n.m.r. 
spectra.  
 
Methyl 2,3,4-tri-O-benzyl-6-O-(2,3,4,6-tetra-O-benzyl-D-mannopyranosyl)-α-D-
glucopyranoside (2.3c). The title compound was obtained by Method A or B from donor 
2.1c and acceptor 2.2 as a clear syrup in 65% (α/β = 1/1.4, 5.0 mM) or 67% yield (α/β = 
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1/1, 5.0 mM), respectively. Analytical data for 2.3c was in accordance with that reported 
previously.14  
Methyl 6-O-(6-O-benzoyl-2,3,4-tri-O-benzyl-α/β-D-mannopyranosyl)-2,3,4-tri-O-
benzyl-α-D-glucopyranoside (2.3d). The title compound was obtained by Method A or 
B from donor 2.1d and acceptor 2.2 as a clear syrup in 68% (α/β = 1/1, 5.0 mM) or 70% 
yield (α/β = 1/1, 5.0 mM), respectively. Analytical data for α-2.3d: Rf = 0.66 (ethyl 
acetate/hexane, 1/1, v/v); [α]D23 +20.8 (c = 1.0, CHCl3); 1H n.m.r. (300 MHz): δ, 3.33 (s, 
3H, OCH3), 3.35-3.57 (m, 3H, H-2, 4, 6a), 3.65-3.88 (m, 2H, H-5, 5’), 3.99-4.07 (m, 2H, 
H-2’, 3), 4.15 (m, 1H, H-6b), 4.25 (dd, 1H, J4’,5’ = 9.5, H-4’), 4.39 (s, 1H, H-1’), 4.53-
4.77 (m, 14H, H-1, 6a’, 6b’, 51/2 CH2Ph ), 5.03 (d, 1H, 2J = 10.9 Hz, 1/2 CH2Ph), 5.16 (dd, 
1H, J3’,4’ = 9.5 Hz, H-3’), 7.06-8.05 (m, 33H, aromatic), 8.72-8.84 (m, 2H, aromatic) 
ppm; 13C n.m.r. (150 MHz): δ, 55.5, 63.5, 67.4, 68.5, 69.7, 72.1, 73.7, 73.8, 74.8, 75.0, 
75.2, 76.1, 77.7, 79.1, 80.1, 98.6, 100.5 (1JC1,H1 = 175.2 Hz, 
1JC1’,H1’ = 168.7 Hz) 128.1, 
129.7, 129.8, 130.0, 130.2 (x2), 130.4 (x2), 130.5, 130.6 (x2), 130.7 (x2), 130.8 (x2), 
130.84 (x2), 130.87 (x2), 131.0 (x4), 131.84 (x2), 131.8, 132.3 (x2), 132.3 (x2), 132.4 
(x2), 135.4, 135.9, 139.8, 140.3, 140.8, 140.9, 141.9, 149.5, 152.8, 166.2, 167.9, 168.7 
ppm; HR FAB MS [M+Na+] calcd for C62H64NaO12 1023.4295, found 1023.4291. 
 
Methyl 2,3,4-tri-O-benzyl-6-O-(2,4,6-tri-O-benzyl-3-O-picoloyl-α/β-D-
mannopyranosyl)-α-D-glucopyranoside (2.3e). The title compound was obtained by 
Method A or B from donor 2.1e and acceptor 2.2 as a clear syrup in 92% (α/β = 1/7, 5.0 
mM) or 89% yield (α/β = 1/8, 5.0 mM), respectively. Analytical data for β-2.3e: Rf = 0.39 
(ethyl acetate/hexane, 1/1, v/v); [α]D20  -24.1 (c = 1.0, CHCl3); 1H n.m.r. (300 MHz): δ, 
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3.32 (s, 3H, OCH3), 3.35-3.50 (m, 4H, H-2, 4, 5, 5’), 3.76-3.74 (m, 3H, H-3, 6a’, 6b’), 
3.94 (d, 1H, J2,3 = 4.0 Hz, H-2), 3.97-4.15 (m, 3H, H-4’, 6a, 6b), 4.25 (s, 1H, H-1’), 4.51-
4.61 (m, 6H, 3 x CH2Ph), 4.64-4.74 (m, 2H, H-1, 
1/2 CH2Ph), 4.78-4.87 (m, 3H, 1
1/2 x 
CH2Ph), 4.99 (d, 1H, 
2J = 10.9 Hz, 1/2 CH2Ph), 5.05 (dd, 1H, J3’,4’ = 9.8 Hz, H-3’), 6.97-
7.37 (m, 30H, aromatic), 7.44-7.49 (m, 1H, aromatic), 7.77 (m, 1H, J = 1.6 Hz, aromatic), 
7.93 (d, 1H, J = 7.8 Hz, aromatic), 8.78 (m, 1H, aromatic) ppm; 
13C n.m.r. (150 MHz): δ, 
55.2, 68.6, 69.6, 70.1, 73.4, 73.5, 73.7, 74.5, 74.8, 75.0, 75.1, 75.9, 75.9, 77.4, 80.0, 82.4, 
82.4, 97.9, 101.3 (1JC1,H1 = 161.7 Hz, 
1JC1’,H1’ = 155.6=5 Hz), 125.4, 127.1, 127.6, 127.7, 
127.8 128.0 (x2) 128.1 (x2), 128.1 (x2), 128.2 (x2), 128.2 (x2), 128.3 (x3), 128.4 (x2), 
128.5 (x4), 128.5 (x2), 128.6 (x2), 128.7 (x2), 137.0, 138.1, 138.2, 138.3, 138.4, 138.5, 
138.9, 147.8, 150.2 (x2), 164.2 ppm; HR FAB MS [M+Na+] calcd for C61H63NNaO12 
1024.4242, found 1024.4342. 
 
Methyl 2,3,4-tri-O-benzyl-6-O-(2,4-di-O-benzyl-3,6-di-O-picoloyl-α/β-D-
mannopyranosyl)-α-D-glucopyranoside (2.3f). The title compound was obtained by 
Method A or B from donor 2.1f and acceptor 2.2 as a clear syrup in 72% (α/β = 1/10, 5.0 
mM) or 86% yield (α/β = 1/8.7, 5.0 mM), respectively. Analytical data for 2.3f Rf  = 0.3 
(acetone/toluene, 1/4, v/v); [α]D20 -1.76 (c = 1.0, CHCl3); 1H n.m.r. (300 MHz): δ, 3.28 
(s, 3H, OCH3), 3.37-3.49 (m, 3H, H-2, 4, 6a), 3.65-3.82 (m, 2H, H-5, 5’), 3.94-4.00 (m, 
2H, H-2’, 3), 4.09-4.12 (m, 1H, H-6b), 4.20 (dd, 1H, J4’,5’ = 9.5 Hz, H-4’), 4.34 (s, 1H, H-
1’), 4.48-4.86 (m, 12H, H-1, 6a’, 6b’, 41/2 CH2Ph ), 4.98 (d, 1H, 2J = 10.9 Hz, 1/2 CH2Ph), 
5.11 (dd, 1H, J2’,3’ = 3.1 Hz, H-3’), 7.12-7.50 (m, 27H, aromatic), 7.46-7.50 (m, 1H, 
aromatic), 7.77-7.82 (m, 1H, aromatic), 7.97-8.00 (m, 1H, aromatic), 8.71-8.80 (m, 2H, 
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aromatic) ppm; 13C n.m.r. (150 MHz): δ 55.1, 64.9, 68.5, 69.9, 73.3, 7.38, 73.4, 74.3, 
74.7, 74.9, 75.0, 75.8, 77.2, 77.6, 79.9, 82.2, 97.8, 101.2 (1JC1,H1 = 171.6 Hz, 
1JC1’,H1’ = 
155.6 Hz), 125.3, 125.4, 126.8, 127.1, 127.5, 127.7, 127.8, 128.0 (x2), 128.1 (x7), 128.2 
(x4), 128.4 (x4), 128.5 (x4), 128.6, 136.9, 137.0, 137.6, 138.1 (x2), 138.2, 138.8, 147.6, 
147.9, 150.0, 150.1, 164.7, 164.7 ppm; HR FAB MS [M+Na+] calcd for C60H60N2NaO13 
1039.3993, found 1039.3943. 
 
Methyl 2,3,4-tri-O-benzyl-6-O-(2-O-benzyl-4,6-benzylidene-3-O-picoloyl-α/β-D-
mannopyranosyl)- α-D-glucopyranoside (2.3g). The title compound was obtained by 
Method A or B from donor 2.1g and acceptor 2.2 as a clear syrup in 73% (α/β = 1/5.7, 5 
mM) or 73% yield (α/β = 1/6.5, 5 mM) respectively. Analytical data for 2.3g: Rf  = 0.45 
(ethyl acetate/hexane, 1/1, v/v); [α]D24 -7.3 (c = 1.0, CHCl3); 1H n.m.r. (300 MHz): δ, 
3.32 (s, 3H, OCH3), 3.39-3.51 (m, 4H, H-2, 4, 5’, 6a), 3.75 (m, 1H, H-5), 3.88-4.11 (m, 
4H, H-2’, 3, 6a’, 6b), 4.25-4.29 (m, 2H, H-1’, 6b’), 4.33 (dd, 1H, J4’,5’ = 9.5 Hz, H-4’), 
4.52-4.65 (m, 4H, H-1, 11/2 CH2Ph), 4.75-4.86 (m, 4H, 2 x CH2Ph), 5.00 (d, 1H, 
2J = 10.9 
Hz, 1/2 CH2Ph), 5.15 (dd, 1H, J2’,3’ = 3.2 Hz, H-3’), 5.54 (s, 1H, >CHPh), 7.04-7.07 (m, 
3H, aromatic), 7.19-7.47 (m, 18H, aromatic), 7.77 (m, 1H, aromatic), 7.80-8.02 (m, 1H, 
aromatic), 8.78-8.79 (m, 1H, aromatic) ppm; 13C n.m.r. (150 MHz): δ, 55.3, 64.4, 67.5, 
68.5, 69.1, 69.8, 72.6, 73.0, 73.5, 73.7, 74.9, 75.0, 75.6, 75.6, 75.9, 77.9, 80.0, 82.1, 97.8, 
101.6 (1JC1,H1 = 168.1 Hz, 
1JC1’,H1’ = 157.3 Hz), 102.1, 125.6, 126.2, 127.3, 127.9 (x2), 
128.1 (x2), 128.2, 128.3 (x2), 128.4 (x2), 128.6 (x3), 128.8 (x2), 129.8, 130.1, 133.0, 
133.1, 136.9, 137.1, 137.8, 138.1, 138.2, 138.3, 138.8, 147.6, 150.1, 164.0, 165.7, 166.2 
ppm; HR FAB MS [M+H+] calcd for C54H56NO12 910.3803, found 910.3790. 
Salvatore G. Pistorio| UMSL 2016 | Page  66 
 
 
Methyl 6-O-(4,6-di-O-benzoyl-2-O-benzyl-3-O-picoloyl-α/β-D-mannopyranosyl)-
2,3,4-tri-O-benzyl-α-D-glucopyranoside (2.3h). The title compound was obtained by 
Method A or B from donor 2.1h, 2.4 or 2.5 and acceptor 2.2 as a clear syrup in 86% (α/β 
= 1/12.1, 5 mM), 89% (α/β = 1/9.5, 5 mM), 91% (α/β = 1/18.5, 5 mM), 72% (α/β = 1/7.2, 
5 mM), 86% (α/β = 1/7.2, 5 mM), or 96% (α/β = 1/7.2, 5 mM). Additional experiments 
have been done using the donor 2.5 and acceptor 2.2 as shown in Table 3.2. Analytical 
data for 2.3h: Rf  = 0.5 (ethyl acetate/hexane, 1/1, v/v); [α]D20 -18.8 (c = 1.0, CHCl3); 1H 
n.m.r. (300 MHz): δ, 3.29 (s, 3H, OCH3), 3.36-3.53 (m, 3H, H-2, 4, 6a), 3.73-3.80 (m, 
1H, H-5), 3.88-3.92 (m, 1H, H-5’), 3.96-4.01 (m, 2H, H-2’, 3), 4.10-4.14 (m, 1H, H-6b), 
4.38 (s, 1H, H-1’), 4.49-4.64 (m, 6H, H-1, 6a’, 6b’, 11/2 CH2Ph), 4.73-4.87 (m, 4H, 2 x 
CH2Ph), 4.98 (d, 1H, 
2J = 10.8 Hz, 1/2 CH2Ph), 5.24 (dd, 1H, J3’,4’ = 10.1 Hz, H-3’), 5.88 
(dd, 1H, J4,5 = 9.9 Hz, H-4), 7.00-7.05 (m, 3H, aromatic), 7.19-7.45 (m, 24H, aromatic), 
7.69-7.72 (m, 1H, aromatic), 7.83-7.93 (m, 5H, aromatic), 8.69 (d, 1H, aromatic) ppm; 
13C n.m.r. (150 MHz): δ 55.5, 63.5, 67.4, 68.5, 69.7, 72.1, 73.7 (x2), 73.8, 74.8, 75.1, 
75.2, 76.1, 77.7, 79.1, 80.2, 98.6, 100.5 (1JC1,H1 = 168.6 Hz, 
1JC1’,H1’ = 156.5 Hz), 125.6, 
127.2, 127.3, 127.5, 127.6 (x2), 127.9 (x4), 128.2 (x6), 128.3 (x2), 128.4 (x2), 128.5 (x4), 
128. 9 (x2), 129.3, 129.8 (x4), 129.9, 132.9, 122.4, 137.3, 137.8, 138.3, 138.5, 139.5, 
147.0, 150.3, 163.7, 165.4, 166.2  ppm; HR FAB MS [M+Na+] calcd for C61H59NNaO14 
1052.3833, found 1052.3943. 
 
Methyl 2,3,6-tri-O-benzyl-4-O-(2,4,6-tri-O-benzyl-3-O-picoloyl-α/β-D-
mannopyranosyl)-α-D-glucopyranoside (2.7). The title compound was obtained by 
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Method B from donor 2.1e and acceptor 2.613b as a clear syrup in 80% yield (α/β = 1/2.9, 
5 mM). Analytical data for 2.7: Rf = 0.38 (ethyl acetate/hexane, 1/1, v/v); [α]D24 -47.9 (c 
= 1.0, CHCl3); 
1H n.m.r. (300 MHz): δ, 3.32-3.33 (m, 1H, H-5’), 3.38 (s, 3H, OCH3), 
3.48 (dd, 1H, J2,3 = 3.7 Hz, H-2), 3.54-3.72 (m, 5H, H-5, 6a, 6b, 6a’, 6b’), 3.88-4.01 (m, 
3H, H-2’, 3, 4), 4.16 (dd, 1H, J4’,5’ = 9.7 Hz, H-4’), 4.42-4.79 (m, 13H, H-1, 1’, 51/2 
CH2Ph), 4.99 (dd, 1H, H-3’), 5.20 (d, 1H, 2J = 11.3 Hz, 1/2 CH2Ph), 7.03-7.38 (m, 31H, 
aromatic), 7.74-7.80 (m, 1H, aromatic), 7.90-7.93 (m, 1H, aromatic), 8.79-8.81 (m, 1H, 
aromatic) ppm; 13C n.m.r. (150 MHz): δ, 55.4, 68.7, 69.3, 69.9, 73.3, 73.7, 73.8 (x2), 
74.8, 74.9, 75.3, 76.0, 76.2, 79.2, 80.5, 98.5, 100.7, (1JC1,H1 = 166.1 Hz, 
1JC1’,H1’ = 154.1 
Hz), 125.3, 127.0, 127.2, 127.3, 127.4, 127.5 (x2), 127.6, 127.7, 127.8 (x2), 127.9 (x4), 
128.2 (x8), 128.3 (x2), 128.4 (x4), 128.3 (x2), 128.5 (x2), 128.6, 137.0, 137.7, 138.3, 
138.5, 138.6, 138.9, 139.8, 147.8, 150.2, 164.2 ppm; HR FAB MS [M+Na+] calcd for 
C61H63NNaO12 1024.4248, found 1024.4342. 
 
Methyl 3,4,6-tri-O-benzyl-2-O-(2,4,6-tri-O-benzyl-3-O-picoloyl-α/β-D-
mannopyranosyl)-α-D-glucopyranoside (2.9). The title compound was obtained by 
Method B from donor 2.1e and acceptor 2.8 as a clear syrup in 80% yield (α/β = 1/2.9, 5 
mM). Analytical data for 2.9: Rf = 0.39 (ethyl acetate/hexane, 1/1, v/v); [α]D24 +2.5 (c = 
1.0, CHCl3); 
1H n.m.r. (300 MHz): δ 3.36 (s, 3H, OCH3), 3.42-3.46 (m, 1H, H-5), 3.62-
3.84 (m, 7H, H-2, 3, 4, 6a, 6b, 6a’, 6b’), 3.97 (m, 1H, J4,5 = 9.7 Hz, H-5), 4.05 (d, J2’,3’ = 
3.1 Hz, H-2’), 4.21 (t, 1H, J4’,5’ = 9.7 Hz, H-4’), 4.47-4.4.91 (m, 13H, H-1’, 6 x CH2Ph), 
4.96 (s, 1H,  Hz, H-1), 5.04 (dd, 1H, J3’,4’ = 9.8 Hz, H-3’), 7.04-7.35 (m, 30H, aromatic), 
7.45-7.49 (m, 1H, aromatic),7.78 (m, 1H, aromatic), 7.96 (d, 1H, J = 7.8 Hz, aromatic), 
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8.79 (d, 1H, J = 3.9 Hz, aromatic) ppm; 13C n.m.r. (150 MHz): δ, 55.3, 55.4, 68.6, 68.7, 
69.2, 70.3, 70.5, 73.1, 73.2, 73.8, 74.4, 75.1 (x2), 75.2, 75.5, 75.8, 76.1, 76.9, 77.6, 78.4, 
79.0, 82.1, 83.4, 99.5, 100.0 (1JC1,H1 = 165.7 Hz, 
1JC1’,H1’ = 152.5 Hz), 102.2, 125.3, 127.4, 
127.6, 127.7, 127.8 (x3), 127.9, 128.0 (x2), 128.1 (x3), 128.2, 128.3, 128.4, 128.5 (x4), 
128.6, 128.9, 136.9 (x2), 138.1, 138.2, 138.3, 138.4, 138.5, 138.6, 138.8, 147.9, 150.2 
(x2), 164.1 ppm; HR FAB MS [M+Na+] calcd for C61H63NNaO12 1024.4248 found 
1024.4342. 
 
Methyl 2,3,6-tri-O-benzyl-4-O-(2,4-di-O-benzyl-3,6-di-O-picoloyl-α/β-D-
mannopyranosyl)-α-D-glucopyranoside (2.10). The title compound was obtained by 
Method A or Method B from donor 2.1f and acceptor 2.6 as a clear syrup in 73% yield 
(α/β 1/2.9, 5 mM) or 87% yield (α/β = 1/2.9, 5 mM), respectively. Analytical data for 
2.10: Rf = 0.3 (acetone/toluene, 1/4, v/v); [α]D25 -10.7 (c = 1.0, CHCl3); 1H n.m.r. (300 
MHz): δ, 3.35 (s, 3H, OCH3), 3.39-3.44 (m, 1H, H-5’), 3.47 (dd, 1H, J2,3 = 3.8 Hz, H-2), 
3.60-3.68 (m, 3H, H-5, 6a, 6b), 3.86 (dd, 1H, J3,4 = 8.9 Hz, H-3), 3.92 (m, 1H, H-4), 3.99 
(d, 1H, J2’,3’ = 2.9 Hz, H-2’), 4.20 (dd, 1H, J4’,5’ = 9.6 Hz, H-4’), 4.41-4.23 (m, 3H, H-1’, 
CH2Ph), 4.45-4.78 (m, 10H, H-1, 6a’, 6b’, 31/2 CH2Ph), 4.99 (dd, 1H, J3’,4’ = 9.7 Hz, H-
3’), 5.13 (d, 1H, 2J = 11.2 Hz, 1/2 CH2Ph), 7.04-7-49 (m, 28H, aromatic), 7.75-7.84 (m, 
2H, aromatic), 7.96 (d, 1H, J = 7.8 Hz, aromatic), 8.69-8.71 (m, 1H, aromatic), 8.77-8.78 
(m, 1H, aromatic) ppm; 13C n.m.r. (150 MHz): δ, 55.5, 64.3, 68.6, 69.8, 72.7, 73.3, 73.7, 
73.8, 74.8, 74.9, 75.2, 75.3, 77.7, 78.0, 79.0, 80.4, 98.6, 100.8 (1JC1,H1 = 166.6 Hz, 
1JC1’,H1’ 
= 157.5 Hz), 125.4, 125.6, 136.7, 127.2 (x2), 127.4 (x2), 127.6, 127.8, 127.9, 128.0 (x2), 
128.1 (x4), 128.2 (x4), 128.3 (x4), 128.4 (x2), 128.5 (x2), 128.8 (x2), 136.9, 137.1, 137.8, 
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138.4, 138.7, 139.5, 147.7, 147.8, 150.1, 150.3, 164.3, 164.4 ppm HR FAB MS [M+Na+] 
calcd for C60H60N2NaO13 1039.3993, found 1039.4087. 
 
Methyl 4-O-(4,6-di-O-benzoyl-2-O-benzyl-3-O-picoloyl-α/β-D-mannopyranosyl)-
2,3,6-tri-O-benzyl-α-D-glucopyranoside (2.11). The title compound was obtained by 
Method A or B from donor 2.1h and acceptor 2.6 as a clear syrup in 86% yield (α/β = 
1/5.2, 50 mM) or 72% (α/β = 1/3.5, 5 mM), respectively. Analytical data for 2.11: Rf = 
0.29 (ethyl acetate/hexane, 1/1, v/v); [α]D25 -29.4 (c = 1.0, CHCl3); 1H n.m.r. (300 MHz): 
δ, 3.36 (s, 3H, OCH3), 3.45-3.52 (m, 2H, H-2, 5’), 3.65-3.70 (m, 3H, H-5, 6a, 6b), 3.88 
(dd, 1H, J3,4 = 6.3 Hz, H-3), 3.95-3.98 (m, 2H, H-2’, 4), 4.14 (dd, 1H, J6a’,6b’ = 12.0 Hz, 
H-6a’), 4.31 (dd, 1H, H-6b’), 4.39 (m, 1H, 1/2 CH2Ph), 4.53-4.78 (m, 8H, H-1, 1’, 3 x 
CH2Ph), 5.00 (d, 1H, J2’,3’ = 3.1 Hz, H-3’), 5.10 (d, 1H, 1/2 CH2Ph), 5.84 (dd, 1H, J4’,5’ = 
9.7 Hz, H-4’), 7.07-7.47 (m, 27H, aromatic), 7.67-7.72 (m, 1H, aromatic), 7.73-7.79 (m, 
6H, aromatic), 8.69 (m, 1H, aromatic) ppm; 13C n.m.r. (150 MHz): δ, 55.3, 64.2, 67.9, 
68.7, 70.0, 72.4, 73.5, 74.4, 74.7, 74.8, 74.9, 75.9, 80.0, 82.3, 97.9, 101.4 (1JC1,H1 = 168.1 
Hz, 1JC1’,H1’ = 157.3 Hz), 125.7, 127.2, 127.7, 127.8, 128.1 (x2), 128.2 (x2), 128.3 (x5), 
128.4 (x7), 128.5 (x2), 128.6 (x2), 128.6 (x2), 128.7 (x2), 129.2, 129.8 (x2), 129.8 (x2), 
133.1, 133.5, 137.2, 138.1, 138.2, 138.3, 138.9, 147.0, 150.3, 163.8, 165.6, 166.3 ppm. 
HR-FAB MS [M+Na+] calcd for C61H59NNaO14 1052.3833, found 1052.3943. 
 
Methyl 2,3,6-tri-O-benzyl-4-O-(2-O-benzyl-4,6-O-benzylidene-3-O-picoloyl-α/β-D-
mannopyranosyl)-α-D-glucopyranoside (2.12). The title compound was obtained by 
Method A or Method B from donor 2.1g, 2.16, or 2.17 and acceptor 2.6 as a clear syrup 
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in 71% (α/β = 1/10, 5 mM), 80% (α/β = 1/5.4, 5 mM), 86% (α/β = 1/5.5, 5 mM), 83% 
(α/β = 1/9.8, 5 mM), 96% (α/β = 1/8, 5 mM), or 89% (α/β = 1/7.4, 50 mM). Analytical 
data for 2.12 Rf = 0.41 (ethyl acetate/hexane, 1/1, v/v); [α]D25 -25.1 (c = 1.0, CHCl3); 1H 
n.m.r. (300 MHz): δ, 3.10-3.11 (m, 1H, H-5’), 3.38 (s, 1H, OCH3), 3.47-3.53 (m, 2H, H-
2, 6a’), 3.59-3.64 (m, 3H, H-5, 6a, 6b), 3.83 (dd, 1H, J3,4 = 9.0 Hz, H-3), 3.92-3.98 (m, 
2H, H-2’, 4), 4.02-4.07 (m, 1H, H-6b’), 4.19 (dd, 1H, J4’,5’ = 9.8 Hz, H-4’), 4.40 (d, 1H, 
2J = 12.0 Hz, 1/2 CH2Ph), 4.52-4.81 (m, 8H, H-1, 1’, 3 x CH2Ph), 4.97 (dd, 1H, J3’4’ = 
10.4 Hz, H-3’), 5.04 (d, 1H, 2J = 10.9 Hz, 1/2 CH2Ph), 5.46 (s, 1H, >CHPh), 7.07-7.09 
(m, 23H, aromatic), 7.77 (m, 1H, aromatic), 8.01 (d, 1H, J =7.9 Hz, aromatic), 8.82 (d, 
1H, J =3.8 Hz, aromatic) ppm; 13C n.m.r. (150 MHz): δ, 55.4, 68.0, 69.2, 70.1, 73.5, 
73.9, 74.9, 75.0, 75.3, 75.5, 75.7, 76.7, 78.2, 79.0, 80.5, 82.9, 85.0, 98.5, 102.6 (1JC1,H1 = 
166.0 Hz, 1JC1’,H1’ = 155.0 Hz), 126.9, 127.7 (x2), 127.9 (x6), 128.1 (x2), 128.2 (x2), 
129.4 (x3), 128.5 (x6), 128.6 (x2), 129.2, 129.9, 134.6, 138.0, 138.1, 138.4, 138.6, 138.7 
(x2), 138.8, 139.7, ppm. HR- FAB MS [M+H+] calcd for C54H56NO12 910.3803, found 
910.3790. 
 
Methyl 3,4,6-tri-O-benzyl-2-O-(2-O-benzyl-4,6-O-benzylidene-3-O-picoloyl-α/β-D-
mannopyranosyl)-α-D-glucopyranoside (2.13) The title compound was obtained by 
Method A from donor 2.1g and acceptor 2.8 as a clear syrup in 78% yield (α/β = 1/7.3, 5 
mM). Analytical data for 2.13: Rf = 0.53 (acetone/toluene, 1/4, v/v); [α]D25 -8.8 (c = 1.0, 
CHCl3); 
1H n.m.r. (300 MHz): δ, 3.41 (s, 3H, OCH3), 3.36-3.44 (m, 1H, H-5’), 3.64-3.79 
(m, 5H, H-2, 3, 4, 5, 6a), 3.86-4.06 (m, 2H, H-6a’,6b), 4.06 (d, 1H, J2’,3’ = 3.2 Hz, H-2’), 
4.24-4.37 (m, 2H, H-4’, 6b), 4.68-4.56 (m, 3H, H-1’, CH2Ph,), 4.63 (d, 1H, 2J = 12.1 Hz , 
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1/2 CH2Ph), 4.69 (d, 1H, 
2J = 12.1 Hz , 1/2 CH2Ph)  4.79-4.93 (m, 5H, H-1, 2 x CH2Ph), 
5.12 (dd, 1H, J3’,4’ = 10.3 Hz, H-3’), 5.54 (s, 1H, >CHPh), 7.08-7.48 (m, 25H, aromatic), 
7.76-7.82 (m, 1H, aromatic), 7.76-7.82 (m, 1H, aromatic), 8.04-8.07 (d, 1H, J = 7.8 Hz, 
aromatic), 8.79 (m, 1H, aromatic) ppm; 13C n.m.r. (150 MHz): δ, 55.4, 67.6, 68.6, 67.6, 
68.6, 70.4, 73.7, 73.8, 75.1, 75.2, 75.6, 78.5, 78.7, 82.2, 99.9, 101.8 (1JC1,H1 = 167.0 Hz, 
1JC1’,H1’ = 160.0 Hz), 102.7, 125.6, 126.3 (x2), 126.6, 127.1, 127.7, 127.93 (x3), 128.1 
(x2), 128.2 (x3), 128.3 (x2), 128.4 (x2), 128.5, 128.6 (x4), 128,7 (x2), 120.9 (x2), 129.1, 
129.2, 137.0, 137.3, 138.1, 138.1, 138.4, 147.9, 150.2, 164.2 ppm. HR FAB MS [M+H+] 
calcd for C54H56NO12 910.3803, found 910.3790. 
 
Methyl 2,4,6-tri-O-benzyl-3-O-(2-O-benzyl-4,6-benzylidene-3-O-picoloyl-α/β-D-
mannopyranosyl)-α-D-glucopyranoside (2.15). The title compound was obtained by 
Method A or B from donor 2.1g and acceptor 2.14 as a clear syrup in 71% (α/β = 1/6.0, 5 
mM) or 88% yield (α/β = 1/10, 5 mM), respectively. Analytical data for 2.15: Rf = 0.52 
(ethyl acetate/hexane, 1/1, v/v); [α]D25 +23.7 (c = 1.0, CHCl3); 1H n.m.r. (300 MHz): δ, 
3.35 (s, 3H, OCH3), 3.39-3.80 (m, 6H, H-2, 4, 5, 5’, 6a, 6a’), 4.19-4.39 (m, 5H, H-2’, 3, 
4’, 6b, 6b’), 4.54 (d, 1H, 2J = 12.1 Hz, 1/2 CH2Ph), 4.60-4.74 (m, 5H, H-1, 2 x CH2Ph), 
4.84 (d, 1H, 2J = 12.0 Hz, 1/2 CH2Ph), 5.15 (d, 1H,
 2J = 9.3 Hz, 1/2 CH2Ph), 5.27 (dd, 1H, 
J3’,4’ = 10.4 Hz, H-3’), 5.59 (s, 1H, >CHPh), 7.07-7.13 (m, 3H, aromatic), 7.21-7.53 (m, 
23H, aromatic), 7.81-7.84 (m, 1H, aromatic), 8.09 (d, 1H, J = 7.86 Hz aromatic), 8.84 (d, 
1H, J = 4.11 Hz aromatic) ppm; 13C n.m.r. (150 MHz): δ, 55.3, 67.3, 68.5, 68.8, 69.9, 
73.3, 73.7, 73.9, 75.0, 75.5, 75.9, 76.1, 76.5, 80.0, 80.2, 97.5, 101.8 (1JC1,H1 = 166.9 Hz, 
1JC1’,H1’ = 161.0 Hz), 102.1, 125.6, 126.3 (x2), 127.1, 127.7, 127.8, 127.9, 128.2 (x4), 
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128.3 (x4), 128.5 (x2), 128.6 (x5), 128.8 (x2), 129.0 (x2), 129.1, 137.0, 137.4, 137.6, 
138.0, 138.3, 138.7, 147.8, 150.2, 164.3 ppm. HR FAB MS [M+H+] calcd for 
C54H56NO12 910.3803, found 910.3790. 
 
2.4.6   Synthesis of trisaccharide 2.19 
Methyl O-(2-O-benzyl-4,6-O-benzylidene-3-O-picoloyl-β-D-mannopyranosyl)-
(13)-O-(4,6-di-O-benzoyl-2-O-benzyl-β-D-mannopyranosyl)-(16)-2,3,4-tri-O-
benzyl-α-D-glucopyranoside (2.19).  Cu(OAc)2 (9 mg, 0.05 mmol), was added to a 
solution of disaccharide 2.3h (39 mg, 0.039 mmol) in CH2Cl2 (2.0 mL) and MeOH (0.1 
mL) and the resulting mixture was stirred under argon for 3 h at rt. The reaction mixture 
was quenched with sat. aq. NH4Cl (~1.0 mL), the solid was filtered off, and rinsed 
successively with CH2Cl2. The combined filtrate (~10 mL) was washed with 1M aq. HCl 
(2 x 3 mL), and water (3 x 3 mL). The organic phase was separated, dried with 
magnesium sulfate, and concentrated in vacuo. The residue was purified by column 
chromatography on silica gel (ethyl acetate-hexane gradient elution) to give methyl 2,3,4-
tri-O-benzyl-6-O-(4,6-di-O-benzoyl-2-O-benzyl-β-D-mannopyranosyl)-α-D-
glucopyranoside (2.18) as an amorphous powder in 75% yield (27 mg, 0.029 mmol). 
Analytical data for 2.18: Rf  = 0.7 (ethyl acetate/hexane, 1/1, v/v); [α]D21 +0.22 (c = 1.0, 
CHCl3): 
1H n.m.r. (300 MHz): δ, 2.61 (d, 1H, J = 10.6 Hz, OH), 3.35 (s, 3H, OCH3), 
3.45 (dd, 1H, J4,5 = 9.7 Hz, H-4), 3.51 (dd, 1H, J2,3 = 3.5 Hz, H-2), 3.60-3.64 (m, 1H, H-
6a), 3.78-3.89 (m, 4H, H-2’, 3’, 5, 5’), 4.04 (dd, 1H, J3,4 = 9.3 Hz, H-3), 4.20-4.24 (m, 
1H, H-6b), 4.48-5.08 (m, 12H, H-1, 1’, 6a’, 6b’, 4 x CH2Ph), 5.43 (dd, 1H, J4’,5’ = 9.1 Hz, 
H-4’), 7.27-7.57 (m, 26H, aromatic), 7.97-8.01 (m, 4H, aromatic) ppm; 13C n.m.r. (75 
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MHz): δ, 55.2, 64.2, 68.9, 71.3, 71.8, 72.4, 73.5, 74.8, 75.0, 76.1 77.9, 80.2, 82.3, 97.9, 
102.2, 127.9, 128.0, 128.1, 128.2 (x7), 128.3 (x4), 1288.4 (x2), 128.5 (x2), 128.6 (x3), 
128.6 (x5), 129.6, 129.8 (x2), 129.9, 130.0 (x2), 133.1, 133.5, 138.1, 138.3, 138.4, 138.8, 
166.2, 166.3 ppm; HR FAB MS [M+Na+] calcd for C55H56NaO13 947.3619 found, 
947.3605. 
The title compound was obtained by Method B from donor 2.1g and acceptor 2.18 as 
clear syrup in 76% yield α/β > 1/25). Analytical data for 2.19 Rf = 0.5 (ethyl acetate/ 
hexane, 2/3, v/v); [α]D23 -7.5 (c = 1.0, CHCl3); 1H n.m.r. (300 MHz): δ, 3.07 (m, 1H, H-
5), 3.30 (s, 3H, OCH3), 3.34-3.61 (m, 4H, H-2, 4, 6a, 6a’), 3.83-3.90 (m, 4H, H-2’, 2”, 5, 
5’), 3.97-4.04 (m, 5H, H-3, 3’, 4”, 6b, 6b”), 4.08 (s, 1H, H-1’), 4.32-4.38 (m, 2H, H-1”, 
1/2 CH2Ph), 4.49-4.57 (m, 3H,
 H-1, 6a’, 6b’), 4.62 (d, 1H, 2J = 12.0 Hz, 1/2 CH2Ph), 4.74-
4.82 (m, 3H, 11/2 CH2Ph), 4.88 (d, 1H, 
2J = 10.3 Hz, 1/2 CH2Ph), 4.93-5.00 (m, 2H, H-3”, 
1/2 CH2Ph), 5.41 (s, 1H, >CHPh), 5.68 (dd, 1H, J4’,5’ = 9.7 Hz, H-4’), 6.90-7.08 (m, 5H, 
aromatic), 7.21-7.52 (m, 32H, aromatic), 7.70-7.76 (m, 1H, aromatic), 7.90-7.97 (m, 5H, 
aromatic), 8.74-8.76 (m, 1H, aromatic) ppm; 13C n.m.r. (150 MHz): δ, 64.2, 67.4, 68.3, 
68.4, 69.0, 69.6, 71.5, 72.5, 72.8, 73.3, 73.5, 74.7, 74.8, 75.2, 75.4, 75.5, 75.7, 77.8, 79.8, 
82.0, 97.7, 97.8, 101.5 (1JC1,H1 = 170.3 Hz, 
1JC1’,H1’ = 163.7 Hz, 
1JC1’’,H1’’ = 157.0), 101.9, 
125.4, 126.1 (x2), 126.8, 127.2, 127.6, 127.7, 127.8 (x2), 127.9 (x5), 128.0 (x2), 128.1 
(x3), 128.2 (x5), 128.3, 128.4 (x5), 128.5 (x2), 128.6 (x2), 128.7 (x2), 129.0, 129.6 (x2), 
129.7, 129.9 (x2), 130.0, 132.8, 132.9, 136.7, 137.0, 137.6, 137.9, 138.0, 138.2, 138.6, 
147.4, 149.9, 163.8, 165.6, 166.2 ppm. HR FAB MS [M+Na+] calcd for C81H79O19NNa 
1392.5144. found 1392.5131. 
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 CHAPTER 3 
 
 
Hydrogen bond-mediated 
aglycone delivery: synthesis 
of the N-linked glycoprotein 
core pentasaccharide. 
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3.1.   Introduction  
The glycoproteins equipped with N-glycans play diverse roles in a wide range 
of fundamental biological processes.1-3 N-Glycans and post-translational 
oligosaccharides are covalently attached to proteins at asparagine (Asn) residues by an 
N-glycosidic bond. N-Glycans are also found on the surface of a variety of pathogens 
and are involved in mediation of the pathogenesis of cancers,4 AIDS,5 Alzheimer’s 
disease,6 etc.7-8 All N-glycans are classified into three general classes: high-mannose, 
hybrid, and complex,9 but all share the common core sequence, 
Manα16(Manα13)Manβ14GlcNAcβ14GlcNAcβ1Asn (Scheme 3.1). The 
construction of the core structure as the key intermediate towards a diverse library of 
N-glycans has been a vibrant area of research. Chemical and chemoenzymatic syntheses 
of the N-glycan core pentasaccharide have been reported by Ogawa,10 Danishefsky,11-
12 Seeberger,13-14 Boons,3 Wang,15 and Ito,16-18 amongst others. Nevertheless, the 
construction of these glycan sequences remains a notable challenge, which slows 
biomedical studies related to understanding the roles of glycoproteins and creation of 
N-glycan-derived pharmaceuticals.19 
Scheme 3.1.  The core pentasaccharide sequence of all N-glycans with the most 
challenging Manβ(14)GlcNAc linkage highlighted 
 
  
One of the challenges of the chemical synthesis of N-glycans is the introduction 
of the Manβ(14)GlcNAc unit present at the branching point of the core sequence.20-
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21 A strong anomeric effect in mannosides, and the impossibility of using the 
neighboring group participation to aid in the synthesis of the β-linkage in the manno 
series, make this bond one of the most difficult steps in the synthesis.21 Some promising 
methods have been established by Crich22-28 and others,29-31 the approach developed by 
us (see Chapter 2) also allows us to achieve excellent stereocontrol in β-
mannosylation.32  Our approach relies on the use of picoloyl (Pico) protecting groups 
at remote positions capable of controlling the stereoselectivity via the H-bond-mediated 
Aglycone Delivery (HAD).33-35 According to this approach, the hydroxyl of the 
glycosyl acceptor forms the hydrogen bond with the picoloyl nitrogen of the glycosyl 
donor. As a result, the nucleophile is delivered from the same (syn) face of the sugar 
ring in respect to the picoloyl group (Scheme 3.2). For compounds of the D-manno 
series, excellent stereocontrol could be achieved with picoloyl groups at C-3 and/or C-
6 positions. A series of β-mannosides have been obtained with high stereoselectivity 
and yields. Hence, we were curious to investigate whether this approach would be 
suitable for the synthesis of the core pentasaccharide sequence of N-glycans. 
Scheme 3.2.  H-bond-mediated Aglycone Delivery (HAD) assisted by the remote 
picoloyl substituents 
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3.2.  Results and Discussion 
Described herein is our approach to the synthesis of the N-linked core 
pentasaccharide 3.1, using the HAD reaction for controlling the formation of the β-
mannosidic linkage. For this synthesis, three building blocks (3.2-3.4) were designed 
in accordance of the retrosynthetic analysis of the final target depicted in Scheme 3.3. 
Among these, building block 3.436 was chosen for introducing the two glucosamine 
units at the reducing end of the sequence. Building block 3.3 equipped with the picoloyl 
protecting group at position C-3, the key intermediate of the entire synthesis, was 
selected to carry out the HAD-assisted synthesis of the Manβ(14)GlcNAc linkage. 
Finally, building block 3.237 was selected for the introduction of the two terminal α-
mannosyl residues. 4-Azidobutyl spacer was selected to allow for a selective 
conjugation or surface immobilization of the final product because the azido group can 
be easily transformed into a versatile amino group. 
Scheme 3.3.  Retrosynthetic analysis of pentasaccharide 3.1 from building blocks 
3.2-3.4. 
 
 
In accordance with the retrosynthetic analysis, the assembly of the target 
pentasaccharide 3.1 started with the universal precursor 3.4 that was used to introduce 
both glucosamine units. First, compound 3.4 was converted into glycosyl donor 3.5 that 
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was reacted with 4-azidobutanol 3.6 to give the functionalized monosaccharide 3.7 in 
82% yield. Second, glycosylation of acceptor 3.7 with donor 3.4 led to the formation 
of disaccharide 3.8 in 87% yield. The subsequent reductive cleave of the benzylidene 
acetal afforded compound 3.9 in 94% yield.  Disaccharide 3.9 was then used as a 
glycosyl acceptor for β-mannosylation. 
Scheme 3.4.  Synthesis of disaccharide acceptor 3.9 
 
 
The next synthetic step, the introduction of the β-linked mannose unit, 
represents the key step in the entire synthesis of the N-glycan pentasaccharide. 
Originally we were planning to use 3-6-O-dipicolylated ethylthio glycosyl donor 3.10 
for the glycosylation of acceptor 3.9, however all attempts were unsuccessful (Table 
3.1). All attempts to achieve the glycosylation product including the amount of the 
donor, type and amount of the promoter have failed (entries 1-5). Hence, we decided to 
investigate 3-O-picoloylated ethylthio glycosyl donor 3.3 for the introduction of the β-
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linked mannose unit. Initially, our attempts were unsuccessful, and conventional 
reaction conditions for the HAD reaction did not work (entries 6 and 7).32  
Table 3.1.  Optimization of the synthesis of trisaccharide 3.11 
 
entry donor (equiv.) promoter (equiv.) Product (yield, α/β ratio) 
1 3.10 (1.1) NIS (2.0), TfOH (0.2) no reaction 
2 3.10 (1.3) NIS (2.0), TfOH (0.2) no reaction 
3 3.10 (3.0) NIS (3.0), TfOH (0.3) no reaction 
4 3.10 (1.3) DMTST (2.0) no reaction 
5 3.10 (1.3) MeOTf (4.5) no reaction 
6 3.3 (1.1) NIS (2.0), TfOH (0.2) no reaction 
7 3.3 (1.1) DMTST (2.0) no reaction 
8 3.3 (1.1) NIS (6.0), TfOH (0.3) 3.11 (50%, α/β = 1/11.2) 
9 3.3 (1.3) NIS (6.0), TfOH (0.3) 3.11 (56%, α/β = 1/10.0) 
10 3.3 (1.6) NIS (4.0), TfOH (0.3) 3.11 (61%, α/β = 1/13.1) 
11 3.3 (3.0) NIS (3.0), TfOH (0.3) 3.11 (92%, α/β = 1/12.0) 
 
Success then emerged when we decided “to push” the reaction and added large 
access of NIS. Under these conditions the coupling of donor 3.3 and acceptor 3.9 
produced trisaccharide 3.11 in 50% yield (α/β =1/11.2, entry 8). Encouraged by this 
progress, we continued the optimization of the reaction conditions and discovered that 
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using 3 equiv. of donor 3.3 and 3 equiv. of NIS in respect to the donor (9 equiv. in 
respect to the acceptor) are necessary to bring the reaction to completion. As a result, 
trisaccharide 3.11 was obtained in a high yield of 92% and commendable 
stereoselectivity (α/β = 1/12, entry 10). It should be noted that this reaction was 
performed at the ambient temperature, which offers an important experimental 
advantage over other known methods for β-mannosylation that require super-low 
temperatures.21, 27, 38-39  
With trisaccharide 3.11 in hand, we continued the synthesis of the target 
pentasaccharide core depicted in Scheme 3.4. 3”-O-Picoloyl group in 3.11 was 
removed with NaOMe in MeOH-DCM. The resulting trisaccharide acceptor 3.12 was 
glycosylated with mannosyl donor 3.2 in the presence of NIS/TfOH to afford 
tetrasaccaharide 3.13 in 91% yield. The latter was subjected to acid hydrolysis of 4”,6”-
O-benzylidene acetal. The resulting tetrasaccharide acceptor 3.14, obtained in 88% 
yield, was coupled with mannosyl donor 3.2 to afford the protected N-linked core 
pentasaccharide 3.15 in 60% yield. With compound 3.15 in hand, we began the global 
deprotection shown in Scheme 3.4. Benzoyl protecting groups were removed by the 
treatment with NaOMe/MeOH. The resulting crude product was then subjected to the 
treatment with 1,2-ethylenediamine in n-butanol-toluene to remove the phthaloyl 
groups. Finally, the crude deprotected product was per-acetylated with acetic anhydride 
in the presence of pyridine to afford compound 3.16 in 90% yield over the three steps. 
The latter was subjected to the Birch conditions (Na/liq. NH3) that affected the global 
deprotection by removing benzyls, acetates, and reducing the azide group.  The fully 
deprotected N-glycan pentasaccharide core 3.1 was isolated in 66% yield.       
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Scheme 3.5. The final assembly and deprotection to obtain the N-glycan 
pentasaccharide core 3.1 
 
 
3.3.  Conclusions  
In summary, this Chapter discussed the application of the H-bond-mediated aglycone 
delivery (HAD) method on the synthesis of the N-linked glycan core pentasaccharide, 
which represents a number of synthetic challenges to chemists. The synthesis of the 
final oligosaccharide sequences was accomplished with a high overall yield step. High 
diastereoselectivity for β-mannosylation was achieved at room temperature.   
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3.4.  Experimental  
3.4.1. General Methods 
Column chromatography was performed on silica gel 60 (70-230 mesh), 
reactions were monitored by TLC on Kieselgel 60 F254. The compounds were detected 
by examination under UV light and by charring with 10% sulfuric acid in methanol. 
Solvents were removed under reduced pressure at <40 °C. CH2Cl2 and ClCH2CH2Cl 
(1,2-DCE) were distilled from CaH2 directly prior to application. Pyridine was dried by 
refluxing with CaH2 and then distilled and stored over molecular sieves (3 Å). 
Molecular sieves (3 Å or 4 Å), used for reactions, were crushed and activated in vacuo 
at 390 °C during 8 h in the first instance and then for 2-3 h at 390 °C directly prior to 
application. Optical rotations were measured at ‘Jasco P-1020’ polarimeter. Unless 
noted otherwise, 1H n.m.r. spectra were recorded in CDCl3 at 300 MHz, 
13C n.m.r. 
spectra were recorded in CDCl3 at 75 or 150 MHz. Two-dimensional heteronuclear J-
resolved spectra (HETERO2D) were recorded in CDCl3 at 600 MHz. 
 
3.4.2. Synthesis of Glycosyl Donors 
Ethyl 2,3,4,6-tetra-O-benzoyl-1-thio-α-D-mannopyranoside (3.2). The title 
compound was synthesized according to the reported procedure and its analytical data 
was essentially the same as reported previously.37  
Ethyl 2-O-benzyl-4,6-O-benzylidene-3-O-picoloyl-1-thio-α-D-mannopyranoside 
(3.3).  The title compound was synthesized according to the reported procedure and 
its analytical data was essentially the same as reported previously.32 
Ethyl 3-O-benzyl-4,6-O-benzylidene-2-deoxy-2-phthalimido-1-thio-β-D-
glucopyranoside (3.4).  The title compound was synthesized according to the reported 
procedure and its analytical data was essentially the same as reported previously.36  
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Ethyl 3,6-di-O-benzyl-2-deoxy-2-phthalimido-1-thio-β-D-glucopyranoside (3.5).  
The title compound was synthesized according to the reported procedure and its 
analytical data was essentially the same as reported previously.36 
Ethyl 2,4-di-O-benzyl-3,6-di-O-picoloyl-1-thio-α-D-mannopyranoside (3.10).  The 
title compound was synthesized according to the reported procedure and its analytical 
data was essentially the same as reported previously.32  
 
3.4.3.  Assembly of pentasaccharide 3.14.  
4-Azidobutyl 3,6-di-O-benzyl-2-deoxy-2-phthalimido-1-thio-β-D-glucopyranoside 
(3.7).  A mixture of 3.5 (0.36 g, 0.66 mmol), 4-azidobutanol40 (3.6, 0.09 g, 0.80 mmol), 
and freshly activated molecular sieves (4 Å, 0.90 g) in CH2Cl2 (15 mL) was stirred 
under argon for 1 h at rt. N-Iodosuccinimide (NIS, 0.30 g, 1.30 mmol) and TfOH (12 
μL, 0.13 mmol) were added, and the resulting mixture was stirred for 10 min at rt. After 
that, the solids were filtered off through a pad of Celite and washed successively with 
CH2Cl2. The combined filtrate (~100 mL) was washed with sat. aq. Na2SO4 (10 mL) 
and water (3 x 10 mL). The organic phase was separated, dried with MgSO4, and 
concentrated in vacuo. The residue was purified by column chromatography on silica 
gel (ethyl acetate - hexane gradient elution) to afford the title compound (0.322 g, 82%) 
as a colorless foam. Analytical data for 3.7: Rf = 0.46 (ethyl acetate / hexanes, 1/1.5, 
v/v); [α]D20  +58.2 (c = 1.0, CHCl3); 1H NMR (300 MHz, CDCl3): δ, 1.23-1.46 (m, 4H, 
2 x CH2), 2.92 (d, 1H, J = 2.4 Hz, OH), 3.01 (t, 2H, J = 6.8 Hz, NCH2), 3.35-3.39 (m, 
1H, OCH2
a), 3.63 (m, 1H, H-6a), 3.73-3.84 (m, 4H, H-4, 5, 6b, OCH2
b), 4.09-4.24 (m, 
2H, H-2, 3), 4.52 (d, 1H, 2J = 12.2 Hz, ½ CH2Ph), 4.46 (d, 2H, 
2J = 8.7 Hz, CH2Ph), 
4.73 (d, 1H, 2J = 12.0 Hz, ½ CH2Ph), 5.12 (d, 1H, J1,2 = 8.0 Hz, H-1), 6.92-6.96 (m, 
3H, aromatic), 7.03-7.05 (m, 2H, aromatic), 7.24-7.35 (m, 5H, aromatic), 7.61-7.85 (m, 
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4H, aromatic) ppm; 13C NMR (75 MHz, CDCl3): δ, 27.9, 29.1, 53.5, 57.9, 71.3, 73.4, 
76.0, 76.4, 76.9, 77.2, 81.2, 100.9, 130.1 (x2), 130.4 (x2),130.5 (x4), 130.6 (x2), 130.8 
(x4), 131.1 (x2), 131.2 (x2), 140.2, 140.8 ppm; HR-FAB MS [M+Na]+ calcd for 
C32H34N4O7Na 609.2339, found 609.2309. 
 
4-Azidobutyl O-(3-O-benzyl-4,6-O-benzylidene-2-deoxy-2-phthalimido-β-D-
glucopyranosyl)-(1→4)-3,6-O-benzyl-2-deoxy-2-phthalimido-β-D-
glucopyranoside (3.8).  A mixture of 3.4 (0.59 g, 1.10 mmol), 3.7 (0.50 g, 0.80 mmol), 
and freshly activated molecular sieves (4 Å, 1.50 g) in CH2Cl2 (24 mL) was stirred 
under argon for 1 h at rt. N-Iodosuccinimide (NIS, 0.50 g, 2.20 mmol) and TfOH (20 
μL, 0.20 mmol) were added, and the resulting mixture was stirred for 5 min at rt. After 
that, the solids were filtered off through a pad of Celite and washed successively with 
CH2Cl2. The combined filtrate (~200 mL) was washed with sat. aq. Na2SO4 (10 mL) 
and water (3 x 10 mL). The organic phase was separated, dried with MgSO4, and 
concentrated in vacuo. The residue was purified by column chromatography on silica 
gel (ethyl acetate - hexane gradient elution) to afford the title compound (1.00 g, 87%) 
as a colorless foam. Analytical data for 3.8: Rf = 0.68 (ethyl acetate / hexanes, 1/1 v/v); 
[α]D20 +58.2 (c = 1.0, CHCl3); 1H NMR (300 MHz, CDCl3): δ, 1.38-1.44 (m, 4H, 2 x 
CH2), 3.01-3.05 (m, 2H, J = 6.8 Hz, NCH2), 3.31-3.63 (m, 6H, H-4, 5, 5’, 6a, 6a’, 
OCH2
a), 3.71-3.81 (m, 2H, H-4’, OCH2b), 4.13-4.32 (m, 5H, H-2, 2’, 3, 6b, 6b’), 4.44-
4.57 (m, 5H, H-3’, 2 x CH2Ph), 4.85 (dd, 2H, 2J= 8.5 Hz, CH2Ph), 5.00 (d, 1H, J1,2 = 
8.0 Hz, H-1), 5.43 (d, 1H, J1,2 = 8.3 Hz, H-1’), 5.57 (s, 1H, CHPh), 6.94-7.13 (m, 10H, 
aromatic), 7.33-7.57 (m, 10H, aromatic), 7.70-8.10 (m, 8H, aromatic) ppm; 13C NMR 
(75 MHz, CDCl3): δ, 14.3, 21.1, 25.3, 26.4, 50.9, 55.7, 56.6, 60.4, 65.8, 68.5, 72.8, 74.6, 
83.2, 97.8, 98.1, 101.3, 123.3, 136.1, 126.2 (x3), 127.2, 127.4 (x3), 127.5, 127.6, 127.9 
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(x3), 128.1 (x10), 128.2 (x3), 128.3 (x10), 129.1, 131.6, 133.9, 137.5, 138.0, 138.3, 
138.6 ppm; HR-FAB MS [M+Na]+ calcd for C60H57N5O13Na 1078.3851, found 
1078.3838. 
 
4-Azidobutyl O-(3,6-di-O-benzyl-2-deoxy-2-phthalimido-β-D-glucopyranosyl)-
(1→4)-3,6-O-benzyl-2-deoxy-2-phthalimido-β-D-glucopyranoside (3.9).  Sodium 
cyanoborohydride (NaCNBH3, 0.80 g, 12.9 mmol) was added to a solution of 3.8 (1.00 
g, 0.96 mmol) and molecular sieves (3 Å, 3 g) in dry THF (30 mL) at rt. A solution of 
HCl in diethyl ether (details, ~6.4 mL) was added dropwise under vigorous stirring until 
gas evolution ceased. The resulting mixture was stirred for 1 h at. After that, the solids 
were filtered off through a pad of Celite and washed successively with CH2Cl2. The 
combined filtrate (~100 mL) was washed with water (10 mL), NaHCO3 (10 mL) and 
water (3 x 10 mL). The organic phase was separated, dried with MgSO4, and 
concentrated in vacuo. The residue was purified by column chromatography on silica 
gel (ethyl acetate - hexane gradient elution) to afford the title compound (0.94 g, 94%) 
as a white amorphous solid. Analytical data for 3.9: Rf = 0.43 (ethyl acetate / hexanes, 
1/1.5 v/v); [α]D20 +29.4 (c = 1.0, CHCl3); 1H NMR (500 MHz, CDCl3): δ, 1.35-1.41 (m, 
4H, 2 x CH2), 3.01 (t, 2H, J = 6.8 Hz, NCH2), 3.17 (d, 1H, J = 1.2 Hz, OCH2
a), 3.32-
3.34 (m, 2H, H-4, 6a), 3.43-3.46 (m, 2H, H-5’, 6b’) 3.33-3.59 (m, 2H, H-6a’, 6b), 3.71-
3.74 (m, 2H, H-5, OCH2
b), 3.85 (dd, 1H, J4,5 = 4.8 Hz, H-4’), 4.12-4.21 (m, 3H, H-2, 
2’, 3), 4.28 (dd, 1H, J3,4 = 5.0 Hz, H-3’), 4.49-4.59 (m, 6H, 3 x CH2Ph), 4.82 (dd, 2H, 
2J = 7.3 Hz, CH2Ph), 4.97 (d, 1H, J1,2 = 4.7 Hz, H-1), 5.33 (d, 1H, J1’,2’ = 4.9 Hz, H-1’), 
6.87-7.06 (m, 10H, aromatic), 7.33-7.39 (m, 10H, aromatic), 7.55-7.80 (m, 8H, 
aromatic) ppm; 13C NMR (125 MHz, CDCl3): δ, 25.7, 26.7, 51.2, 56.0, 56.5, 68.5, 68.8, 
71.3, 73.0, 73.2, 74.1, 74.6, 74.7, 74.9, 75.8, 76.1, 78.7, 97.4, 98.4, 123.5, 124.0, 127.3, 
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127.7 (x3), 127.8, 128.1 (x3), 128.1 (x3), 128.2 (x6), 128.3 (x3), 128.5 (x3), 128.6 (x3), 
128.9 (x4), 132.0, 132.2, 134.3, 134.4, 138.7 (x2), 139.0, 168.8, 168.8 ppm; HR-FAB 
MS [M+Na]+ calcd for C60H59N5O13Na 1080.4007, found 1080.4017. 
 
4-Azidobutyl O-(2-O-benzyl-4,6-O-benzylidene-3-O-picoloyl-β-D-
mannopyranosyl)-(1→4)-O-(3,6-di-O-benzyl-2-deoxy-2-phthalimido-β-D-
glucopyranosyl)-(1→4)-3,6-O-benzyl-2-deoxy-2-phthalimido-β-D-
glucopyranoside (3.11).  A mixture of 3.3 (0.452 g, 0.90 mmol), 3.9 (0.313 g, 0.30 
mmol), and freshly activated molecular sieves (4 Å, 1.50 g) in 1,2-dichloroethane (90 
mL) was stirred under argon for 1 h at rt. N-Iodosuccinimide (NIS, 0.60 g, 2.60 mmol) 
and TfOH (230 μL, 0.26 mmol) were added, and the resulting mixture was stirred for 
10 min at rt. After that, the solids were filtered off through a pad of Celite and washed 
successively with CH2Cl2. The combined filtrate (~200 mL) was washed with sat. aq. 
Na2SO4 (10 mL) and water (3 x 10 mL). The organic phase was separated, dried with 
MgSO4, and concentrated in vacuo. The residue was purified by column 
chromatography on silica gel (acetone-toluene) to afford the title compound (0.425 g, 
95%) as a white amorphous solid. Analytical data for 3.11: Rf = 0.34 (acetone / toluene, 
1/10, v/v); [α]D20 -18.3 (c = 1.0, CHCl3); 1H NMR (300 MHz, CDCl3): δ, 1.12-1.21 (m, 
4H, 2 x CH2), 2.85 (t, 2H, J = 6.8 Hz, NCH2), 3.08-3.21 (m, 4H, H-5’, 6a, 6a’, OCH2a), 
3.28-3.44 (m, 4H, H-5’’, 6a’’, 6b, 6b’’), 3.52.-3.58 (m, 2H, H-6b’, OCH2b) 3.97-4.14 
(m, 10H, H-1’’, 2, 2’, 2’’, 3, 3’, 4, 4’, 4’’, 5), 4.14-4.56 (m, 6H, 3 x CH2Ph), 4.65-4.82 
(m, 5H, H-1, 2 x CH2Ph) 4.99 (d, 1H, J2’’,3’’ = 3.1 Hz, H-3’’), 5.17 (d, 1H, J1’,2’ = 9.0 
Hz, H-1’), 5.33 (s, 1H, CHPh), 6.65-7.01 (m, 14H, aromatic), 7.14-7.66 (m, 26H, 
aromatic), 7.89 (d, 1H, aromatic), 8.71 (d, 1H, aromatic) ppm; 13C NMR (75 MHz, 
CDCl3): δ, 25.4, 26.5, 51.0, 55.8, 56.7, 67.3, 67.9, 68.4, 68.5, 68.6, 72.8, 73.5, 73.9, 
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74.5, 74.7 (x2), 75.7, 75.8, 76.0, 76.6, 76.9, 77.2, 77.4, 79.2, 97.2, 98.3, 101.1, 101.7, 
123.3, 123.8, 125.6 (x2), 126.3 (x2), 127.0 (x2), 127.1 (x2), 127.3 (x2), 127.4 (x2), 
127.5 (x2), 127.7 (x2), 127.8 (x2), 127.0 (x5), 128.2 (x3), 128.3 (x2), 128.4 (x10), 128.5 
(x2), 128.8 (x2), 129.1, 131.8, 133.8, 134.04, 137.0, 137.4, 137.9, 138.2, 138.6, 138.8, 
139.0, 147.7, 150.2, 164.4 ppm; HR-FAB MS [M+Na]+ calcd for C86H82N6O19Na 
1525.5532, found 1525.5530. 
 
4-Azidobutyl O-(2-O-benzyl-4,6-O-benzylidene-β-D-mannopyranosyl)-(1→4)-O-
(3,6-di-O-benzyl-2-deoxy-2-phthalimido-β-D-glucopyranosyl)-(1→4)-3,6-O-
benzyl-2-deoxy-2-phthalimido-β-D-glucopyranoside (3.12).  A 1 M solution of 
NaOMe in MeOH (2.0 mL) was added to a solution of trisaccharide 3.11 (0.480, 0.319 
mmol) in CH2Cl2 (2.0 mL) and MeOH (18 mL) and the resulting mixture was stirred 
for 1 h at rt. DOWEX (H+) was added until pH = 6, the resin was filtered off, and rinsed 
successively with CH2Cl2 (5 x 5.0 mL) and MeOH (5 x 5.0 mL). The combined filtrate 
(~70 mL) was concentrated in vacuo and the residue was purified by column 
chromatography on silica gel (ethyl acetate-hexane gradient elution) to give the title 
compound as a white amorphous solid in 86% yield (380 mg, 0.272 mmol). Analytical 
data for 3.12: Rf = 0.55 (ethyl acetate / hexane gradient elution, 1/1, v/v); [α]D20 +0.64 
(c = 1.0, CHCl3); 
1H NMR (300 MHz, CDCl3): δ, 1.20-1.44 (m, 4H, 2 x CH2), 2.33 (d, 
1H, OH), 2.97 (t, 2H, CH2), 3.10-3.33 (m, 4H), 3.39-3.70 (m, 8H) 4.06-4.24 (m, 7H), 
4.36-4.68 (m, 9H), 4.83-5.00 (m, 4H), 5.27 (d, 1H, J1’,2’ = 3.2 Hz, H-1’), 5.40 (s, 1H, 
CHPh), 6.76-6.98 (m, 11H, aromatic), 7.23-7.43 (m, 19H, aromatic), 7.64-7.68 (m, 8H, 
aromatic), ppm; 13C NMR (75 MHz, CDCl3): δ 25.4, 26.5, 50.9 (x2), 55.8, 56.6, 66.9, 
67.9, 68.3, 68.5, 68.6, 71.0, 72.7, 73.5, 74.4, 74.6, 74.7 (x3), 75.9, 76.8, 79.0, 79.2, 
79.5, 97.1, 98.2, 102.0 (x2), 123.2, 126.4 (x3), 127.0, 127.1, 127.4 (x5), 127.6 (x5), 
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127.9 (x5), 128.0 (5), 128.1 (x5), 128.3 (x6), 128.6 (x3), 128.7 (x3), 129.1, 131.7, 
133.7, 137.3, 137.8, 138.3, 138.5, 138.7, 138.9 ppm; HR-FAB MS [M+Na]+ calcd for 
C80H79N5O18Na 1420.5318, found 1420.5320. 
 
4-Azidobutyl O-(2,3,4,6-tetra-O-benzoyl-α-D-mannopyranosyl)-(1→4)-O-(2-O-
benzyl-4,6-O-benzylidene-β-D-mannopyranosyl)-(1→4)-O-(3,6-di-O-benzyl-2-
deoxy-2-phthalimido-β-D-glucopyranosyl)-(1→4)-3,6-di-O-benzyl-2-deoxy-2-
phthalimido-β-D-glucopyranoside (3.13).  A mixture of 3.2 (0.524 g, 0.81 mmol), 
trisaccharide 3.12 (0.880 g, 0.62 mmol), and freshly activated molecular sieves (4 Å, 
1.50 g) in 1,2-dichloromethane (40 mL) was stirred under argon for 1 h at rt.  N-
Iodosuccinimide (NIS, 0.364 g, 1.60 mmol) and TfOH (14 μL, 0.16 mmol) were added, 
and the resulting mixture was stirred for 20 min at rt. After that, the solids were filtered 
off through a pad of Celite and washed successively with CH2Cl2. The combined filtrate 
(~200 mL) was washed with sat. aq. Na2SO4 (20 mL) and water (3 x 20 mL). The 
organic phase was separated, dried with MgSO4, and concentrated in vacuo. The residue 
was purified by column chromatography on silica gel (acetone-toluene gradient elution) 
to afford the title compound (1.10 g, 91%) as a white amorphous solid. Analytical data 
for 3.13: Rf = 0.60 (acetone / toluene, 1/10, v/v); [α]D21 -3.84 (c = 1.0, CHCl3); 1H NMR 
(300 MHz, CDCl3): δ, 1.30-1.51 (m, 4H, 2 x CH2), 3.08 (t, 2H, J = 6.8 Hz, NCH2), 3.14 
(m, 1H), 3.34-3.37 (m, 3H), 3.39-3.60 (m, 4H) 3.73-3.76 (m, 2H), 3.87 (m, 1H), 3.95 
(m, 1H), 4.16-4.76 (m, 19H), 4.91-5.10 (m, 4H), 5.39 (d, 1H, J1’,2’ = 8.1 Hz, H-1’) 5.54-
5.57 (m, 2H), 5.95 (m, 1H), 6.03-6.13 (m, 2H), 7.01-7.29 (m, 11H, aromatic), 7.30-8.08 
(m, 47H, aromatic) ppm; 13C NMR (75 MHz, CDCl3): δ, 25.4 (x2), 26.5 (x2), 51.0 (x2), 
55.9, 56.7, 62.6, 63.0, 65.5, 66.8, 67.3, 67.8, 68.6, 69.6, 71.1, 70.6, 72.9, 73.5, 74.6, 
74.7, 74.8, 75.5, 75.7, 76.3, 78.3, 78.4, 79.3 (x2), 82.9, 97.4, 98.2, 99.0, 101.1, 123.3, 
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125.4, 126.0, 127.0, 127.2 (x5), 127.5 (x2), 127.6 (x2), 128.0 (x2), 128.1 (x5), 128.2 
(x4), 128.4 (x4), 128.6 (x8), 128.7 (x7), 128.8, 129.0, 129.1 (x2), 129.2 (x4), 129.3, 
129.5, 129.9 (x4), 130.0 (x4), 133.3, 133.4, 133.6, 133.7, 134.6, 135.9, 137.9 (x2), 
138.0, 138.6, 138.7, 138.8, 165.1, 165.5, 165.6 (x2), 165.8, 166.3 ppm; HR-FAB MS 
[M+Na]+ calcd for C114H105N5O27Na 1998.6895, found 1998.6915. 
 
4-Azidobutyl O-(2,3,4,6-tetra-O-benzoyl-α-D-mannopyranosyl)-(1→3)-O-(2-O-
benzyl-β-D-mannopyranosyl)-(1→4)-O-(3,6-di-O-benzyl-2-deoxy-2-phthalimido-
β-D-glucopyranosyl)-(1→4)-3,6-di-O-benzyl-2-deoxy-2-phthalimido-β-D-
glucopyranoside (3.14).  Water (350 μL) and trifluoroacetic acid (TFA, 3.5 mL) were 
added to a stirring mixture of trisaccharide 3.13 (1.80 g, 0.60 mmol) in CH2Cl2 (35 mL) 
and the resulting mixture was stirred for 1 h at rt. After that, the reaction mixture was 
neutralized with Et3N (~4 mL), diluted with CH2Cl2 (~200 mL), and washed with cold 
water (20 mL), sat. aq. NaHCO3 (20 mL), and cold water (3 x 20 mL). The organic 
phase was separated, dried with magnesium sulfate, and concentrated in vacuo. The 
residue was purified by column chromatography on silica gel (ethyl acetate-hexane 
gradient elution) to afford the title compound as a white amorphous solid in 88% yield 
(0.98 g, 0.52 mmol). Analytical data for 3.14: Rf = 0.33 (ethyl acetate/hexane, 1/1, v/v); 
[α]D21 -7.20 (c = 1.0, CHCl3); 1H NMR (300 MHz, CDCl3): δ, 1.20-1.34 (m, 4H, 2 x 
CH2), 2.96 (t, 2H, J = 6.8 Hz, NCH2), 3.10 (m, 1H), 3.24-3.33 (m, 3H), 3.40-3.46 (m, 
3H) 3.51-3.54 (m, 2H), 3.64-3.69 (m, 3H), 3.81-3.82 (m, 1H,) 4.04-4.45 (m, 12H), 4.49-
4.58 (m, 5H), 4.73-4.94 (m, 4H), 5.09-5.13 (d, 2H, J = 12 Hz), 5.29 (d, 1H, J = 7.4 Hz) 
5.38 (s, 1H), 5.73 (s, 1H), 5.90 (dd, 1H, J = 2.8 Hz), 6.08 (dd, 1H, J = 9.9 Hz), 6.74-
6.76 (m, 3H, aromatic), 6.88-6.97 (m, 8H, aromatic), 7.16-7.67 (m, 33H, aromatic), 
7.82-7.84 (m, 5H, aromatic), 7.98-8.01 (m, 4H, aromatic) ppm; 13C NMR (75 MHz, 
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CDCl3): δ, 50.8, 55.7, 56.5, 62.5, 62.8, 66.6, 67.1, 67.7, 68.2, 68.4, 69.5, 69.9, 70.4, 
70.5, 72.7, 73.3, 74.4, 74.5 (x2), 74.6, 75.5, 76.1, 78.3, 78.4, 82.7, 97.2, 98.1, 98.8, 
100.9, 123.1, 123.7, 126.9, 127.0 (x2), 127.1, 127.2 (x2), 127.3 (x3), 127.4 (x2), 127.5 
(x2), 127.6, 127.8 (x2), 127.9 (x2), 128.0 (x4), 128.1 (x2), 128.2 (x3), 128.3 (x2), 128.4 
(x6), 128.5 (x2), 128.6 (x4), 128.9, 129.0, 129.2, 129.6, 129.7 (x2), 129.8 (x4), 129.9 
(x2), 131.4, 131.7, 133.2, 133.3, 133.4, 133.5, 133.6, 133.9, 134.1, 137.7, 138.4, 138.5, 
138.6, 138.7, 165.4 (x2), 165.6, 166.1, 167.6 (x2), 168.6 ppm; HR-FAB MS [M+Na]+ 
calcd for C107H101N5O27Na 1910.6582, found 1910.6584. 
 
4-Azidobutyl di-O-(2,3,4,6-tetra-O-benzoyl-α-D-mannopyranosyl)-(1→3,1→6)-O-
(2-O-benzyl-β-D-mannopyranosyl)-(1→4)-O-(3,6-di-O-benzyl-2-deoxy-2-
phthalimido-β-D-glucopyranosyl)-(1→4)-3,6-di-O-benzyl-2-deoxy-2-phthalimido-
β-D-glucopyranoside (3.15).  A mixture of 3.2 (0.365 g, 0.570 mmol), tetrasaccharide 
3.14 (0.980 g, 0.519 mmol), and freshly activated molecular sieves (4 Å, 1.50 g) in 1,2-
dichloromethane (70 mL) was stirred under argon for 1 h at rt.  N-Iodosuccinimide 
(NIS, 0.256 g, 1.14 mmol) and TfOH (10 μL, 0.114 mmol) were added, and the 
resulting mixture was stirred for 10 min at rt. After that, the solids were filtered off 
through a pad of Celite and washed successively with CH2Cl2. The combined filtrate 
(~200 mL) was washed with sat. aq. Na2SO4 (20 mL) and water (3 x 20 mL). The 
organic phase was separated, dried with MgSO4, and concentrated in vacuo. The residue 
was purified by column chromatography on silica gel (ethyl acetate-hexane gradient 
elution) to afford the title compound (0.740 g, 60%) as a white amorphous solid. 
Analytical data for 3.15: Rf = 0.51 (ethyl acetate/hexane, 1/1, v/v); [α]D21 -1.41 (c = 1.0, 
CHCl3); 
1H NMR (300 MHz, CDCl3): δ, 1.23-1.49 (m, 4H, 2 x CH2), 2.96 (t, 2H, J = 
6.8 Hz, NCH2), 3.26-3.47 (m, 8H), 3.61-3.70 (m, 2H), 3.80-3.91 (m, 2H) 4.22-4.51 (m, 
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10H), 4.53-4.67 (m, 4H), 4.84-4.95 (m, 4H,) 5.13-5.37 (m, 4H), 5.69 (dd, 1H, J = 3 
Hz), 5.82-5.88 (m, 2H), 5.99-6.02 (m, 3H), 6.62-6.64 (m, 2H, aromatic), 6.73-6.75 (m, 
2H, aromatic), 67.22-7.62 (m, 32H, aromatic), 7.73-7.75 (m, 14H, aromatic), 7.80-8.06 
(m, 19H, aromatic), ppm; 13C NMR (75 MHz, CDCl3): δ, 14.0, 20.9, 25.1 (x2), 26.2 
(x2), 50.6 (x2), 55.5, 56.3, 60.2, 62.4, 62.5, 66.5, 66.7, 67.3, 67.8, 68.0, 68.2, 68.7, 69.3, 
69.8, 69.9, 70.0, 70.3, 72.4, 73.0, 74.2 (x2), 73.0, 74.2 (x2), 74.3, 74.4, 74.7,79.3, 82.8, 
97.0, 97.8, 97.9, 99.0, 101, 122.9 (x2), 127.3 (x4), 127.5 (x4), 127.6 (x8), 127.8 (x4), 
127.9 (x4),  128.0 (x4), 128.1 (x4), 128.2 (x4), 128.3 (x4), 128.4 (x3), 128.7 (x3), 128.8, 
128.9, 129.1 (x3), 129.6 (x4), 129.7 (x4), 131.3 (x2), 131.6 (x2), 133.2 (x2), 133.3 (x2), 
133.6 (x2), 137.7 (x2), 138.2 (x2), 138.4 (x2), 138.5 (x4), 164.7 (x2), 165.0 (x2), 165.1 
(x2), 165.2 (x2), 165.3 (x2), 165.4 (x2), 165.9 (x2), 166.0 (x2), 167.2, 167.4, 168.1 
ppm; HR-FAB MS [M+Na]+ calcd for C141H127N5O36Na 2488.8158, found 2488.8135. 
 
3.4.4.  Global deprotection   
4-Azidobutyl di-O-(2,3,4,6-tetra-O-acetyl-α-D-mannopyranosyl)-(1→3,1→6)-O-
(2-O-benzyl-β-D-mannopyranosyl)-(1→4)-O-(2-acetamido-3,6-di-O-benzyl-2-
deoxy-β-D-glucopyranosyl)-(1→4)-2-acetamido-3,6-O-benzyl-β-D-
glucopyranoside (3.16).  A 1 M solution of NaOMe in MeOH (4.0 mL) was added to 
a solution of 3.15 (0.460 mg, 0.186 mmol) in CH2Cl2 (3.8 mL) and MeOH (38 mL) and 
the resulting mixture was kept for 12 h at rt. DOWEX (H+) was added until pH = 6, the 
resin was filtered off and washed with MeOH (7 x 10 mL). The combined filtrate (~ 
120 mL) was concentrated under the reduced pressure. The crude residue was dissolved 
in toluene (6.1 mL) and n-BuOH (12 mL), 1,2-ethylenediamine (3.7 mL) was added 
and the resulting mixture was stirred for 12 h at 90 ºC. The volatiles were removed in 
vacuo and the residue was co-evaporated with toluene (2 x 10 mL).  The crude residue 
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was dissolved in pyridine (10 mL), Ac2O (5.0 mL) was added and the resulting mixture 
was kept for 12 h at rt. Methanol (~ 10 mL) was added, the volatiles were evaporated 
in vacuo, and the residue was co-evaporated with toluene (2 x 10 mL). The residue was 
purified by column chromatography on silica gel (acetone-toluene) to afford compound 
3.16 (0.309 g, 90%) as a white amorphous solid. Analytical data for 3.16: Rf = 0.44 
(acetone / toluene, 4/6, v/v); [α]D21 -2.42 (c = 1.0, CHCl3); 1H NMR (300 MHz, CDCl3): 
δ, 1.50-1.56 (m, 4H, 2 x CH2), 1.75-2.14 (m, 33H, 11 x COCH3), 3.19-3.42 (m, 7H), 
3.52-3.86 (m, 13H), 3.94-4.04 (m, 5H) 4.19 (dd, 1H, J = 8.2 Hz), 4.32 (dd, 1H, J = 15 
Hz), 4.40-4.60 (m, 6H), 4.64-4.69 (m, 4H), 4.72-4.97 (m, 3H), 5.10 (m 1H), 5.16-5.30 
(m, 6H), 6.40 (d, 1H), 7.13-7.38 (m, 25H, aromatic) ppm; 13C NMR (75 MHz, CDCl3): 
δ, 20.8 (x4), 20.9 (x2), 21.0 (x2), 23.3, 23.6, 25.7, 26.8, 51.3, 55.5, 62.4, 65.6, 66.1, 
68.1, 68.5 (x2), 68.6, 68.9, 69.1, 69.4, 69.8, 72.3, 73.0, 73.5, 73.7, 73.9, 74.1, 74.5, 
74.7, 74.9, 78.6, 79.6, 97.34, 99.0, 100.1, 100.2, 100.5, 127.3 (x3), 127.5, 127.7 (x3), 
127.9, 128.0, 128.1 (x3), 128.2 (x3), 128.3 (x3), 128.4 (x3), 128.5 (x7), 128.6 (x3), 
128.8 (x3), 137.9, 138.1, 138.3, 138.7, 138.8, 169.6, 169.7, 169.9, 170.1, 170.2 (x2), 
170.4 (x2), 170.5, 170.7, 171.0 ppm; HR-FAB MS [M+Na]+ calcd for C91H113N5O35Na 
1858.7135, found 1858.7153. 
 
4-Aminobutyl di-O-(α-D-mannopyranosyl)-(1→3,1→6)-O-(β-D-
mannopyranosyl)-(1→4)-O-(2-acetamido-2-deoxy-β-D-glucopyranosyl)-(1→4)-2-
acetamido-2-deoxy-β-D-glucopyranoside (3.1).  A three-necked flask equipped with 
a Dewar-type condenser was cooled to -78 ºC and charged with predried (Na) liquid 
ammonia (150 mL) and anhydrous THF (15 mL). Sodium (0.250 g, 0.01 mmol) was 
added and the resulting mixture was stirred for 1 h at -78 ºC. A suspension of 
pentasaccharide 3.16 (0.300 g, 0.19 mmol) in THF (15 mL) was added and the resulting 
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mixture was stirred for 6 h at -78 ºC. After that, NH4Cl (0.30 g) was added and the 
resulting mixture was allowed to warm to rt. The volatiles were removed by passing a 
stream of nitrogen (16 h). The residue was dissolved in water, purified by passing 
through a short column of Sephadex G-10, and lyophilized to provide the title 
compound (0.105 g, 66%) as a white amorphous solid. Analytical data for 3.1: Rf = 0.55 
(methanol / dichloromethane, 3/7, v/v); [α]D21 +0.46 (c = 1.0, CHCl3); 1H NMR (300 
MHz, CDCl3): δ, 1.52-1.56 (m, 4H, 2 x CH2), 1.94, 1.98 (2 s, 6H, 2 x OCH3), 2.97 (t, 
2H, CH2), 3.41-3.87 (m, 40H), 3.96 (m, 1H), 4.15 (m, 1H), 4.38 (d, 1H), 4.50 (d, 1H), 
4.81 (d, 1H), 5.08 (d, 1H) ppm; 13C NMR (75 MHz, CDCl3): δ, 22.4, 23.0, 22.4, 23.1 
(x2), 25.6, 30.7, 40.6, 56.5, 61.4 (x2), 63.0, 63.2, 67.3, 67.9, 68.9, 69.1, 70.1, 71.2, 71.3, 
72.0 (x2), 72.4, 73.4, 74.4, 75.1, 76.3, 76.4, 81.2 (x2), 82.5, 92.1, 101.1, 102.0, 102.9 
(x2), 104.1 ppm; HR-FAB MS [M+Na]+ calcd for C38H67N3O26Na 1004.3910, found 
1004.3929.  
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CHAPTER 4 
 
 
 
HPLC-assisted automated 
oligosaccharide synthesis: the 
implementation of the autosampler as a 
mode of the reagent delivery  
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4.1   Introduction 
Glycans are oligomeric carbohydrates wherein monomers are connected via 
the glycosidic linkage. This linkage is obtained by a glycosylation reaction, which 
remains challenging to synthetic chemists due to the requirement to achieve high 
stereocontrol1 and yields by suppressing side reactions.2 Beyond that, glycan synthesis 
may require further manipulations between each glycosylation step. Due to significant 
advances, the chemical synthesis of many glycans can now be streamlined by using 
expeditious strategies.3 Solid-phase synthesis,4 which eliminates the need for 
purifying intermediates and simplifies the removal of excess reagents, has been 
widely used in the preparation of peptides5 and oligonucleotides.6 Since 1971, solid-
phase synthesis has been used for the preparation of oligosaccharides;7 and in 2001 
Seeberger et al. reported the first automated oligosaccharide synthesis using a 
modified peptide synthesizer.8 In 2012, Seeberger reported “the first fully automated 
solid-phase oligosaccharide synthesizer,” initially in its experimental form;9 and in 
2013 it was marketed as Glyconeer 2.1. Approaches by Wong,10 Takahashi,11 Chen,12 
Pohl,13 Wang,14 and Nokami15 are based on the automation of chemical, enzymatic, or 
chemoenzymatic syntheses in solution with or without using tags.16 
In light of recent progress made in the areas of glycobiology17 and glycomics18 
“widely applicable methods to generate both large and small quantities of glycans are 
needed.”19 Oligosaccharides can be obtained by isolation/release from natural sources, 
or prepared enzymatically and/or chemically. All three approaches are viable, each 
offering certain advantages, but none can significantly outperform the others. 
Oligosaccharide synthesis in solution requires a significant deal of know-how. The 
automated platform for solid-phase synthesis developed by Seeberger introduces an 
idea of operational simplicity and highlights that the development of accessible 
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methods for glycan production is essential for further innovations and practical 
applications in all areas of glycosciences.  
Scheme 4.1. The original set-up for HPLC-assisted synthesis.20 
 
 
The development of the automated synthesizer in our labs began with the 
introduction of the Surface-Tethered Iterative Carbohydrate Synthesis (STICS).21 The 
basis for this concept is a surface-functionalized stack of nanoporous gold plates that 
simplifies the transfer of the gold surface-bound molecules between reaction vessels. 
At the end of the synthesis, the resulting glycan can be either cleaved-off for further 
processing or deprotected directly on the gold surface to be used for recognition 
studies or immunoassay development.22 The STICS concept was developed with 
robotic arm automation in mind. However, we discovered that standard HPLC 
equipment would offer a more accessible platform for automation. This approach was 
discovered with nanoporous gold,23 but we have also investigated more traditional 
polymer supports. Using the acceptor-bound approach,24 preloaded Tentagel® resin 
was packed in the Omnifit® column and integrated into the HPLC system (Scheme 
4.1).20 All steps were automated using a three-headed HPLC pump and the reagent 
consumption was monitored using a standard UV detector.  Reagents were 
recirculated, but still 10 equiv. of trichloroacetimidate donors were used for each 
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glycosylation.20 More recently, Pentelute (and co-workers) investigated the HPLC-
assisted synthesis of peptides.25 Other exciting developments in the area of high 
throughput and automated syntheses have been paticularly inspiring to our own 
research endeavors.26 
 
4.2   Results and Discussion 
Presented herein is the development of a broadly useful technology for 
simple, scalable, and transformative automation of solid-phase synthesis that does not 
rely on specialized equipment. Broadly available and used in most labs, the setup of 
the HPLC equipment requires no investment. This platform allows for real-time UV 
detector monitoring of all steps including glycosylation, which, in turn, helps reduce 
the reaction time and the amount of reagents and solvents needed. The use of a 
computer interface and standard HPLC liquid handling equipment and software will 
allow recording a successful automated sequence as a computer program that can then 
be reproduced by both specialists and non-specialists with a “press of a button”. 
While this approach has a potential to revolutionize the way the automation is 
conducted, solid-phase synthesis suffers from many inherent limitations. Practically 
every aspect of solid-phase synthesis needs to be refined. Along with the introduction 
of the autosampler for the reagent delivery, this article is also dedicated to the 
refinement of some basic aspects of this methodology. Our new basic set-up is using 
standard Agilent 1260 Infinity series HPLC system equipped with a quad pump, a UV 
detector and a autosampler. 
  
Salvatore G. Pistorio| UMSL 2016 | Page  107 
 
 
4.2.1   Selection of resins, spacers and linkers  
Our preliminary work on the HPLC-assisted synthesis was solely based on 
Tentagel resin.20 Previously, we compared Tentagel vs. Merrifield resins using 
manual approach, but saw no significant difference in efficiency and yields.24 A 
recent comparative study by Seeberger et al. determined that the Merrifield resin 
gives the best efficiency in application to their automation platform.27 To gain a better 
understanding of how loading, swelling, mechanical robustness, size, and other 
factors may affect the HPLC-assisted synthesis we performed a side-by-side 
comparison study of Merrifield, Wang,28 and JandaJel,29 all of which have been found 
to be excellent supports for oligosaccharide synthesis and have loading capacities up 
to 1.0 mmol g-1. Although identifying the best support for universal application might 
be simply impossible, in a series of comparative experiments we identified JandaJel 
as the most suitable resin for HPLC-mediated synthesis in terms of loading, reaction 
times and yields.  
It has become common knowledge that the type of the spacer and/or linker 
between the acceptor and the polymer support may be of critical importance.30 Factors 
to consider are the chemical composition, stability towards various experimental 
conditions, and selective (mild) conditions for its cleavage. In our preliminary study, 
we were using a C4 spacer in combination with succinoyl linker that worked well, and 
the cleavage was reliably achieved using a small amount (~2 mL) of a recirculating 
0.1 M solution of NaOMe in MeOH-CH2Cl2. With the general anticipation that 
extension of the spacer length could move the glycosyl acceptor further out into 
solution and enhance the efficiency of the reaction with the solution-based glycosyl 
donor we performed a comparative study. In our study of glycosylations using 
nanoporous gold, we obtained better yields with the acceptor equipped with longer 
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C8-O-C8 spacer than those of acceptors with shorter C4 or C8 spacers.23 With the use 
of polymer beads we report that while the C8-O-C8 spacer helps to enhance the yields 
obtained with the C4 spacer, it practically offers no advantage over the more 
synthetically accessible C8 spacer. Hence, all syntheses described in the article used 
the C8 spacer. 
 
4.2.2   Loading practices and quantification 
The resin loading capacity is important, but over-crowding of the reactive 
sites may prevent further elongation, particularly in case of sterically demanding and 
branched oligosaccharides. During our exploratory study with JandaGel and Tentagel 
resins, it was observed that the desired loading capacities could be achieved much 
faster using HPLC-based reagent delivery rather than the manual loading in a flask. 
Nevertheless, large-scale resin preloading (2-10 g) for this study was performed by 
the manual approach using the flask and the shaker as depicted in Scheme 4.2. 
Building block 4.1 was coupled with amine JandaJel resin in the presence of 1-ethyl-
3-(3-dimethylaminopropyl)carbodiimide (EDC) and 4-dimethylaminopyridine 
(DMAP). The loading can be confirmed by weighing the unloaded versus loaded 
resin, as well as cleaving and quantifying of the loaded acceptor if so desired.  The 
preloaded JandaJel resin 4.2 was then subjected to detritylation with 10% 
trifluoroacetic acid in wet CH2Cl2. The detritylation results in the formation of 
glycosyl acceptor 4.3, but is also releases triphenylcarbinol (TrOH), which could be 
used for the initial quantification of the loading by its isolation by evaporation and 
weighing.  Quantification of TrOH is the key step for determining of the loading 
capacity of the resin.   
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Scheme 4.2.  The synthesis of the solid-phase-bound acceptor 4.3. 
 
 
4.2.3 Glycosylation: reagent delivery, recirculation, monitoring, and synthetic 
methods 
Glycosylation is a complex multi-step process, and reactions on solid 
supports bring additional hurdles related to the mismatch between highly reactive 
solution-based vs. unreactive solid-phase-based reactants. This mismatch is typically 
addressed by using a large excess (5-10 equiv.) of the solution-based reactant, most 
commonly the donor, and repeating the reaction 2-3 times to ensure that all solid-
supported acceptor is consumed.7e Automation offers some operational simplicity to 
oligosaccharide synthesis, but the entire concept may suffer from the inherited 
drawbacks of conventional methods.  
Our experience with HPLC-assisted reactions is still limited, but we already 
established the protocol for separate delivery of solutions of glycosyl donor and 
promoter using HPLC pumps.20 The primary focus of the earlier study was to 
determine ranges of the variables, beginning with reagent ratios, concentration, 
velocity, and pressure. The reaction efficiency is likely to improve with increased 
speed of the reagent delivery. However, this may have potential downfalls if not 
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properly addressed. If the reagents are delivered too fast, the internal column pressure 
may increase to a point where the resin beads collapse or fracture.4b We have not 
observed this at our operating velocity of 0.5-2.0 mL/min (1-12 bar). 
The initial reagent delivery via HPLC pump offered a notable limitation of 
our platform in comparison to Seeberger’s automated synthesizer that has 32 intake 
lines.9 In principle, essentially the same capability can be achieved with the HPLC 
setup by splitting of the pump intake lines with eight-way split valves. However, as 
further steps towards complete automation, we envisaged the use of a standard HPLC 
autosampler. Autosamplers are abundant, cheap, easily fit into the HPLC-automation 
concept. This approach opens access to hundreds of intake/delivery lines. This 
approach allows us to liberate other pump intake lines for the delivery of solvent for 
reactions, washing, and deprotection because only one line is now used for the donor 
delivery and recirculation. It should be mentioned that the recirculation has already 
been previously optimized with the purpose of addressing the main drawback of all 
solid-phase syntheses: the requirement for a large excess of solution-based reagents. 
The outline of the automation set-up, program sequence, and the key results 
for basic glycosylation reactions are depicted in Scheme 4.3.  JandaJel resin (50 mg) 
functionalized with glycosyl acceptor 4.3 (0.022 mmol) was packed in an Omnifit® 
glass chromatography column. The column was connected to the standard Agilent 
Infinity 1260 HPLC system and the automation sequence was programmed as 
follows. Pump D was programmed to deliver CH2Cl2 at a flow rate of 1.0 mL/min. 
After discarding the first ~5 mL of the eluate (washing, step 1, Scheme 4.3) the 
system was switched to the recirculation mode and 2 mL of CH2Cl2 was recirculated 
for 30 min at a flow rate of 1.0 mL/min (swelling, step 2).   After that, pump C was 
programmed to deliver   
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Scheme 4.3.  Refinement of the glycosylation-cleavage sequence for the  
synthesis of disaccharide 4.11. 
 
  
Step Operation Mode Flow rate  Total volume Time 
1 Washing of the resin with CH2Cl2 (50 
mg, 0.022 mmol) 
Pump D 1.0 
mL/min 
5.0 mL 5 min 
2 Swelling resin with CH2Cl2 Pump D 1.0 
mL/min 
2.0 mL 
 (recirculation) 
30 min 
3A 
 
 
 
3B 
Glycosylation, delivery of the donor 
(4.4-4.10, 4.4 equiv., 0.10 mmol or 10 
equiv., 0.22 mmol, see the table below) 
in CH2Cl2 
Glycosylation, injection of the promoter 
(see the table below) at 10, 12, 14 min 
time points  
Pump C 
 
 
 
Autosampler 
0.5 
mL/min 
 
2.0 mL 
 (recirculation) 
 
 
3 x 100 μL 
10 min 
 
 
 
60-90 
min 
4 Washing with CH2Cl2 Pump D 1.0 
mL/min 
10 mL 10 min 
5 Cleavage with 0.1 N NaOMe/MeOH/ 
CH2Cl2 to release the disaccharide 
Pump B 1.0 
mL/min 
10 mL 
 (recirculation) 
20 min 
 
Entry Donor Promoter 
Yield 
of 
4.11 
1 
 
 (0.10 mmol) 
AgOTf 50% 
2 
 
 (0.22 mmol) 
NIS/TfOH 57% 
3 
 
 (0.10 mmol) 
TMSOTf 73% 
4 
 
 (0.10 mmol) 
TMSOTf 
 
75% 
 
Entry Donor Promoter 
Yield 
of 
4.11 
5 
 
 (0.10 mmol) 
TMSOTf 
 
85% 
6 
 
 (0.10 mmol) 
TMSOTf 
 
89% 
7 
 
 (0.10 mmol) 
 (0.22 mmol) 
TMSOTf 
 
76% 
95% 
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a solution of the glycosyl donor (0.10 mmol) in CH2Cl2 (2 mL) at 0.5 mL/min and the 
system was left recirculating for 10 min (step 3A).  Beginning from this stage the 
synthesis was monitored using the integrated UV detector set at 254 nm. A typical trace 
is shown in Scheme 4.3.  
The integrated autosampler was then programmed to inject a solution of 
promoter (40 μL) in CH2Cl2 (3 injections of 100 μL) at 10, 12, and 14 min after the initial 
delivery of the donor (step 3B).  The system was left recirculating for 60-90 min, and the 
reaction was monitored by the UV detector in real-time. When the detector trace reaches 
the plateau, no change in the absorbance of the recirculating solution, the reaction is 
stopped. In principle, low-efficiency reactions can be supplemented with fresh 
reagents/reactants at this time. After a typical reaction time of 60-90 min, the system was 
switched to pump D and washed with CH2Cl2 (1.0 mL/min flow rate) to remove excess 
reagents (step 4). The eluate from the washing step (~10 mL) total is discarded. Again, 
this step was monitored by the UV detector, and the washing was typically stopped after 
~10 min when the detector trace reached the base line corresponding to pure CH2Cl2.  
To affect the product cleavage from the solid support, pump B was then 
programmed to deliver a solution of NaOMe/CH2Cl2/MeOH (0.04/1/1, v/v/v) at a flow 
rate of 1.0 mL/min for 10 min (step 5).  This step was also monitored by the UV detector. 
Typically, the cleavage is completed at this stage and the use of the detector monitoring is 
discontinued. The resulting mixture was recirculated for an additional ~10 min. The 
eluate was collected, neutralized, concentrated under the reduced pressure and the residue 
was acetylated with Ac2O in pyridine to afford disaccharide 4.11. The purification of 4.11 
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was achieved by conventional column chromatography and its identity was proven by 
traditional spectral methods.  
Our initial study of the HPLC-assisted synthesis20 was exclusively based on 
trichloroacetimidates31 as glycosyl donors. In an attempt to broaden the scope of this 
methodology, we performed a comparative study of other common and novel leaving 
groups. Thioglycosides are generally much less reactive than O-imidates and hence 
considered less desirable for polymer-supported synthesis. With some prior success of 
using thioglycosides in glycosylations using polymer24 and nanoporous supports21 we 
investigated the S-benzoxazolyl (SBox) donor 4.432 and the S-phenyl glycosyl donor 
4.533 in the HPLC-automated reactions. Glycosylation of SBox donor 4.4 with resin-
bound acceptor 4.3 was performed in the presence of AgOTf. Following the general 
programming described above, disaccharide 4.11 was obtained in a good yield of 50% 
(Scheme 4.3, entry 1). A similar result was achieved with SPh donor 4.5, wherein 
NIS/TfOH promoted reaction afforded disaccharide 4.11 in 57% yield (entry 2). While 
the outcome of these reactions could be improved by injecting additional quantities of 
reagents, we chose to explore other classes of glycosyl donors. 
Recently, we developed a new class of glycosyl donors, O-benzoxazolyl (OBox) 
imidates, which were also tested in the HPLC-based applications, but could not 
outperform traditional trichloroacetimidates.34 We also introduced 3,3-difluoro-3Hindol-
2-yl (OFox) imidates,35 which showed a very high reactivity and allowed us to obtain 
impressive results in the HPLC-based application. Thus, glycosylation of OFox donor 4.6 
with resin-bound acceptor 4.3 was performed in the presence of TMSOTf. Following the 
general programming, disaccharide 4.11 was obtained in a good yield of 73% (entry 3). A 
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very similar outcome was obtained with phosphate donor 4.7, a glycosylation approach 
frequently used in Seeberger’s automation method.36 The phosphate donor 4.7 also 
provided a very impressive result in our HPLC-based platform wherein TMSOTf-
promoted activation led to disaccharide 4.11 in 75% yield (entry 4). Nevertheless, the 
most consistent result and the highest yield was obtained with trichloroacetimidate 4.8.37 
TMSOTf-promoted activation led to disaccharide 4.11 in an excellent yield of 85% using 
only 4.4 equiv of the donor (entry 5). In order to expand this procedure to selectively 
protected imidates we investigated donors 4.9 and 4.1020 containing a selectively 
removable Fmoc protecting group at C-4 and C-6, respectively. TMSOTf promoted 
glycosylations afforded disaccharide 4.11 in 89 and 76% yields, respectively. The latter 
yield could be increased to 95% by using 10 equiv of donor 4.10. 
 
4.2.4   Fmoc deprotection and reiteration for the synthesis of oligosaccharides 
Having optimized conditions for glycosylation we decided to undertake the 
synthesis of two linear oligosaccharides 4.12 and 4.14. General programming outline is 
presented in Scheme 4.4. For the synthesis of trisaccharide 4.12 we selected glycosyl 
donor 4.10 equipped with the selectively removable Fmoc group at C-6. Previously, we 
have shown that Fmoc can be removed using mild reagents (piperidine/DMF, 2-5 min or 
TEA/CH2Cl2 10-20 min using a HPLC set-up) and also provides a very straightforward 
and informative mode for monitoring the deprotection step and quantification of the 
glycosylation.20 To gain better yields and minimize side reactions, we decided to use a 
larger excess of donor 4.10 (10 equiv). After washing and swelling of the resin containing 
the acceptor 4.3 (0.022 mmol, pump D, steps 1 and 2, Scheme 4.4), pump C was 
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programmed to deliver donor 4.10 (0.22 mmol) in CH2Cl2 (2 mL total volume) at 0.5 
mL/min, which was then recirculated for 10 min. Again, all automated sequence steps 
have been monitored with the UV detector. The autosampler was programmed to deliver 
a solution of promoter in CH2Cl2 (3 injections of 100 μL each) and the resulting reaction 
mixture was recirculated for 60-90 min. When the UV-monitoring showed no change in 
absorbance of the eluate passing through the detector, the system was washed with 
CH2Cl2 (pump D, 1.0 mL/min rate flow for 10 min).  
A capping step in the synthetic cycle is important because it prevents the 
accumulation of shorter oligosaccharides due to incomplete reactions. Capping can be as 
simple as acetylation with Ac2O in pyridine,
38 or by using benzoyl isocyanate in CH2Cl2, 
a procedure developed by Schmidt.39 It should be mentioned that due to high yields 
achieved in glycosylations of reactive primary hydroxyls with trichloroacetimidates, 
capping was found unnecessary.  To affect the deprotection of the Fmoc group, pump A 
was programmed to deliver a solution of triethylamine/CH2Cl2 (1/1, v/v 1.0 mL/min flow 
rate).  
The release of the dibenzofulvene-triethylamine adduct was monitored by using 
the UV detector set at 312 nm. Upon reaching the base line indicating that 
dibenzofulvene-triethylamine is no longer produced (20 min/20 mL total volume for step 
5), the pump D was engaged for washing (step 6, 10 min). The resulting solid-phase 
bound disaccharide acceptor was glycosylated with donor 4.10 following essentially the 
same programming sequence as that for the first cycle.  Upon completion of the 
glycosylation and washing (steps 7 and 8) pump B was engaged to deliver a solution of 
NaOMe/CH2Cl2/MeOH (0.04/1/1, v/v/v) at the flow rate of 1.0 mL/min for 10 min to 
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remove the resulting trisaccharide (step 13).  The eluate was collected, neutralized, 
concentrated and the residue was acetylated with Ac2O in pyridine to afford trisaccharide 
4.12 in 80% yield.  
Scheme 4.4.  Automation of glycosylation-deprotection-cleavage sequences for the 
synthesis of oligosaccharides 4.12 and 4.14. 
 
Step Operation Mode Flow rate  Total volume Time 
1 Washing of the resin with CH2Cl2 (50 mg, 0.022 
mmol) 
Pump D 1.0 
mL/min 
5.0 mL 5 min 
2 Swelling resin with CH2Cl2 Pump D 1.0 
mL/min 
2.0 mL  
(recirculation) 
30 
min 
3 Glycosylation, delivery of 4.10 (10 equiv, 0.22 
mmol) in CH2Cl2 
Injection of TMSOTf of 10, 12 and 14 min  
Pump C 
 
Autosampler 
0.5 
mL/min 
 
2.0 mL  
(recirculation) 
3 x 100 μL 
 
60-90 
min 
4 Washing with CH2Cl2 Pump D 1.0 
mL/min 
10 mL 10 
min 
5 Fmoc deprotection, delivery of Et3N/CH2Cl2 Pump A 1.0 
mL/min 
20 mL 20 
min 
6 Washing with CH2Cl2 Pump D 1.0 
mL/min 
10 mL 10 
min 
7 Glycosylation, delivery of 4.10 (10 equiv, 0.22 
mmol) in CH2Cl2 
Injection of TMSOTf at 10, 12, and 14 min 
Pump C 
Autosampler 
0.5 
mL/min 
 
2.0 mL  
(recirculation) 
3 x 100 μL 
 
60-90 
min 
8 Washing with CH2Cl2 Pump D 1.0 
mL/min 
10 mL 10 
min 
 Synthesis of 4.12 go to step 13, Synthesis of 4.14 continue to step 9    
9 Fmoc deprotection, delivery of Et3N/CH2Cl2 Pump A 1.0 
mL/min 
20 mL 20 
min 
10 Washing with CH2Cl2 Pump D 1.0 
mL/min 
10 mL 10 
min 
11 Glycosylation, delivery of 4.13 (10 equiv 0.22 
mmol) in CH2Cl2 
Injection of TMSOTf at 10, 12, 14 min time points  
Pump C 
 
Autosampler 
0.5 
mL/min 
 
2.0 mL  
(recirculation) 
3 x 100 μL 
 
60-90 
min 
12 Washing with CH2Cl2 Pump D 1.0 
mL/min 
10 mL 10 
min 
13 Cleavage with 0.1 N NaOMe/MeOH/CH2Cl2 to 
release the oligosaccharide 
Pump B 1.0 
mL/min 
10 mL  
recirculation) 
20 
min 
Salvatore G. Pistorio| UMSL 2016 | Page  117 
 
 
 
To investigate whether the trisaccharide sequence achieved during the synthesis 
of 4.12 could be extended further we explored a possibility for the chain elongation. For 
this purpose, we repeated the same steps 1-8 as those described for the synthesis of 4.12. 
It should be noted that in this case a completely automated sequence was reproduced 
simply by using the same program as previously. The solid phase bound trisaccharide 
intermediated was subjected to Fmoc deprotection (step 9) and washing (step 10). The 
subsequent glycosylation step was performed using lactosyl donor 4.1340 with the main 
aim of determining the scope of using larger building blocks (step 11). The glycosylation 
with disaccharide donor 4.13 was performed following essentially the same programming 
sequence as that for other glycosylations described in this article. Upon completion of the 
glycosylation and washing (steps 11 and 12), pump B was engaged to deliver a solution 
of NaOMe/CH2Cl2/MeOH (0.04/1/1, v/v/v) at the flow rate of 1.0 mL/min for 10 min 
followed by recirculation for additional 10 min to remove the resulting pentasaccharide 
(step 13). The eluate was collected, neutralized, concentrated and the residue was 
acetylated with Ac2O in pyridine to afford pentasaccharide 4.14 in 67% yield over-all. 
 
4.3  Conclusions 
In conclusion, we optimized the synthetic and operational strategies for HPLC-
based automation, and have created a generally useful tool for accelerating glycan 
synthesis. This automated technology offering a transformative, semi-automated 
approach to synthesis. Automated HPLC-based synthesis introduces rather sophisticated 
yet affordable in-situ monitoring and reagent recirculation concepts. This basic approach 
provided a solid basis for the implementation of a standard autosampler system for the 
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fully automated delivery of reagents. Further optimization of HPLC technology and its 
application using different resin, spacers, linkers is currently underway. Our efforts are 
also focusing on developing efficient protocols for the synthesis of branched 
heterooligosaccharides as well as using the autosampler for delivering all sugar building 
blocks and deprotecting reagents necessary for the synthesis. 
 
4.4   Experimental 
4.4.1   General methods  
The reactions were performed using commercial reagents and ACS grade 
solvents were purified and dried according to standard procedures.  Column 
chromatography was performed on silica gel 60 (70-230 mesh), reactions were monitored 
by TLC on Kieselgel 60 F254. The compounds were detected by examination under UV 
light and by charring with 10% sulfuric acid in methanol. Solvents were removed under 
reduced pressure at <40 oC. CH2Cl2 and ClCH2CH2Cl were distilled from CaH2 directly 
prior to application. Pyridine and acetonitrile were dried by refluxing with CaH2 and then 
distilled and stored over molecular sieves (3 Å). Molecular sieves (4Å), used for 
reactions, were crushed and activated in vacuo at 390 °C during 8 h in the first instance 
and then for 2-3 h at 390 °C directly prior to application. DOWEX MONOSPHERE 
650C (H+) was washed three times with MeOH and stored under MeOH. Optical 
rotations were measured using a polarimeter. 1H NMR spectra were recorded at 300 or 
600 MHz , 13C NMR spectra were recorded at 75 MHz or 150 MHz. The 1H chemical 
shifts are referenced to the signal of residual CHCl3 (δH = 7.24 ppm). The 13C chemical 
shifts are referenced to the central signal of CDCl3 (δC = 77.23 ppm). HRMS 
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determinations were performed with the use of a mass spectrometer with FAB ionization 
and ion-trap detection. Agilent 1260 infinity HPLC System and an Agilent 1260 Variable 
Wavelength UV-vis Detector were used to assemble the automated synthesizer. 
 
4.4.2   Synthesis of Glycosyl Acceptor 4.3 
8-(tert-Butyldiphenylsilyloxy)oct-1-yl 2,3,4-tri-O-benzyl-6-O-triphenylmethyl-α-D-
glucopyranoside (4.17).  A mixture of ethyl 2,3,4-tri-O-benzyl-1-thio-6-O-
triphenylmethyl-α-D-glucopyranoside (4.15,41 3.0 g, 4 mmol), 8-(tert-
butyldiphenylsilyloxy)octan-1-ol (4.16,42 1.3 g, 3.3 mmol), and freshly activated 
molecular sieves (4 Å, 3.0 g) in diethyl ether (100 mL) was stirred under argon for 1 h at 
rt. N-Iodosuccinimide (NIS, 1.8 g, 8.0 mmol) and TfOH (71 μL, 0.8 mmol) were added, 
and the resulting mixture was stirred for 20 min at rt. After that, the solids were filtered 
off and washed successively with CH2Cl2. The combined filtrate (~200 mL) was washed 
with sat. aq. Na2SO4 (10 mL) and water (3 x 10 mL). The organic phase was separated, 
dried with MgSO4, and concentrated in vacuo. The residue was purified by column 
chromatography on silica gel (ethyl acetate - hexane gradient elution) to afford compound 
4.17 (2.27 g, 65%) as a colorless foam. Analytical data for 4.17: Rf = 0.62 (ethyl acetate / 
hexanes, 1/4, v/v);  [α]D25 +25.3 (c = 1.0, CHCl3); 1H NMR (300 MHz, CDCl3): δ, 0.89 
(s, 9H, C(CH3)3), 1.12-1.20 (m, 8H, 4 x CH2), 1.38, 1.50 (2 m, 4H, 2 x CH2), 3.03 (dd, 
1H, J5,6b = 4.8 Hz, J6a,6b = 9.9 Hz, H-6a), 3.31-3.32 (m, 2H, H-6b, OCH2
a), 3.42-3.50 (m, 
4H, H-2, 4, CH2), 3.56 (m, 1H, OCH2
b), 3.68 (m, 1H, H-5), 3.82 (dd, 1H, J3,4 = 9.2 Hz, 
H-3), 4.13 (d, 1H, 2J = 10.4 Hz, ½ CH2Ph), 4.52-4.72 (m, 5H, H-1, 2 x CH2Ph), 4.81 (d, 
1H, 2J = 10.6 Hz, ½ CH2Ph), 6.69-7.52 (m, 40H, aromatic) ppm; 
13C NMR (75 MHz, 
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CDCl3): δ, 19.4, 25.9 (x3), 26.4, 29.5 (x2), 29.6 (x4), 30.2, 32.7 (x2), 63.8, 64.2, 70.5, 
73.3, 75.2, 76.1, 78.5, 80.6, 82.5, 86.4, 96.7, 126.9 (x2), 127.1, 127.7 (x6), 127.8 (x4), 
127.9 (x3), 128.1, 128.3 (x2), 128.4, 128.6 (x3), 128.9 (x4), 129.0 (x3), 129.6 (x3), 134.3, 
135.7 (x6), 138.1, 138.7, 139.0, 144.1, 144.7 ppm; HR-FAB MS [M+Na]+ calcd for 
C70H78O7SiNa 1081.5415, found 1081.5435. 
 
8-Hydroxyoct-1-yl 2,3,4-tri-O-benzyl-6-O-triphenylmethyl-α-D-glucopyranoside 
(4.18).  Tetrabutylammonium fluoride (TBAF, 1.72 mL, 1.995 mmol) was added to a 
solution of 4.17 (2.0 g, 1.995 mmol) in THF (14 mL) and the resulting mixture was 
stirred under argon for 3 h at rt. After that, the reaction mixture was diluted with CH2Cl2 
(~150 mL), washed with water (20 mL), sat. aq. NaHCO3 (20 mL), and water (20 mL). 
The organic phase was separated, dried with MgSO4, and concentrated in vacuo. The 
residue was purified by column chromatography on silica gel (ethyl acetate – toluene 
gradient elution) to afford compound 4.18 (1.68 g, 95%) as a colorless foam. Analytical 
data for 4.18: Rf = 0.45 (ethyl acetate / hexanes, 1/2, v/v);  [α]D26 +19.7 (c = 1.0, CHCl3); 
1H NMR (300 MHz, CDCl3): δ, 1.21-1.29 (m, 8H, 4 x CH2), 1.43, 1.61 (2 m, 4H, 2 x 
CH2), 3.17 (dd, 1H, J5,6a = 3.0 Hz, J6a,6b = 9.8 Hz, H-6a), 3.45-3.61 (m, 6H, H-2, 4, 6b, 
OCH2
a, OCH2), 3.66 (m, 1H, OCH2
b), 3.83 (m, 1H, H-5), 3,96 (dd, 1H, J3,4 = 10.2 Hz, H-
3), 4.27 (d, 1H, 2J = 10.4 Hz, ½ CH2Ph), 4.67 (d, 1H, 
2J = 10.3 Hz, ½ CH2Ph), 4.69 (d, 
1H, 2J = 12.1 Hz, ½ CH2Ph), 4.76-4.86 (m, 3H, H-1, CH2Ph), 4.95 (d, 1H, 
2J = 10.6 Hz, 
½ CH2Ph), 6.83-7.46 (m, 30H, aromatic) ppm; 
13C NMR (75 MHz, CDCl3): δ, 25.8, 26.3, 
29.4, 29.5, 29.6, 32.9, 62.8, 63.1, 68.1, 70.5, 73.2, 75.2, 76.0, 78.4, 80.6, 82.4, 86.4, 96.7, 
127.0 (x3) 127.7, 127.8, 127.9 (x6), 128.0 (x3), 128.2 (x2) 128.3 (x5), 128.4 (x4), 128.9 
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(x6), 138.0, 138.6, 138.9, 144.1 (x2) ppm; HR-FAB MS [M+Na]+ calcd for C54H60O7Na 
843.4237, found 843.4257. 
 
8-(3-Carboxypropanoyloxy)oct-1-yl 2,3,4-tri-O-benzyl-6-O-triphenylmethyl-α-D-
glucopyranoside (4.1).  Succinic anhydride (0.440 g, 4.39 mmol) and 4-
dimethylaminopyridine (DMAP, 0.053 g, 0.438 mmol) were added to a solution of 
compound4.18 (1.3 g, 1.464 mmol) in pyridine (5.0 mL) and the resulting mixture was 
stirred under argon for 16 h at 65 °C. After that, the volatiles were removed under the 
reduced pressure and the residue was co-evaporated with toluene (3 x 10 mL) and 
purified by column chromatography on silica gel (ethyl acetate – toluene gradient elution) 
to afford the title compound (1.30 g, 97%) as a colorless foam. Analytical data for 4.1: Rf 
= 0.25 (ethyl acetate / hexanes, 1/1, v/v); [α]D27 +21.8 (c = 1.0, CHCl3); 1H NMR (300 
MHz, CDCl3): δ, 1.28-1.37 (m, 8H, CH2), 1.54-1.66 (m, 4H, 2 x CH2), 2.55-2.63 (m, 4H, 
2 x CH2), 3.17 (dd, 1H, J5,6a = 4.9 Hz, J6a,6b = 9.8 Hz, H-6a), 3.44-3.47 (m, 2H, H-6b, 
OCH2
a), 3.53-3.61 (m, 2H, H-2, 4), 3.69-3.72 (m, 1H, OCH2
b), 3.82 (m, 1H, H-5), 3.95 
(dd, 1H, J3,4 = 9.2 Hz, H-3), 4.03 (t, 2H, J = 6.6 Hz, CH2), 4.25 (d, 1H, 
2J = 10.3 Hz, ½ 
CH2Ph), 4.66 (d, 1H, 
2J = 10.4 Hz, ½ CH2Ph), 4.68 (d, 1H, 
2J = 12.1 Hz, ½ CH2Ph), 
4.75-4.84 (m, 4H, H-1, 1½ CH2Ph) 4.93 (d, 1H, 
2J = 10.7 Hz, ½ CH2Ph), 6.83-7.44 (m, 
30H, aromatic) ppm; 13C NMR (75 MHz, CDCl3): δ, 25.1, 26.1, 28.5, 28.7, 28.9, 29.1, 
29.3, 20.4, 62.7, 65.0, 67.9, 70.3, 73.1, 75.1, 75.9, 78.3, 80.4, 82.2, 86.3, 95.5, 126.9 (x3), 
127.7 (x2), 127.8 (x6), 127.9 (x2), 128.1 (x3), 128.2 (x3), 128.3 (x5), 128.4, 128.8 (x5), 
137.8, 138.4, 138.6, 138.8, 144.0 (x3), 144.5, 172.2 ppm; HR-FAB [M+Na]+ calcd for 
C58H64NaO10 943.4397, found 943.4371.  
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Resin-bound acceptor 4.3.  JandaJelTM amine resin (1% cross-linked polystyrene, 500 
mg, 0.25 mmol) was added to a solution of 4.1 (253 mg, 0.275 mmol), 1-ethyl-3-(3-
dimethylaminopropyl)carbodiimide hydrochloride (EDC, 105.4 mg, 0.55 mmol), and 
DMAP (30 mg, 0.25 mmol) in CH2Cl2 (5.0 mL) and the resulting suspension was 
agitated under argon for 18 h at rt. When the Kaiser test43 showed the negative result, the 
resin was filtered off, washed with CH2Cl2 (3 x 20 mL), methanol (3 x 20 mL) and 
CH2Cl2 (3 x 20 mL), and dried in vacuo for 4 h. The resulting resin 4.2 was swelled in 
CH2Cl2 (10 mL) for 60 min at rt. A 10% solution of TFA in wet CH2Cl2 (5.0 mL) was 
added dropwise and the resulting suspension was agitated for 3 h at rt. The resin was 
filtered off, washed with CH2Cl2 (3 x 20 mL), methanol (3 x 20 mL) and CH2Cl2 (3 x 20 
mL), and dried in vacuo for 6 h to afford the title compound. The loading (0.44 mmol/g) 
was determined by the quantification of TrOH forming as a result of the treatment with 
TFA.  
 
4.4.3   Synthesis of Glycosyl Donors 
Benzoxazolyl 2,3,4,6-tetra-O-benzoyl-1-thio-β-D-glucopyranoside (4.4).  The 
synthesis of the title compound was performed in accordance with the reported procedure 
and its analytical data was in accordance with that previously described.32 
 
Phenyl 2,3,4,6-Tetra-O-benzoyl-1-thio--D-glucopyranoside (4.5). The synthesis of 
the title compound was performed in accordance with the reported procedure and its 
analytical data was in accordance with that previously described.44 
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3,3-Difluoro-3H-indol-2-yl 2,3,4,6-tetra-O-benzoyl-α-D-glucopyranoside (4.6).  The 
synthesis of the title compound was performed in accordance with the reported procedure 
and its analytical data was in accordance with that previously described.35 
 
2,3,4,6-Tetra-O-benzoyl-β-D-glucopyranoside bis(butyl)phosphate (4.7).  A mixture 
of 4.5 (700 mg, 1.0 mmol), dibutyl phosphate (0.58 mL, 3.0 mmol), and freshly activated 
molecular sieves (4 Å, 1.5 g) in CH2Cl2 (15 mL) was stirred under argon for 1 h at rt.  
After that, NIS (265 mg, 1.2 mmol) and TfOH (10 µL, 0.12 mmol) were added and the 
resulting mixture was stirred for 18 h at rt. The solid was then filtered off and rinsed 
successively with CH2Cl2. The combined filtrate (~40 mL) was washed with sat. aq. 
Na2SO4 (10 mL) and water (3 x 10 mL). The organic phase was separated, dried with 
MgSO4, and concentrated in vacuo. The residue was purified by column chromatography 
on silica gel (ethyl acetate - hexane gradient elution) to afford the title compound (1.30 g, 
97%) as a clear syrup.  Analytical data for 4.7: Rf = 0.24 (ethyl acetate / hexanes, 1/1, 
v/v); [α] D26 +33.9 (c = 1.0, CHCl3); 1H NMR (300 MHz, CDCl3): δ, 0.64, 0.79 (2 t, 6H, 2 
x CH3), 0.90 (2 m, 4H, 2 x CH2), 1.18-1.69 (m, 4H, 2 x CH2), 3.73 (m, 2H, OCH2
a), 3.99 
(m, 2H, OCH2
b), 4.28 (m, 1H, H-5), 4.46 (dd, 1H, J5,6a = 5.0 Hz, J6a,6b = 12.3 Hz, H-6a), 
4.64 (dd, 1H, J5,6b  = 2.5 Hz, H-6b), 5.60-5.75 (m, 3H, H-1, 2, 4), 5.91 (dd, 1H, J3,4 = 10.5 
Hz, H-3), 7.15-7.80 (m, 20H, aromatic) ppm; 13C NMR (75 MHz, CDCl3): δ, 13.4, 13.5, 
18.2, 18.5, 31.7, 31.8, 32.0, 62.6, 67.0, 68.0, 68.1, 68.2, 69.0, 71,7, 71.8, 72.5, 73.0, 96.6, 
128.3 (x4), 128.5 (x4), 128.6, 128.7, 129.4, 129.8 (x5), 129.9 (x4), 133.3, 133.4, 133.5, 
133.6 ppm. HR-FAB [M+Na]+ calcd for C42H45O13PNa 811.2495, found 811.2505. 
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2,3,4,6-Tetra-O-benzoyl--D-glucopyranosyl trichloroacetimidate (4.8).  The 
synthesis of the title compound was performed in accordance with the reported procedure 
and its analytical data was in accordance with that previously described.37, 45 
 
2,3,6-Tri-O-benzoyl-4-O-(9-fluorenylmethoxycarbonyl)--D-glucopyranosyl 
trichloroacetimidate (4.9).  The synthesis of the title compound was performed in 
accordance with the reported procedure and its analytical data was in accordance with 
that previously described.20 
 
2,3,4-Tri-O-benzoyl-6-O-(9-fluorenylmethoxycarbonyl)--D-glucopyranosyl 
trichloroacetimidate (4.10).  The synthesis of the title compound was performed in 
accordance with the reported procedure and its analytical data was in accordance with 
that previously described.20 
 
O-(2,3,4,6-Tetra-O-benzoyl--D-galactopyranosyl)-(1→4)-2,3,6-tri-O-benzoyl--D-
glucopyranosyl trichloroacetimidate (4.13).  The synthesis of the title compound was 
performed in accordance with the reported procedure and its analytical data was in 
accordance with that previously described.40 
 
4.4.4 HPLC-Mediated Synthesis of Oligosaccharides 
A general procedure for glycosylation and cleavage.  Functionalized JandaJel resin 4.3 
(50 mg, 0.022 mmol) was packed in an OmnifitTM glass chromatography column and the 
latter was integrated into the HPLC system. Pump D was programmed to deliver CH2Cl2 
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at 1.0 mL/min, and the eluate was discarded after washing for 5 min (5 mL, step 1). The 
system was then switched to the recirculation mode and the delivery of CH2Cl2 continued 
for 30 min at 1.0 mL/min (swelling, step 2). After that, pump D was stopped and pump C 
was programmed to deliver a solution of glycosyl donor (4.4 - 4.10, 0.10 mmol) in 
CH2Cl2 (2 mL) at a flow rate of 0.5 mL/min (step 3). This step was monitored by the 
integrated UV detector (λmax = 254 nm). The integrated autosampler was programmed to 
inject a solution of the promoter in CH2Cl2 (3 x 100 μL) at 10, 12, and 14 min and the 
resulting mixture (~2.3 mL) was recirculated for 60-90 min until the UV detector 
recorded no change in absorbance of the eluate. After that, pump C was stopped and 
pump D was programmed to deliver CH2Cl2 at 1.0 mL/min, and the eluate was discarded 
after washing for 10 min (10 mL, step 4). After that, pump D was stopped and pump B 
was programmed to deliver a 0.1 M solution of NaOMe in CH3OH/CH2Cl2 (10 mL, 
0.04/1/1, v/v/v) that was recirculated at 1.0 mL/min for 20 min (step 5). Pump B was 
stopped and pump D was programmed to deliver CH2Cl2 at 1.0 mL/min for 10 min, and 
the combined eluate was neutralized with Dowex (H+) resin. The resin was filtered off, 
washed successively with CH2Cl2 and CH3OH, and the combined filtrate was 
concentrated in vacuo to afford the crude residue that was subjected to subsequent 
acetylation.  
 
A general procedure for acetylation of released disaccharide.  A crude residue was 
redissolved in pyridine (2.0 mL), Ac2O (73 µL, 0.771 mmol) was added dropwise and the 
resulting mixture was stirred for 16 h at rt. The reaction mixture was quenched with 
CH3OH (~1.0 mL) and the volatiles were removed under the reduced pressure. The 
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residue was diluted with CH2Cl2 (20 mL) and washed with 1 N HCl (2 x 10 mL), water 
(20 mL), sat. aq. NaHCO3 (20 mL), and water (2 x 20 mL). The organic phase was 
separated, dried with MgSO4, and concentrated in vacuo. The residue was purified by 
column chromatography on silica gel (ethyl acetate – toluene gradient elution) to afford 
disaccharide 4.11. 
 
8-Acetyloxyoct-1-yl O-(2,3,4,6-tetra-O-acetyl-β-D-glucopyranosyl)-(1→6)-2,3,4-tri-
O-benzyl-α-D-glucopyranoside (4.11).  The title compound was synthesized from 
glycosyl donors 4.4-4.10 and glycosyl acceptor 4.3 in 50-89% yield.  Analytical data for 
4.11: Rf = 0.57 (ethyl acetate / hexanes, 1/1, v/v); [α]D27 + 8.90 (c = 1.0, CHCl3); 1H NMR 
(300 MHz, CDCl3): δ, 1.22-1.29 (m, 8H, 4 x CH2), 1.50-1.58 (m, 4H, 2 x CH2), 1.91-2.07 
(5 s, 15H, 5 x COCH3), 3.32-3.50 (m, 3H, H-2, 4, OCH2
a), 3.55-3.75 (m, 4H, ½ OCH2
a, 
H-5, H-6b, H-5’), 3.95 (dd, 1H, J3,4 = 9.3 Hz, H-3), 3.98-4.23 (m, 5H, H-6a, 6’a, 6’b, 
OCH2
b), 4.47 (d, 1H, J1’,2’ = 7.5 Hz, H-1’), 4.50 (dd, 1H, 2J = 9.8 Hz, ½ CH2Ph), 4.60 (d, 
1H, 2J = 12.0 Hz, ½ CH2Ph), 4.68 (d, 1H, J1,2 = 3.5 Hz, H-1), 4.74 (d, 1H, 
2J = 12.0 Hz, 
½ CH2Ph), 4.76 (d, 1H, 
2J = 10.9 Hz, ½ CH2Ph), 4.83 (d, 1H, 
2J = 10.7 Hz, ½ CH2Ph), 
4.96 (d,1H, 2J = 11.0 Hz, ½ CH2Ph), 5.02 (dd, 1H, J2’,3’ = 9.2 Hz, H-2’), 5.05 (dd, 1H, 
J4’,5’ =  9.6 Hz, H-4’), 5.15 (dd, 1H, J3’,4’ = 9.4 Hz, H-3’), 7.22-7.31 (m, 15H, aromatic) 
ppm; 13C NMR (75 MHz, CDCl3): δ, 20.8 (x2), 20.9 (x2), 21.3, 26.1, 26.3, 28.7, 29.4, 
29.5, 29.6, 57.2, 62.1, 64.8, 68.2, 68.3, 68.5, 68.6, 69.6, 71.4, 71.9, 73.0, 73.2, 73.3, 75.1, 
75.8, 80.2, 96.8, 100.8, 101.8, 127.7, 128.0 (x2), 128.1, 128.2, 128.3 (x2), 128.5 (x2), 
128.6 (x2), 128.7 (x2), 138.3, 138.4, 139.0, 169.2, 169.5, 170.5, 170.8, 171.4 ppm; HR-
FAB [M+Na]+ calcd for C51H66O17 Na
  973.4198, found 973.4175. 
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8-Acetyloxyoct-1-yl-O-(2,3,4,6-tetra-O-acetyl-β-D-glucopyranosyl)-(1→6)-O-(2,3,4-
tri-O-acetyl-β-D-glucopyranosyl)-(1→6)-2,3,4-tri-O-acetyl-α-D-glucopyranoside 
(4.12). Functionalized JandaJel resin 4.3 (50 mg, 0.022 mmol) was packed in an 
OmnifitTM glass chromatography column and the latter was integrated into the HPLC 
system. Pump D was programmed to deliver CH2Cl2 at 1.0 mL/min, and the eluate was 
discarded after washing for 5 min (5 mL, step 1). The system was then switched to the 
recirculation mode and the delivery of CH2Cl2 continued for 30 min at 1.0 mL/min 
(swelling, step 2). After that, pump D was stopped and pump C was programmed to 
deliver a solution of donor 4.10 (188 mg, 0.22 mmol) in CH2Cl2 (2 mL) at a flow rate of 
0.5 mL/min (step 3). This step was monitored by the integrated UV detector (λmax = 254 
nm). The integrated autosampler was programmed to inject a solution of TMSOTf (81 
μL, 0.44 mmol) in CH2Cl2 (3 x 100 μL) at 10, 12, and 14 min and the resulting mixture 
(~2.3 mL) was recirculated for 60-90 min until the UV detector recorded no change in 
absorbance of the eluate. After that, pump C was stopped and pump D was programmed 
to deliver CH2Cl2 at 1.0 mL/min, and the eluate was discarded after washing for 10 min 
(10 mL, step 4). After that, pump D was stopped and pump A was programmed to deliver 
a solution of TEA/CH2Cl2 (1/1, v/v) for 20 min at 1.0 mL/min (step 5). This step was 
monitored by the integrated UV detector (λmax = 312 nm). After that, pump A was 
stopped and pump D was programmed to deliver CH2Cl2 at 1.0 mL/min, and the eluate 
was discarded after washing for 10 min (10 mL, step 6). After that, pump D was stopped 
and pump C was programmed to deliver a solution of donor 4.10 (188 mg, 0.22 mmol) in 
CH2Cl2 (2 mL) at a flow rate of 0.5 mL/min (step 7). This step was monitored by the 
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integrated UV detector (λmax = 254 nm). The integrated autosampler was programmed to 
inject a solution of TMSOTf (81 μL, 0.44 mmol) in CH2Cl2 (3 x 100 μL) at 10, 12, and 
14 min and the resulting mixture (~2.3 mL) was recirculated for 60-90 min until the UV 
detector recorded no change in absorbance of the eluate. After that, pump C was stopped 
and pump D was programmed to deliver CH2Cl2 at 1.0 mL/min, and the eluate was 
discarded after washing for 10 min (10 mL, step 8). After that, pump D was stopped and 
pump B was programmed to deliver a 0.1 M solution of NaOMe in CH3OH/CH2Cl2 (10 
mL, 0.04/1/1, v/v/v) that was recirculated at 1.0 mL/min for 20 min (step 9). Pump B was 
stopped and pump D was programmed to deliver CH2Cl2 at 1.0 mL/min for 10 min, and 
the combined eluate was neutralized with Dowex (H+) resin. The resin was filtered off, 
washed successively with CH2Cl2 and CH3OH, and the combined filtrate was 
concentrated in vacuo to afford the crude residue that was subjected to subsequent 
acetylation in accordance with the general procedure, as described for the synthesis of 
compound 4.11. The crude residue was purified by column chromatography on silica gel 
(ethyl acetate – toluene gradient elution) to afford trisaccharide 4.12 in 80% yield. 
Analytical data for 4.12: Rf = 0.44 (ethyl acetate / hexanes, 1/1, v/v); [α]D27 +6.34 (c = 
1.0, CHCl3); 
1H NMR (600 MHz, CDCl3): δ, 1.22-1.28 (m, 8H, 4 x CH2), 1.58-159 (m, 
4H, 2 x CH2), 1.95-2.06 (8 s, 24H, 8 x COCH3), 3.31 (m, 1H, OCH2
a), 3.45-3.49 (m, 2H, 
H-2, 4), 3.56-3.63 (m, 4H, H-5’, 5”, 6’a, OCH2b), 3.74-3.70 (m, 2H, H-5, 6a), 3.81 (d, 
1H, J6’a,6’b = 10.5 Hz, H-6’b), 3.96 (dd, 1H, J3,4 = 9.1 Hz, H-3), 3.93-4.08 (m, 4H, H-6”a, 
6b, CH2), 4.22 (dd, 1H, J5”,6”b = 4.4 Hz, J6”a,6”b  = 12.3 Hz, H-6”b), 4.46-4.49 (m, 3H, H-
1’, 1”, ½ CH2Ph), 4.60 (d, 1H, 2J = 12.1 Hz, ½ CH2Ph), 4.68 (d, 1H, J1,2 = 2.8 Hz, H-1), 
4.75 (dd, 2H, 2J = 13.7 Hz, CH2Ph), 4.86-4.82 (m, 2H, H-4’, ½ CH2Ph), 4.90-5.01 (m, 
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4H, H-2’, 2”, 4”, ½ CH2Ph), 5.08-5.12 (m, 2H, H-3’, 3”), 7.23-7.32 (m, 15H, aromatic) 
ppm; 13C NMR (150 MHz, CDCl3): δ, 20.7, 20.8, 20.9 (x2), 20.92, 21.2, 25.9, 26.4, 28.7, 
29.4, 29.5, 29.6, 61.9, 64.7, 68.0, 68.1, 63.3, 68.4, 69.2, 69.7, 71.2, 71.5, 72.1, 72.8, 73.1, 
73.2, 73.4, 75.1, 75.8, 77.6, 80.2, 82.0, 96.9, 100.5, 100.9, 127.7, 128.0 (x3), 128.1 (x3), 
128.2 (x2), 128.4, 128.5 (x2), 128.6 (x2), 128.7, 128.8 (x2), 138.3, 138.4, 139.0, 169.2, 
169.3, 169.5, 169.7, 170.3, 170.4, 170.8, 171.4 ppm;  HR-FAB [M+Na]+ calcd for 
C63H82O25Na
  1261.5025, found 1261.5071. 
 
8-Acetyloxyoct-1-yl O-(2,3,4,6-tetra-O-acetyl-β-D-galactopyranosyl)-(1→4)-O-(2,3,6-
tri-O-acetyl-β-D-glucopyranosyl)-(1→6)-O-(2,3,4-tri-O-acetyl-β-D-glucopyranosyl)-
(1→6)-O-(2,3,4-tri-O-acetyl-β-D-glucopyranosyl)-(1→6)-2,3,4-tri-O-benzyl-α-D-
glucopyranoside (4.14). Functionalized JandaJel resin 4.3 (50 mg, 0.022 mmol) was 
packed in an OmnifitTM glass chromatography column and the latter was integrated into 
the HPLC system. Pump D was programmed to deliver CH2Cl2 at 1.0 mL/min, and the 
eluate was discarded after washing for 5 min (5 mL, step 1). The system was then 
switched to the recirculation mode and the delivery of CH2Cl2 continued for 30 min at 1.0 
mL/min (swelling, step 2). After that, pump D was stopped and pump C was programmed 
to deliver a solution of donor 4.10 (188 mg, 0.22 mmol) in CH2Cl2 (2 mL) at a flow rate 
of 0.5 mL/min (step 3). This step was monitored by the integrated UV detector (λmax = 
254 nm). The integrated autosampler was programmed to inject a solution of TMSOTf 
(81 μL, 0.44  mmol) in CH2Cl2 (3 x 100 μL) at 10, 12, and 14 min and the resulting 
mixture (~2.3 mL) was recirculated for 60-90 min until the UV detector recorded no 
change in absorbance of the eluate. After that, pump C was stopped and pump D was 
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programmed to deliver CH2Cl2 at 1.0 mL/min, and the eluate was discarded after washing 
for 10 min (10 mL, step 4). After that, pump D was stopped and pump A was 
programmed to deliver a solution of TEA/CH2Cl2 (1/1, v/v) for 20 min at 1.0 mL/min 
(step 5). This step was monitored by the integrated UV detector (λmax = 312 nm). After 
that, pump A was stopped and pump D was programmed to deliver CH2Cl2 at 1.0 
mL/min, and the eluate was discarded after washing for 10 min (10 mL, step 6). After 
that, pump D was stopped and pump C was programmed to deliver a solution of donor 
4.10 (188 mg, 0.22 mmol) in CH2Cl2 (2 mL) at a flow rate of 0.5 mL/min (step 7). This 
step was monitored by the integrated UV detector (λmax = 254 nm). The integrated 
autosampler was programmed to inject a solution of TMSOTf (81 μL, 0.44  mmol) in 
CH2Cl2 (3 x 100 μL) at 10, 12, and 14 min and the resulting mixture (~2.3 mL) was 
recirculated for 60-90 min until the UV detector recorded no change in absorbance of the 
eluate. After that, pump C was stopped and pump D was programmed to deliver CH2Cl2 
at 1.0 mL/min, and the eluate was discarded after washing for 10 min (10 mL, step 8). 
After that, pump D was stopped and pump A was programmed to deliver a solution of 
TEA/CH2Cl2 (1/1, v/v) for 20 min at 1.0 mL/min (step 9). This step was monitored by the 
integrated UV detector (λmax = 312 nm). After that, pump A was stopped and pump D 
was programmed to deliver CH2Cl2 at 1.0 mL/min, and the eluate was discarded after 
washing for 10 min (10 mL, step 10). After that, pump D was stopped and pump C was 
programmed to deliver a solution of donor 4.13 (266 mg, 0.22 mmol) in CH2Cl2 (2 mL) 
at a flow rate of 0.5 mL/min (step 11). This step was monitored by the integrated UV 
detector (λmax = 254 nm). The integrated autosampler was programmed to inject a 
solution of TMSOTf (81 μL, 0.44 mmol) in CH2Cl2 (3 x 100 μL) at 10, 12, and 14 min 
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and the resulting mixture (~2.3 mL) was recirculated for 60-90 min until the UV detector 
recorded no change in absorbance of the eluate. After that, pump C was stopped and 
pump D was programmed to deliver CH2Cl2 at 1.0 mL/min, and the eluate was discarded 
after washing for 10 min (10 mL, step 12). After that, pump D was stopped and pump B 
was programmed to deliver a 0.1 M solution of NaOMe in CH3OH/CH2Cl2 (10 mL, 
0.04/1/1, v/v/v) that was recirculated at 1.0 mL/min for 20 min (step 13). Pump B was 
stopped and pump D was programmed to deliver CH2Cl2 at 1.0 mL/min for 10 min, and 
the combined eluate was neutralized with Dowex (H+) resin. The resin was filtered off, 
washed successively with CH2Cl2 and CH3OH, and the combined filtrate was 
concentrated in vacuo to afford the crude residue that was subjected to subsequent 
acetylation in accordance with the general procedure, as described for the synthesis of 
compound 4.11. The crude residue was purified by column chromatography on silica gel 
(ethyl acetate – toluene gradient elution) to afford pentasaccharide 4.14 in 67% yield. 
Analytical data for 4.14: Rf = 0.26 (ethyl acetate / hexanes, 1/1, v/v); [α]D27 -1.94 (c = 1.0, 
CHCl3); 
1H NMR (600 MHz, CDCl3): δ, 1.26-1.30 (m, 8H, 4 x CH2), 1.55-159 (m, 4H, 2 
x CH2), 3.30 (m, 1H, OCH2
a), 3.44-3.46 (m, 2H, H-2, 4), 3.53-3.63 (m, 6H, H-5’, 5”, 5”’, 
6’a, 6”a, OCH2b), 3.68-3.73 (m, 2H, H-6a, 6”b), 3.77-3.86 (m, 4H, H-5, 5””, 6””a, 6’b), 
3.94 (dd, 1H, J3,4 = 9.2 Hz, H-3), 4.03-4.10 (m, 7H, H-2”, 2””, 6b, 6”b, 6””b, CH2), 4.42-
4.52 (m, 6H, H-1’, 1”, 1”’, 1””, 6”’b, ½ CH2Ph), 4.59 (d, 1H, 2J = 12.0 Hz, ½ CH2Ph), 
4.69 (d, 1H, J1,2 = 3.1 Hz, H-1), 4.73 (dd, 2H, 
2J = 11.6 Hz, CH2Ph), 4.82-7.97 (m, 7H, 
H-2’, 2”’, 4’, 4”, 4”’, ½ CH2Ph), 4.99 (dd, 1H, J3””,4”” = 8.4 Hz, H-3’’’’), 5.06-5.16 (m, 
4H, H-3’, 3”, 3”’, ½ CH2Ph), 5.31 (d, 1H, J4””,5”” = 2.1 Hz, H-4””), 7.24-7.32 (m, 15H, 
aromatic) ppm; 13C NMR (150 MHz, CDCl3): δ, 20.6 (x2), 20.7 (x3), 20.8, 20.9 (x2), 
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21.1, 26.0, 26.2, 28.7, 29.4, 29.5, 29.8 (x2), 62.0, 64.4 (x2), 66.6, 68.0, 68.1, 69.0, 69.1, 
69.2 (x2), 69.7, 70.7 (x2), 71.0, 71.2, 71.4 (x2), 71.5, 72.8, 72.9, 73.0, 73.1 (x2), 73.2, 
75.0, 75.7, 76.2, 77.5, 80.1, 81.9, 96.7, 100.5, 100.7, 100.9, 101.1, 127.6, 127.9 (x7), 
128.0, 128.1 (x3), 128.4 (x3), 128.5 (x3), 128.6 (x3), 138.3, 138.4, 138.9, 169.1, 169.2, 
169.3, 169.5, 169.6, 169.8, 170.2, 170.3, 170.4 (x3), 171.3 ppm; HR-FAB [M+Na]+ calcd 
for C87H114O41 Na
  1837.6716, found 1837.6703. 
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5.1   Introduction  
Oligosaccharides play important roles in various biological processes. 
Therefore, the general interest in these compounds has rapidly increased in the recent 
years.1  Unlike proteins and nucleic acids, which can be obtained using automated 
methods such as peptide synthesizer and polymerase chain reaction (PCR),2 glycans 
are most commonly isolated from nature.3 The isolation from natural sources has 
limitations, the quantities that can be obtained from biological systems are often 
small, the purity is low, and structure modification is difficult or impractical.   
The traditional solution phase synthesis is an important alternative method to 
obtain oligosaccharides in high quantity and allow to incorporate structure 
modifications in the final product. Recently, successful methods for the solid-phase 
oligosaccharide synthesis4 have been developed by several research groups.5 This 
approach exhibits important advantages over the traditional solution phase synthesis, 
such as: 1) sample purification process, it is easier to remove excess reactants or 
byproducts from the product; 2) no need to purify the reaction intermediates. 
Seeberger and co-workers have been the first to perform the synthesis of many 
oligosaccharide sequences using an automated oligosaccharide synthesizer.4e, 6 These 
advances have clearly demonstrated that solid phase synthesis can be an important 
alternative for the obtaining of complex glycans. Described herein is an automated 
solid phase synthesis approach for N-linked core oligosaccharides using an HPLC-
based synthesizer developed in our laboratory.5e  
 
5.2  Results and Discussion  
In accordance with the structural analysis, our strategic plan to assemble the N-glycan 
core tetrasaccharide 5.1 and pentasaccharide 5.2 involved building blocks 5.3-5.6 
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depicted in Figure 5.1. The tetra- and the pentasaccharide targets contain two 
synthetic challenges: the presence of branching and the Manβ(1→4)GlcNAc linkage. 
The stereoselective formation of the β-mannosidic linkage is difficult due to the 
strong anomeric effect and the steric effect of the axial substituent at the C2 position, 
both favoring the formation of α-mannosides. A well-known strategy for the synthesis 
of β-mannosidic linkage has been developed by Crich et. al.7 Our laboratory also 
reported β-stereoselective mannosylation using 3- and/or 6-O-picoloyl thiomannosyl 
donor via the H-bond-mediated Aglycone Delivery (HAD).8 Excellent β-
stereoselectivity achieved in preliminary mannosylations (Chapter 2) and orthogonal 
conditions for the removal of picoloyl groups stimulated our interest in studying 3,6-
di-O-picoloyl protected donor 5.5 for the formation of the key Manβ(1→4)GlcNAc 
bond in solid phase synthesis. As a back-up plan, we also decided to explore an 
alternative approach wherein the Manβ(1-4)GlcNAc linkage was presynthesized in 
solution and the resulting disaccharide building block 5.6 was then used for the 
indirect introduction of the β-mannosidic unit on solid support.   
Figure 5.1.  Retrosynthetic analysis of N-linked tetrasaccharide and 
pentasaccharide targets 5.1 and 5.2. 
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5.2.1   The synthesis of the key monosaccharide building blocks 5.3-5.5 
Having identified the building blocks necessary for the synthesis we prepared 
polymer-supported building block 5.3 from known glucosamine derivative 5.7.9 The 
latter was coupled with spacer 5.8 in the presence of NIS/TfOH to afford 
glucosamine-spacer intermediate 5.9 in 92% yield. Next, benzoyl deprotection 
followed by the treatment with succinic anhydride in pyridine allowed us to obtain 
building block 5.10. The latter was coupled with the amine of JandaJel resin in the 
presence of 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC) and 4-
dimethylaminopyridine (DMAP) to afford building block 5.3. The loading capacity of 
JandaJel functionalized acceptor 5.3 was determined to be 0.22 mmol/g by cleaving 
off and quantifying the loaded acceptor.  
Scheme 5.1. Synthesis of the support-bound acceptor 5.3 
 
 
Mannosyl phosphate donors 5.4 and 5.5 were formed by simple conversion 
of the respective known thioglycosides 5.11 and 5.12 by reaction with 
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dibutylphosphate in the presence of NIS/TfOH. It should be noted that highly reactive 
glycosyl phosphates were found to be more suitable glycosyl donors for the polymer-
supported synthesis than their more stable thioglycoside counterparts.10 
Scheme 5.2. Synthesis of mannosyl donors 5.4 and 5.5 
 
5.2.2.  The synthesis of Manβ(1-4)GlcNAc linkage on solid phase and in solution. 
With the necessary building blocks 5.3-5.5 in hand, we investigated the 
applicability of the HAD assisted β-mannosylation using the HPLC synthesizer.5e 
JandaJel resin functionalized with glycosyl acceptor 5.3 (50 mg, 0.011 mmol) was 
packed in OmnifitTM glass chromatography column. The column was integrated into 
the standard Agilent Infinity 1260 HPLC system and the automated assembly was 
programmed as shown in Scheme 5.3. To affect the initial washing and swelling of the 
resin containing acceptor 5.3 (0.011 mmol), Pump D was programmed to delivery 35 
mL of dichloromethane (steps 1 and 2). After that, Pump C was programmed to 
deliver donor 5.5 (0.11 mmol) in CH2Cl2 (2.0 mL total volume) at 0.5 mL/min, which 
was then recirculated for 10 min and the delivery of the donor has been monitored 
with the UV detector. The autosampler was programmed to deliver a solution of 
promoter in CH2Cl2 (3 injections of 100 μL each) and the resulting reaction mixture 
was recirculated for 90 min (steps 3A and 3B). When the UV-monitoring showed no 
change in absorbance of the eluate passing through the detector, the system was 
washed with CH2Cl2 (Pump D, 1.0 mL/min rate flow for 10 min, step 4).  
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Scheme 5.3.  HPLC-assisted synthesis of disaccharide 5.13 
 
Step Operation Mode Flow rate  Total volume Time 
1 Washing of the resin with 
CH2Cl2 (50 mg, 0.011 
mmol) 
Pump D 1.0 
mL/min 
5.0 mL 5 min 
2 Swelling resin with CH2Cl2 Pump D 1.0 
mL/min 
2.0 mL 
(recirculation) 
30 min 
3A 
 
 
3B 
Glycosylation, delivery of 
the donor (5.5, 10 equiv, 
0.11 mmol,) in CH2Cl2 
Glycosylation, injection of 
the promoter ) at 10, 12, 14 
min time points  
Pump C 
 
 
Autosampler 
0.5 
mL/min 
 
2.0 mL 
(recirculation) 
 
3 x 100 μL 
10 min 
 
 
60-90 
min 
4 Washing with CH2Cl2 Pump D 1.0 
mL/min 
10 mL 10 min 
5 Cleavage with 0.1 N 
NaOMe/ MeOH/CH2Cl2 to 
release the disaccharide 
Pump B 1.0 
mL/min 
10 mL 
(recirculation) 
20 min 
 
 The resulting solid-phase bound disaccharide was then cleaved off 
from the solid support by passing a recirculating solution of NaOMe in 
CH2Cl2/MeOH (0.04/1/1, v/v/v, Pump B) at the flow rate of 1.0 mL/min for 10 min 
(step 5).  The eluate was collected, neutralized, concentrated and the residue was 
acetylated with Ac2O in pyridine to afford disaccharide 5.13 in 86% yield.  
Unfortunately, no stereoselectivity (α/β = 1.0/1.0) was obtained. This result indicates 
that no HAD effect took place during the glycosylation step 3 with donor 5.5. Perhaps 
the reason for the poor stereocontrol is the continuous flow of the donor in the system 
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that disfavors the formation of a stable hydrogen bond between the donor and 
acceptor necessary for the HAD.  
With this failure to introduce the β-mannosyl linkage directly, we abandoned 
the idea of obtaining the tetrasaccharide 5.2 and decided to focus on the synthesis of 
pentasaccharide 5.1 instead. For this purpose we turned our attention to the synthesis 
disaccharide building block 5.6. The preassembled building block 5.6 should allow 
for the introduction of this difficult linkage in the target molecule. In our previous 
studies we showed that 3,6-di-O-picoloylated mannosyl donor 5.12 provides excellent 
stereoselectivity in β-mannosylation of primary and secondary acceptors.8 
Unfortunately, all attempts to use donor 5.12 with acceptor 5.14 failed, and no 
formation of the disaccharide product has been observed (Table 5.1, entries 1-4). A 
possible explanation of this result can be that the presence of two disarming 
protecting groups like picoloyl on 3-C and 6-C position affect the reactivity of this 
donor making it impossible to obtain the desired disaccharide. Next, we decided to 
investigate the use of a more reactive donor 5.16. Still, to ensure the completeness of 
the reaction we had to use excess of donor and promoter as shown in Table 5.1 (entry 
5).  Under these conditions we were able to obtain disaccharide 5.17 in excellent yield 
of 95% and commendable stereoselectivity (α/β = 1/6.0).  
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Table 5.1.  Investigation of β-mannosylation in solution 
 
Entry Donor (equiv.) Promoter (equiv.) Yield, % (α/β ratio) 
1 
 
5.12 (1.2) 
NIS/TfOH (2.4/0.24) N.R. 
2 5.12 (1.4) NIS/TfOH (2.8/0.28) N.R. 
3 5.12 (1.5) NIS/TMSOTf (3.0/0.30) N.R. 
4 5.12 (3.0) NIS/TfOH (6.0/0.60) N.R. 
5 
 
5.16 (2.0) 
NIS/TfOH (4.0/0.40) 5.17 (95, 1/6.0) 
 
  
 The intermediate 5.17 was then employed in the synthesis of the key building 
block 5.6. This was accomplished via a series of sequential transformations depicted 
in Scheme 5.4.  Picoloyl deprotection was affected using a 1 M solution of NaOMe in 
MeOH to afford compound 5.18. The reductive opening of the benzylidene acetal 
afforded disaccharide 5.19 in 77% yield. The later was 3,6-di-picoloylated to give 
5.20 in 95% yield. Compound 5.20 was then treated with TBAF to liberate the 
hemiacetal in 60%. Finally, compound 5.21 was converted into imidate donor 5.6 in 
83% yield by reaction with trichloroacetonitrile in the presence of DBU.   
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Scheme 5.4. Synthesis of disaccharide donor 5.6 
 
 
5.2.3   HPLC-assisted assembly of N-glycan core pentasaccharide 5.2  
With the desired building blocks 5.3, 5.5 and 5.6 in hand we proceeded to the 
automated synthesis of the N-glycan core pentasaccharide. The automated assembly 
followed typical cycles of glycosylation and deprotection separated by washing as 
used in our pervious automated oligosaccharide synthesis (Chapter 3). Glycosylation 
with disaccharide 5.6 and acceptor 5.3 seemed to be the most challenging step, and to 
ensure a complete conversion 10 equiv of donor 5.6 has been used during this step. 
Simultaneous deprotection of picoloyl groups from position C3 and C6 was than 
performed using same conditions used for tetrasaccharide synthesis. The final 
branching was introduced by glycosylation with mannosyl donor 5.4. This reaction 
was repeated two times to ensure complete glycosylation of both hydroxyls of the 
trisaccharide acceptor linked to the solid support. Finally, the resin was treated with a 
solution of NaOMe in CH2Cl2 and MeOH (0.04/1/1, v/v/v) at the flow rate of 1.0 
mL/min for 10 min to release the resulting pentasaccharide from the resin. The eluate 
was collected, neutralized, concentrated and the residue was acetylated with Ac2O in 
pyridine to afford pentasaccharide 5.2 in 31% yield. 
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Scheme 5.5. Assembly of N-glycan core pentasaccharide 5.2 on HPLC 
 
 
5.3   Conclusions 
In conclusion, we accomplished the synthesis of the N-glycan core 
pentasaccharide in a total of 8 h using an HPLC-assisted semiautomated approach. 
Unfortunately, the use of the HAD method was much less efficient in solid supported 
glycosylations. This shows a limitation of this promising method and offers venues 
for further explorations. The target synthesis was successfully accomplished using a 
block approach according to which the challenging Manβ(1→4)GlcNAc bond was 
preformed in solution and then introduced using the disaccharide building block. This 
was our first attempt to apply the HPLC-baser synthesizer to the synthesis of 
branched oligosaccharides. The overall assembly stage was swift, 8 h total assembly 
time, and efficient (31% over all yield).   
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5.4   Experimental 
Column chromatography was performed on silica gel 60 (70-230 mesh), 
reactions were monitored by TLC on Kieselgel 60 F254. The compounds were 
detected by examination under UV light and by charring with 10% sulfuric acid in 
methanol. Solvents were removed under reduced pressure at <40 °C. CH2Cl2 and 
ClCH2CH2Cl (1,2-DCE) were distilled from CaH2 directly prior to application. 
Pyridine was dried by refluxing with CaH2 and then distilled and stored over 
molecular sieves (3 Å). Molecular sieves (3 Å or 4 Å), used for reactions, were 
crushed and activated in vacuo at 390 °C during 8 h in the first instance and then for 
2-3 h at 390 °C directly prior to application. Optical rotations were measured at ‘Jasco 
P-1020’ polarimeter. Unless noted otherwise, 1H n.m.r. spectra were recorded in 
CDCl3 at 300 MHz, 
13C n.m.r. spectra were recorded in CDCl3 at 75 or 150 MHz. 
Two-dimensional heteronuclear J-resolved spectra (HETERO2D) were recorded in 
CDCl3 at 600 MHz. 
 
5.4.1   Synthesis glycosyl acceptor 5.3 
N-(p-Benzoyloxymethyl)benzyloxycarbonyl-4-benzylaminobutyl 3,6-O-benzyl-2-
deoxy-2-phthalimido-β-D-glucopyranoside (5.9). A mixture of 5.7 (0.50 g, 0.94 
mmol), N-(p-benzoyloxymethyl)benzyloxycarbonyl-4-benzylaminobutanol (5.8, 0.45 
g, 1.13 mmol), and freshly activated molecular sieves (4 Å, 1.5 g) in CH2Cl2 (40 mL) 
was stirred under argon for 1 h at rt. N-Iodosuccinimide (NIS, 0.42 g, 1.88 mmol) and 
TfOH (17 μL, 0.18 mmol) were added, and the resulting mixture was stirred for 10 
min at rt. After that, the solids were filtered off through a pad of Celite and washed 
successively with CH2Cl2. The combined filtrate (~150 mL) was washed with sat. aq. 
Na2SO4 (10 mL) and water (3 x 10 mL). The organic phase was separated, dried with 
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MgSO4, and concentrated in vacuo. The residue was purified by column 
chromatography on silica gel (ethyl acetate - hexane gradient elution) to afford the 
title compound (0.75 g, 92%) as a colorless syrup. Analytical data for 5.9: Rf = 0.48 
(ethyl acetate / hexanes, 1/1.5, v/v); [α]D21 +13.6 (c = 1.0, CHCl3); 1H NMR (300 
MHz, CDCl3): δ, 1.21-1.33 (m, 4H, 2 x CH2), 2.95-3.04 (m, 2H, ½ NCH2, OH), 3.25-
3.31 (m, 1H, H-5), 3.60-3.64 (m, 1H, ½ NCH2), 3.62-3.78 (m, 3H, H-4, 6a, 6b), 4.06-
4.28 (m, 4H, OCH2, H-2, 3), 4.48-4.63 (m, 3H, 1 ½ CH2Ph), 4.72 (d, 1H, 
2J = 12.2 
Hz, ½ CH2Ph), 5.03-5.07 (m, 3H, H-1, CH2Ph), 5.33 (s, 2H, CH2Ph), 6.91-7.61 (m, 
26H, aromatic), 8.04-8.06 (d, 2H, aromatic) ppm; 13C NMR (75 MHz, CDCl3): δ, 
27.0, 55.5, 66.6, 74.0 (x2), 78.8, 98.5, 107.5 (x2), 127.5, 128.0 (x4), 128.1 (x8), 128.2 
(x4), 128.3 (x4), 128.5 (x4), 128.6 (x4), 128.7 (x8), 129.9 (x4), 130.5, 133.2 (x2), 
137.7, 138.0 ppm; HR-FAB MS [M+Na]+ calcd 941.3625 for C55H54N2O11Na, found 
941.3635. 
 
N-(p-Succinoyloxymethyl)benzyloxycarbonyl-4-benzylaminobutyl 3,6-di-O-
benzyl-2-deoxy-2-phthalimido-β-D-glucopyranoside (5.10) A 1 M solution of 
NaOMe in MeOH (2.0 mL) was added to a solution of 5.9 (0.60 g, 0.69 mmol) in 
MeOH (25 mL) and CH2Cl2 (5.0 mL) and the resulting mixture was stirred for 1 h at 
rt. DOWEX (H+) was added until pH = 6, the resin was filtered off, and rinsed 
successively with CH2Cl2 (5 x 5.0 mL) and MeOH (5 x 5.0 mL). The combined 
filtrate (~80 mL) was concentrated and dried in vacuo for 6 h. The crude residue was 
dissolved in pyridine (20 mL), succinic anhydride (0.11 g, 1.10 mmol) was added. and 
the resulting mixture was stirred under argon for 18 h at 65 °C. After that, the 
volatiles were removed under the reduced pressure, the residue was co-evaporated 
with toluene (3 x 10 mL), and purified by column chromatography on silica gel 
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(methanol – dichloromethane) to afford the title compound (0.52 g, 78%) as a 
colorless foam. Analytical data for 5.10: Rf = 0.41 (methanol/ dichloromethane, 1/10, 
v/v); [α]D21 +16.7 (c = 1.0, CHCl3); 1H NMR (300 MHz, CDCl3): δ, 1.19-1.31 (m, 4H, 
2x CH2), 2,26 (s, 4H, 2x CH2), 2.95-3.04 (m, 2H, ½ NCH2, OH), 3.40-3.43 (m, 1H, H-
5), 3.58-3.64 (m, 1H, ½ NCH2), 3.72-3.77 (m, 3H, H-4, 6a, 6b), 4.07-4.23 (m, OCH2, 
H-2, 3), 4.49-4.63 (m, 1 ½ CH2Ph),4.73 (d, 1H, 
2J = 12.2 Hz , ½ CH2Ph), 5.01-5.10 
(m, 5H, 2 x CH2Ph, H-1), 6.90-7.74 (m, 26h, aromatic), 8.59-8.60 (d, 2H, aromatic) 
ppm; 13C NMR (75 MHz, CDCl3): δ, 24.9, 25.4, 27.4, 28.9, 55.5 (x2), 65.5, 66.4, 
70.4, 73.9, 74.2, 74.5, 75.0,  82.3, 65.5, 66.4, 70.4, 73.9, 75.0, 78.9, 98.5, 127.6 (x4), 
128.0 (x4), 128.1 (x4), 128.3 (x5), 128.4, 128.7 (x8), 133.1, 137.7, 148.0, 157.3, 
172.2   ppm; HR-FAB MS [M+Na]+ calcd 937.3426 for C52H54N2O13Na, found 
937.3514. 
 
Resin-bound acceptor (5.3)  JandaJelTM amine resin (1% cross-linked polystyrene, 
400 mg, 0.20 mmol) was added to a solution of 5.12 (270 mg, 0.29 mmol), 1-ethyl-3-
(3-dimethylaminopropyl)carbodiimide hydrochloride (EDC, 169 mg, 0.88 mmol), and 
DMAP (43 mg, 0.35 mmol) in CH2Cl2 (10.0 mL) and the resulting suspension was 
agitated under argon for 18 h at rt. After that, the resin was filtered off, washed with 
CH2Cl2 (3 x 20 mL), methanol (3 x 20 mL) and CH2Cl2 (3 x 20 mL). The combined 
filtrate was concentrated and dried in vacuo for 4 h. The loading (0.22 mmol/g) of the 
acceptoron the solid phase support was determined by cleaving off the linker from 
0.50 g of the resin.  
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5.4.2   Synthesis of Glycosyl Donors 5.4 and 5.5 
Ethyl 2,4-di-O-benzyl-3,6-di-O-picoloyl-1-thio-α-D-mannopyranoside (5.12).  The 
title compound was synthesized according to the reported procedure and its analytical 
data was essentially the same as reported previously.8 
 
2,4-Di-O-benzyl-3,6-di-O-picoloyl-α-D-mannopyranosyl dibutyl phosphate (5.5).  
A mixture of 5.7 (490 mg, 0.79 mmol), dibutyl phosphate (0.43 mL, 2.39 mmol), and 
freshly activated molecular sieves (4 Å, 1.5 g) in CH2Cl2 (10 mL) was stirred under 
argon for 1 h at rt.  After that, NIS (227 mg, 1.03 mmol) and TfOH (9 µL, 0.10 mmol) 
were added and the resulting mixture was stirred for 1 h at rt. The solid was filtered 
off and rinsed successively with CH2Cl2. The combined filtrate (~40 mL) was washed 
with sat. aq. Na2SO4 (10 mL) and water (3 x 10 mL). The organic phase was 
separated, dried with MgSO4, and concentrated in vacuo. The residue was purified by 
column chromatography on silica gel (ethyl acetate - hexane gradient elution) to 
afford the title compound (0.61 g, 99%) as a clear syrup. Analytical data for 5.4: Rf = 
0.29 (ethyl acetate / hexanes, 1/1.5, v/v); [α] D21 +20.6 (c = 1.0, CHCl3); 1H NMR (300 
MHz, CDCl3): δ, 0.84-0.92 (2 m, 6H, 2 x CH3), 1.34-1.41 (2 m, 4H, 2 x CH2), 1.53-
1.65(2 m, 4H, 2 x CH2), 3.89-4.12 (m, 5H, H-2, 2 x CH2), 4.22-4.25 (m, 1H, H-5), 
4.38 (dd, 1H, J4,5 = 9.7 Hz, H-4), 4.55-4.70 (m, 5H, 1 ½ CH2Ph, H-6a, 6b), 4.82 (d, 
1H, 2J = 10.8 Hz, ½ CH2Ph), 5.57 (dd, 1H, J3,4  = 9.5 Hz, H-3), 5.80 (d, 1H, J1,2  = 6.4 
Hz, H-1), 7.09-8.03 (5 m, 16H, aromatic), 8.03-8.78 (m, 2H, aromatic) ppm; 13C 
NMR (75 MHz, CDCl3): δ, 13.6 (x2), 18.6 (x2), 29.6, 32.2, 63.7, 68.0 (x2), 71.7, 
72.0, 73.0, 74.5, 75.0, 75.3, 95.2, 125.3, 125.4, 126.9, 127.1, 127.8 (x4), 128.2 (x2), 
128.3 (x4), 136.9, 137.0, 137.3, 147.5, 147.6, 150.0 (x2), 164.2, 164.5, 178.0 ppm; 
HR-FAB MS [M+Na]+ calcd 785.2815 for C40H47O11NPNa, found 785.2830. 
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Ethyl 2,3,4,6-tetra-O-benzoyl-1-thio-α-D-mannopyranoside (5.11).  The synthesis 
of the title compound was performed in accordance with the reported procedure and 
its analytical data was in accordance with that previously described.10 
 
2,3,4,6-Tetra-O-benzoyl-α-D-mannopyranosyl dibutyl phosphate (5.4).  A mixture 
of 5.11 (1.30 g, 2.0 mmol), dibutyl phosphate (1.18 mL, 6.0 mmol), and freshly 
activated molecular sieves (4 Å, 3 g) in CH2Cl2 (25 mL) was stirred under argon for 
20 min at rt.  After that, NIS (572 mg, 2.6 mmol) and TfOH (23µL, 0.26 mmol) were 
added and the resulting mixture was stirred for 18 h at rt. The solid was then filtered 
off and rinsed successively with CH2Cl2. The combined filtrate (~40 mL) was washed 
with sat. aq. Na2SO4 (10 mL) and water (3 x 10 mL). The organic phase was 
separated, dried with MgSO4, and concentrated in vacuo. The residue was purified by 
column chromatography on silica gel (ethyl acetate - hexane gradient elution) to 
afford the title compound (1.5 g, 95%) as a clear syrup.  Analytical data for 5.4: Rf = 
0.33 (ethyl acetate / hexanes, 3/7, v/v); [α] D21 -49.2(c = 1.0, CHCl3); 1H NMR (300 
MHz, CDCl3): δ, 0.87-0.89 (2 m, 6H, 2 x CH3), 1.35-1.44 (2 m, 4H, 2 x CH2), 1.64-
1.70 (2 m, 4H, 2 x CH2), 4.07-4.19 (2 m, 4H, 2 x OCH2), 4.47 (dd, 1H, J = 3.93 Hz, 
H6a) 4.60-4.68 (m, 2H, H-5, 6a), 5.75 (d, 1H, J = 2.2 Hz, H-1), 5.84-5.89 (m, 1H, H-
2), 5.71 (d, 1H, J = 3.21 Hz, H-3), 6.18 (dd, 1H, J = 10.1 Hz, H-4), 7.21-7.57 (m, 
12H, aromatic), 7.78-8.08 (m, 8H, aromatic) ppm; 13C NMR (75 MHz, CDCl3): δ, 
13.5 (x2), 13.6 (x2), 18.6, 32.1, 32.2, 62.2, 66.0, 68.2, 68.3, 69.3, 69.7, 70.5, 94.9, 
128.3 (x3), 128.4 (x3), 128.6 (x3), 128.7 (x3), 128.8, 129.7 (x3), 129.8 (x3), 133.1, 
133.3, 133.5, 133.6, 164.9, 165.2, 165.3, 165.7 ppm; HR-FAB MS [M+Na]+ calcd 
811.2451for C42H45O13PNa, found 811.2493. 
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5.4.3   Synthesis of disaccharide Glycosyl Donors 5.17 
tert-Butyldimethylsilyl 3,6-di-O-benzyl-2-deoxy-2-phthalimido-β-D-
glucopyranoside (5.14).  The synthesis of the title compound was performed in 
accordance with the reported procedure and its analytical data was in accordance with 
that previously described.11 
 
Ethyl 2-O-benzyl-4,6-O-benzylidene-3-O-picoloyl-1-thio-α-D-mannopyranoside 
(5.16).  The synthesis of the title compound was performed in accordance with the 
reported procedure and its analytical data was in accordance with that previously 
described.8 
 
tert-Butyldimethylsilyl O-(2-O-benzyl-4,6-O-benzylidene-3-O-picoloyl-β-D-
mannopyranosyl)-(1→4)-3,6-di-O-benzyl-2-deoxy-2-phthalimido-β-D 
glucopyranoside (5.17).  A mixture of 5.15 (1.76 g, 3.48 mmol), 5.14 (1.5 g, 2.48 
mmol), and freshly activated molecular sieves (4 Å, 4.5 g) in CH2Cl2 (550 mL) was 
stirred under argon for 20 min at rt.  After that, NIS (2.26 g, 10 mmol) and TfOH (187 
µL, 1.2 mmol) were added and the resulting mixture was stirred for 6 h at rt. The solid 
was then filtered off and rinsed successively with CH2Cl2. The combined filtrate 
(~800 mL) was washed with sat. aq. Na2SO4 (50 mL) and water (3 x 50 mL). The 
organic phase was separated, dried with MgSO4, and concentrated in vacuo. The 
residue was purified by column chromatography on silica gel (ethyl acetate-hexane 
gradient elution) to afford the title compound (3.0 g, 95%) as a clear syrup.  
Analytical data for 5.17: Rf = 0.32 (ethyl acetate / dichloromethane, 1/19, v/v); [α] D21 
-70.6 (c = 1.0, CHCl3); 
1H NMR (300 MHz, CDCl3): δ, -0.28 (s, 3H, CH3), -0.27 (s, 
3H, CH3), 0.46 (s, 9H, C(CH3)3), 3.10-3.15 (m, 1H, H-5’), 3.34-3.42 (m, 2H, H-5, 6a), 
3.50-3.54 (m, 2H, H-1’, 6b), 3.89-4.15 (m, 4H, H-2, 3, 4, 6a’), 4.29 (d, 1H, 2J = 12.3 
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Hz , ½ CH2Ph), 4.40 (d, 1H, 
2J = 12.1 Hz , ½ CH2Ph), 4.46-4.73 (m, 4H, 2 x CH2Ph), 
4.97 (dd, 1H, J = 3.21 Hz, H-3’), 5.16 (d, 1H, J1,2 = 8.0 Hz, H-1), 5.31 (s, 1H, CHPh), 
6.68-7.61 (m, 26H, aromatic), 7.82-7.84 (m, 1H, aromatic), 8.59-8.60 (m, 1H, 
aromatic) ppm; 13C NMR (75 MHz, CDCl3): δ, 4.01, 5.01, 17.7, 25.5 (x3), 58.0, 67.4, 
68.7 (x2), 73.7, 73.9, 74.5, 74.9, 75.6, 75.8, 76.5, 76.8, 79.5, 93.6, 101.6, 101.7, 
125.6, 126.3 (x3), 127.1 (x2), 127.7, 127.9 (x6), 128.0 (x3), 128.1, 128.4 (x9), 128.7 
(x3), 129.1, 137.0, 137.4, 138.0, 138.1, 139.0, 147.7, 150.2, 164.3 ppm; HR-FAB MS 
[M+Na]+ calcd for C60H64N2O13NaSi 1071.4074, found 1071.4064. 
 
tert-Butyldimethylsilyl O-(2-O-benzyl-4,6-O-benzylidene-β-D-mannopyranosyl)-
(1→4)-3,6-di-O-benzyl-2-deoxy-2-phthalimido-β-D-glucopyranoside (5.18).  A 1 
M solution of NaOMe in MeOH (3.0 mL) was added to a solution of 5.17 (2.37 g, 
2.26 mmol) in CH2Cl2 (10 mL) and MeOH (20 mL) and the resulting mixture was 
stirred for 1 h at rt. DOWEX (H+) was added until pH = 6, the resin was filtered off, 
and rinsed successively with CH2Cl2 (5 x 10 mL) and MeOH (5 x 10 mL). The 
combined filtrate (~140 mL) was concentrated in vacuo and the residue was purified 
by column chromatography on silica gel (ethyl acetate-hexane gradient elution) to 
give the title compound as a white amorphous solid in 98% yield (2.1 g, 2.2 mmol). 
Analytical data for 5.18: Rf = 0.73 (ethyl acetate / hexane gradient elution, 1/1, v/v); 
[α]D21 +11.5 (c = 1.0, CHCl3); 1H NMR (300 MHz, CDCl3): δ, -0.24 (s, 3H, CH3), -
0.08 (s, 3H, CH3), 0.51 (s, 9H, C(CH3)3), 2.20 (d, 1H, J = 8.52 Hz, OH), 3.03-3.08 
(m, 1H, H-5’), 3.49-3.65 (m, 6H, H-6a, 6b, 2’, 3’, 4’, 5), 3.90-4.16 (m, 5H, H-2, 3, 4, 
6a’, 6b’), 4.30 (d, 1H, 2J = 12 Hz , ½ CH2Ph), 4.38 (d, 1H, 2J = 12 Hz , ½ CH2Ph), 
4.51-4.62 (m, 2H, CH2Ph), 4.72 (d, 1H, 
2J = 12 Hz , ½ CH2Ph), 4.89 (d, 1H, 
2J = 12 
Hz , ½ CH2Ph), 5.19 (d, 1H, J = 9 Hz, H-1), 5.30 (s, 1H, CHPh), 6.72-6.82 (m, 5H, 
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aromatic), 7.15-7.33 (m, 14H, aromatic), 5.52-7.53 (m, 5H, aromatic) ppm; 13C NMR 
(75 MHz, CDCl3): δ, 4.08, 5.34, 17.7, 25.4 (x3), 57.9, 67.0, 68.6, 68.7, 71.0, 73.8, 
74.5, 75.8, 79.0, 79.3, 79.8, 93.6, 102.0, 102.2, 126.4 (x3), 127.1, 127.8 (x3), 127.9 
(x3), 128.0 (x19), 128.1, 128.3 (x3), 128.6 (x3), 128.7 (x3), 129.1, 137.3, 137.8, 
138.2, 138.9 ppm; HR-FAB MS [M+Na]+ calcd for C54H61NO12NaSi 966.3860, found 
966.3871. 
 
tert-Butyldimethylsilyl O-(2,4-di-O-benzyl-β-D-mannopyranosyl)-(1→4)-3,6-di-
O-benzyl-2-deoxy-2-phthalimido-β-D-glucopyranoside (5.19). Copper (II) 
trifluoromethanesulfonate (80 mg, 0.22 mmol) was added to a solution of 5.18 (2.1 g, 
2.2 mmol) in a 1 M soln. of BH3 in THF (11 mL) and the resulting mixture was stirred 
under argon for 1 h at rt. The reaction mixture was cooled to 0 ºC and quenched with 
triethylamine (~1 mL) until pH = 7 and the volatiles were removed in vacuo. The 
residue was purified by column chromatography on silica gel (ethyl acetate-hexane 
gradient elution) to give 5.19 as white amorphous solid in 77% yield (1.62 g, 1.71 
mmol). Analytical data for 5.19: Rf =0.4 (ethyl acetate-hexane, 1/1, v/v); [α]D21 
+18.5(c = 1.0, CHCl3); 
1H NMR (300 MHz, CDCl3): δ, -0.22 (s, 3H, CH3), -0.07 (s, 
3H, CH3), 0.55 (s, 9H, C(CH3)3), 189 (dd, 1H, J = 6.87 Hz, OH), 2.19 (dd, 1H, J = 
9.36 Hz, OH), 3.06-3.09 (m, 1H, H-5’), 3.33-3.65 (m, 9H, H-5. 6a, 6b, 1’, 2’, 3’, 4’, 
6a’, 6b’), 3.92 (dd, 1H, J = 9.0 Hz, H-4), 4.02 (d, 1H, J = 8.0 Hz, H-2), 4.18 (dd, 1H, 
J = 9.67 Hz, H-3), 4.33 (d, 1H, 2J = 12 Hz , ½ CH2Ph), 4.40-4.60 (m, 4H, 2x CH2Ph), 
4.75 (dd, 2H, 2J = 12.0 Hz, CH2Ph), 4.92 (d, 1H, 
2J = 12.0 Hz , ½ CH2Ph), 5.23 (d, 
1H, J = 9.0 Hz, H-1), 6.77-6.84 (m, 5H, aromatic), 7.13-7.25 (m, 15H, aromatic), 
7.53-7.56 (m, 4H, aromatic) ppm; 13C NMR (75 MHz, CDCl3); δ, 4.7, 5.2, 17.7, 25.5 
(x2), 58.3, 62.5, 68.7, 73.8, 74.4, 74.5, 74.9, 75.0, 75.3, 77.0, 78.4, 79.2, 93.6, 101.5, 
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107.5, 127.3 (x2), 127.5 (x2), 128.0 (x6), 128.1 (x6), 128.6 (x4), 128.7 (x4), 128.8 
(x4), 137.9, 138.3, 138.4, 138.5 ppm; HR-FAB MS [M+Na]+ calcd for 
C54H63NO12NaSi 968.4016, found 968.4003. 
 
tert-Butyldimethylsilyl O-(2,4-di-O-benzyl-3,6-O-picoloyl-β-D-mannopyranosyl)-
(1→4)-3,6-di-O-benzyl-2-deoxy-2-phthalimido-β-D-glucopyranoside (5.20) 
Picolinic acid (2.08 g, 16.9 mmol), 3-(ethyliminomethyleneamino)-N,N-
dimethylpropan-1-amine (EDC, 3.23 g, 1.69 mmol), and DMAP (237 mg, 1.94 mmol) 
were added to a solution of 5.18 (1.22 g, 1.67 mmol) in CH2Cl2 (70 mL) and the 
resulting mixture was stirred under argon for 20 min at rt. The reaction mixture was 
diluted with CH2Cl2 (~100 mL) and was washed with cold water (10 mL), sat. aq. 
NaHCO3 (10 mL), and water (10 mL). The organic phase was separated, dried with 
magnesium sulfate, and concentrated in vacuo. The residue was purified by column 
chromatography on silica gel (ethyl acetate-hexane gradient elution) to give the title 
compound white amorphous solid in 95% yield (1.67 g, 1.44 mmol). Analytical data 
for 5.20: Rf = 0.25 (ethyl acetate/hexane, 1/1, v/v); [α]D21 -36.5 (c = 1.0, CHCl3); 1H 
NMR (300 MHz, CDCl3): δ, -0.13, 0.02 (2 s, 6H, 2 x CH3), 0.64 (s, 9H, C(CH3)3), 
3.51-3.72 (m, 4H, H-5, 5’, 6a, 6b), 4.09-4.29 (m, 5H, H-2, 3, 4, 4’, 6b’), 4.41 (dd, 1H, 
J = 6 Hz, H-6a’), 4.48-4.89 (m, 10H, 4 x CH2Ph, H-1’, 2’), 5.16 (dd, 1H, J = 6.0 Hz, 
H-3’), 5.29 (d, 1H, J = 9.0 Hz, H-1), 6.62-6.77 (m, 5H, aromatic), 7.09-7.80 (m, 23H, 
aromatic), 7.96-8.01 (m, 2H, aromatic), 8.61-8.63 (m, 1H, aromatic), 8.78-82 (m, 1H , 
aromatic) ppm; 13C NMR (75 MHz, CDCl3); 4.0, 5.3, 17.7, 25.5 (x3), 58.1, 64.5, 68.6, 
73.3, 73.4, 73.7, 74.5, 74.8, 74.9, 75.0, 75.7, 76.7, 80.1, 93.6, 101.3, 107.5, 125.4, 
125.7, 126.9 (x2), 127.2, 127.7, 127.7 (x2), 127.9, (x4), 128.0 (x5), 128.2 (x8), 128.3 
(x2), 128.5 (x2), 128.7 (x2), 137.1, 137.6, 137.7, 137.9, 138.4, 138.9, 147.7, 147.8, 
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149.9, 150.3, 164.3, 164.7 ppm; HR-FAB MS [M+Na]+ calcd for C66H69N3O14NaSi 
1178.4447 found 1178.4457 
 
O-(2,4-Di-O-benzyl-3,6-O-picoloyl-β-D-mannopyranosyl)-(1→4)-3,6-di-O-benzyl-
2-deoxy-2-phthalimido-β-D-glucopyranose (5.21) A 1 M soln. of 
tetrabutylammonium fluoride (TBAF, 4.7 mmol) in THF (1.36 mL) was added to a 
solution of compound 5.20 (1.65 g, 1.4 mmol) in dry THF (45 mL) and the resulting 
mixture was stirred for 2 h at rt. The volatiles were removed under the reduced 
pressure. The residue was purified by column chromatography on silica gel (ethyl 
acetate-hexane gradient elution) to afford the title compound that was contaminated 
with a tetrabutyl ammonium salt. To simplify the separation, the entire mixture was 
dissolved in pyridine (10 mL), acetic anhydride (5 mL) was added and the resulting 
mixture was stirred for 18 h at rt. The reaction mixture was quenched with CH3OH 
(~1.0 mL) and the volatiles were removed under the reduced pressure. The residue 
was diluted with CH2Cl2 (10 mL) and washed with 1 N HCl (2 x 5 mL), water (10 
mL), sat. aq. NaHCO3 (10 mL), and water (2 x 10 mL). The organic phase was 
separated, dried with MgSO4, and concentrated in vacuo.  The residue was purified by 
column chromatography on silica gel (ethyl acetate-hexane gradient elution) to afford 
the acetylated intermediate. The latter was dissolved in DMF (10 mL), hydrazine 
acetate (80 mg) was added and the resulting mixture was stirred for 1h. The reaction 
mixture was concentrated by continuous flashing with a stream of air. The residue 
was purified by column chromatography on silica gel (ethyl acetate-hexane gradient 
elution) to give the title compound as a white amorphous solid in 60% yield (850 mg, 
0.84 mmol). Analytical data for 5.20: Rf = 0.42 (ethyl acetate/hexane, 1/1.5, v/v); 
[α]D22 +28.6 (c = 1.0, CHCl3); 1H NMR (300 MHz, CDCl3): δ, 3.52-3.71 (m, 4Hm H-
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5, 6a, 6b, 5’), 3.98-4.17 (m, 4H, H-2, 4, 4’, 6a’), 4.27 (dd, 1H, J = 9.0 Hz, H-3), 4.41-
4.72 (m, 9H, 3x CH2Ph, H-1’, 2, 6b’),  4.85 (dd, 2H, 2J = 12.0 Hz, CH2Ph), 5.04 (dd, 
1H, J = 3.0 Hz, H-3’), 5.28 (d, 1H, J = 9.0 Hz, H-1), 6.60-6.75 (m, 4H, aromatic), 
7.07-7.99 (m, 26H, aromatic), 8.62-8.94 (m, 1H, aromatic) 8.78-8.79 (m, 1H, 
aromatic) ppm; 13C NMR (75 MHz, CDCl3); 57.3, 64.0, 68.3, 72.7, 73.0, 74.3, 74.4, 
74.6, 74.7, 75.6, 79.5, 92.7, 100.8, 123.1, 125.1, 125.4, 126.6 (x2), 127.0 (x2), 127.4 
(x6), 127.5 (x3), 127.8 (x6), 129.9 (x5), 128.1 (x2), 128.5 (x2), 131.4 (x2), 133.5, 
136.8, 137.1, 137.3, 137.4, 138.0, 138.5, 147.2, 147.3, 149.6, 150.0, 162.5, 163.9, 
164.2 ppm; HR-FAB MS [M+Na]+ calcd for C60H55N3O14Na 10643581, found 
1064.3549 
 
O-(2,4-Di-O-benzyl-3,6-O-picoloyl-β-D-mannopyranosyl)-(1→4)-3,6-O-benzyl-2-
deoxy-2-phthalimido-β-D-glucopyranosyl trichloroacetimidate (5.6).  CCl3CN (80 
μL, 4.0 mmol) and DBU (3.0 μL, 0.02 mmol) were added to a solution of 5.21 (200 
mg, 0.2 mmol) in CH2Cl2 (5.0 mL) and the resulting mixture was stirred for 2 h at rt.  
After that, the volatiles were removed in vacuo and the residue was purified by 
column chromatography on silica gel (ethyl acetate-hexane gradient elution) to give 
the title compound in 83% yield (192 mg, 0.165 mmol) as a white amorphous solid. 
Analytical data for 5.6: Rf = 0.45 (ethyl acetate/hexane, 6/4, v/v); [α]D22 +33.6 (c = 
1.0, CHCl3); 
1H NMR (300 MHz, CDCl3): δ, 3.54-3.67 (m, 1H, H-5’), 3.68-3.82 (m, 
3H, H-4, 2’,4’), 4.29-4.89 (m, 11H, 3 x CH2Ph, H-1’, 2, 3, 6a’, 6b’) 4.86 (dd, 2H, 2J = 
12 Hz, CH2Ph), 5.05 (dd, 1H, J = 9 Hz, H-3’), 6.37 (d, 1H, J = 9 Hz, H-1), 6.60-6.76 
(m, 5H, aromatic), 7.09-8.03 (m, 26H, aromatic), 8.51 (s, 1H, NH), 8.64-8.66 (d, 1H, 
aromatic), 8.78-8.80 (d, 1H, aromatic) ppm; 13C NMR (75 MHz, CDCl3): δ, 14.2, 
21.0, 54.5, 60.3, 64.2, 67.9, 72.9, 73.1, 73.5, 74.6, 74.7, 74.8, 75.5, 75.6, 79.1, 90.3, 
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94.0, 100.8, 123.2, 125.2, 125.6, 126.7,126.8, 127.1, 127.5 (x2), 127.6 (x2), 127.8 
(x2), 128.8 (x3), 127.9 (x3), 128.0 (x4), 128.1 (x2), 128.3 (x3), 128.6 (x2), 131.3, 
133.7, 136.9, 137.3, 137.4, 137.5, 138.1, 138.5, 147.4, 147.5, 149.8, 150.1, 160.8, 
164.1, 164.4 ppm; HR-FAB MS [M+Na]+ calcd 1207.2678 for C62H55Cl3N4O14Na, 
found 1207.2658 
 
5.4.4   HPLC-mediated synthesis of disaccharide and pentasaccharide  
A general procedure for glycosylation and cleavage.  Functionalized JandaJel 
resin 5.3 (50 mg, 0.011 mmol) was packed in an OmnifitTM glass chromatography 
column and the latter was integrated into the HPLC system. Pump D was programmed 
to deliver CH2Cl2 at 1.0 mL/min, and the eluate was discarded after washing for 5 min 
(5 mL,). The system was then switched to the recirculation mode and the delivery of 
CH2Cl2 continued for 30 min at 1.0 mL/min (swelling). After that, pump D was 
stopped and pump C was programmed to deliver a solution of glycosyl donor (5.5 - 
5.4 - 5.6 0.11 mmol) in CH2Cl2 (2 mL) at a flow rate of 0.5 mL/min. This step was 
monitored by the integrated UV detector (λmax = 254 nm). The integrated autosampler 
was programmed to inject a solution of the promoter in CH2Cl2 (3 x 100 μL) at 10, 
12, and 14 min and the resulting mixture (~2.3 mL) was recirculated for 60-90 min 
until the UV detector recorded no change in absorbance of the eluate. After that, pump 
C was stopped and pump D was programmed to deliver CH2Cl2 at 1.0 mL/min, and 
the eluate was discarded after washing for 10 min (10 mL). After that, pump D was 
stopped and pump B was programmed to deliver a 0.1 M solution of NaOMe in 
CH3OH/CH2Cl2 (10 mL, 0.04/1/1, v/v/v) that was recirculated at 1.0 mL/min for 20 
min. Pump B was stopped and pump D was programmed to deliver CH2Cl2 at 1.0 
mL/min for 10 min, and the combined eluate was neutralized with Dowex (H+) resin. 
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The resin was filtered off, washed successively with CH2Cl2 and CH3OH, and the 
combined filtrate was concentrated in vacuo to afford the crude residue that was 
subjected to subsequent acetylation.  
A general procedure for acetylation of released oligosaccharide.  A crude 
residue was redissolved in pyridine (2.0 mL), Ac2O (73 µL, 0.771 mmol) was added 
dropwise and the resulting mixture was stirred for 16 h at rt. The reaction mixture was 
quenched with CH3OH (~1.0 mL) and the volatiles were removed under the reduced 
pressure. The residue was diluted with CH2Cl2 (20 mL) and washed with 1 N HCl (2 
x 10 mL), water (20 mL), sat. aq. NaHCO3 (20 mL), and water (2 x 20 mL). The 
organic phase was separated, dried with MgSO4, and concentrated in vacuo. The 
residue was purified by column chromatography on silica gel (ethyl acetate – toluene 
gradient elution) to afford oligosaccharide.  
 
N-(p-Acetoxymethyl)benzyloxycarbonyl-4-benzylaminobutyl O-(4,6-di-O-acetyl- 
2,3-O-benzyl-α/β-D-mannopyranosyl)-(1→4)-3,6-di-O-benzyl-2-deoxy-2-
phthalimido-β-D glucopyranoside (5.13).  Functionalized JandaJel resin 5.3 (50 mg, 
0.011 mmol) was packed in an OmnifitTM glass chromatography column and the latter 
was integrated into the HPLC system. Pump D was programmed to deliver CH2Cl2 at 
1.0 mL/min, and the eluate was discarded after washing for 5 min (5 mL, step 1). The 
system was then switched to the recirculation mode and the delivery of CH2Cl2 
continued for 30 min at 1.0 mL/min (swelling, step 2). After that, pump D was 
stopped and pump C was programmed to deliver a solution of donor 5.4 (83 mg, 0.11 
mmol) in CH2Cl2 (2 mL) at a flow rate of 0.5 mL/min (step 3). This step was 
monitored by the integrated UV detector (λmax = 254 nm). The integrated autosampler 
was programmed to inject a solution of TMSOTf (20 μL, 0.11  mmol) in CH2Cl2 (3 x 
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100 μL) at 10, 12, and 14 min and the resulting mixture (~2.3 mL) was recirculated 
for 60-90 min until the UV detector recorded no change in absorbance of the eluate. 
After that, pump C was stopped and pump D was programmed to deliver CH2Cl2 at 
1.0 mL/min, and the eluate was discarded after washing for 10 min (10 mL, step 4). 
After that, pump D was stopped and pump B was programmed to deliver a 0.1 M 
solution of NaOMe in CH3OH/CH2Cl2 (10 mL, 0.04/1/1, v/v/v) that was recirculated 
at 1.0 mL/min for 20 min (step 5). Pump B was stopped and pump D was 
programmed to deliver CH2Cl2 at 1.0 mL/min for 10 min, and the combined eluate 
was neutralized with Dowex (H+) resin. The resin was filtered off, washed 
successively with CH2Cl2 and CH3OH, and the combined filtrate was concentrated in 
vacuo to afford the crude residue that was subjected to subsequent acetylation in 
accordance with the general procedure, as described for the synthesis of compound 
5.13. The crude residue was purified by column chromatography on silica gel (ethyl 
acetate – hexane gradient elution) to afford tetrasaccharide 5.13 in 86% yield. 
Analytical data for 5.13: Rf  = 0.52 (ethyl acetate/hexane, 1/1, v/v); [α]D22 + 1.6 (c = 
1.0, CHCl3); 1H NMR (300 MHz, CDCl3): 1.29-1.55 (m, 4H, CH2), 1.89-2.07 (m, 9H, 
3 x CH3), 2.90-3.12 (m, 2H, CH2), 3.20-40 (m, 2H), 3.5-4.10 (m, 7H), 4.12-4.59 (m, 
11H, 4 x CH2Ph), 5.05-5.12 (m, 6H), 6.87-7.34 (m, 28H, aromatic), 7.58-7.82 (m, 5, 
aromatic) ppm; 13C NMR (75 MHz, CDCl3): δ 25.7, 26.7, 51.2, 56.0, 56.5, 68.5, 68.8, 
71.3, 73.0, 73.2, 74.1, 74.6, 74.7, 74.9, 75.8, 76.1, 78.7, 97.4, 98.4, 123.5, 124.0, 
127.3, 127.7 (x3), 127.8, 128.1 (x3), 128.1 (x3), 128.2 (x6), 128.3 (x3), 128.5 (x3), 
128.6 (x3), 128.9 (x4), 132.0, 132.2, 134.3, 134.4, 138.7 (x2), 139.0, 168.8, 168.8 
ppm; HR-FAB MS [M+Na]+ calcd for C74H78N2O18Na 1305.5148, found 1305.5157. 
 
Salvatore G. Pistorio| UMSL 2016 | Page 165 
 
N-(p-Acetoxymethyl)benzyloxycarbonyl-4-benzylaminobutyl di-O-(2,3,4,6-tetra-
O-acetyl-α-D-mannopyranosyl)-(1→3,1→6)-O-(2-O-benzyl-α/β-D 
mannopyranosyl)-(1→4)-O-(3,6-di-O-benzyl-2-deoxy-2-phthalimido-β-D 
glucopyranosyl)-(1→4)-3,6-di-O-benzyl-2-deoxy-2-phthalimido-β-D-
glucopyranoside (5.2).  Functionalized JandaJel resin 5.3 (50 mg, 0.011 mmol) was 
packed in an OmnifitTM glass chromatography column and the latter was integrated 
into the HPLC system. Pump D was programmed to deliver CH2Cl2 at 1.0 mL/min, 
and the eluate was discarded after washing for 5 min (5 mL, step 1). The system was 
then switched to the recirculation mode and the delivery of CH2Cl2 continued for 30 
min at 1.0 mL/min (swelling, step 2). After that, pump D was stopped and pump C 
was programmed to deliver a solution of donor 5.5 (128 mg, 0.11 mmol) in CH2Cl2 (2 
mL) at a flow rate of 0.5 mL/min (step 3). This step was monitored by the integrated 
UV detector (λmax = 254 nm). The integrated autosampler was programmed to inject a 
solution of TMSOTf (20 μL, 0.11 mmol) in CH2Cl2 (3 x 100 μL) at 10, 12, and 14 
min and the resulting mixture (~2.3 mL) was recirculated for 60-90 min until the UV 
detector recorded no change in absorbance of the eluate. After that, pump C was 
stopped and pump D was programmed to deliver CH2Cl2 at 1.0 mL/min, and the 
eluate was discarded after washing for 10 min (10 mL, step 4). After that, pump D 
was stopped and pump A was programmed to deliver a solution of 
Cu(AcO)2/MeOH/CH2Cl2 (50mg/1/10, g/v/v) for 20 min at 1.0 mL/min (step 5). This 
step was monitored by the integrated UV detector (λmax = 254 nm). After that, pump A 
was stopped and pump D was programmed to deliver CH2Cl2 at 1.0 mL/min, and the 
eluate was discarded after washing for 10 min (10 mL, step 6). After that, pump D 
was stopped and pump C was programmed to deliver a solution of donor 5.6 (87 mg, 
0.11 mmol) in CH2Cl2 (2 mL) at a flow rate of 0.5 mL/min (step 7). This step was 
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monitored by the integrated UV detector (λmax = 254 nm). The integrated autosampler 
was programmed to inject a solution of TMSOTf (20 μL, 0.11  mmol) in CH2Cl2 (3 x 
100 μL) at 10, 12, and 14 min and the resulting mixture (~2.3 mL) was recirculated 
for 60-90 min until the UV detector recorded no change in absorbance of the eluate. 
After that, pump C was stopped and pump D was programmed to deliver CH2Cl2 at 
1.0 mL/min, and the eluate was discarded after washing for 10 min (10 mL, step 8). 
After that, pump D was stopped and pump C was programmed to deliver a solution of 
donor 5.6 (87 mg, 0.11 mmol) in CH2Cl2 (2 mL) at a flow rate of 0.5 mL/min (step 
11). This step was monitored by the integrated UV detector (λmax = 254 nm). The 
integrated autosampler was programmed to inject a solution of TMSOTf (20 μL, 0.11 
mmol) in CH2Cl2 (3 x 100 μL) at 10, 12, and 14 min and the resulting mixture (~2.3 
mL) was recirculated for 60-90 min until the UV detector recorded no change in 
absorbance of the eluate. After that, pump C was stopped and pump D was 
programmed to deliver CH2Cl2 at 1.0 mL/min, and the eluate was discarded after 
washing for 10 min (10 mL, step 12). After that, pump D was stopped and pump B 
was programmed to deliver a 0.1 M solution of NaOMe in CH3OH/CH2Cl2 (10 mL, 
0.04/1/1, v/v/v) that was recirculated at 1.0 mL/min for 20 min (step 13). Pump B was 
stopped and pump D was programmed to deliver CH2Cl2 at 1.0 mL/min for 10 min, 
and the combined eluate was neutralized with Dowex (H+) resin. The resin was 
filtered off, washed successively with CH2Cl2 and CH3OH, and the combined filtrate 
was concentrated in vacuo to afford the crude residue that was subjected to 
subsequent acetylation in accordance with the general procedure, as described for the 
synthesis of compound 5.2. The crude residue was purified by column 
chromatography on silica gel (ethyl acetate – hexane gradient elution) to afford 
pentasaccharide 5.2 in 31% yield. Analytical data for 5.2: Rf = 0.6 (ethyl 
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acetate/hexane, 6/4, v/v); [α]D22 +40.7 (c = 1.0, CHCl3); 1H NMR (300 MHz, CDCl3): 
1.19-1.24 (m, 4H, 2 x CH2), 1.79-2.12 (m, 27H, 9 x CH3), 2.90-2.99 (m, 2H), 3.24-
3.37 (m, 5H), 3.44-3.87 (m, 13H), 4.07-4.20 (m, 10H), 4.37-4.63 (m, 8H), 4.71-4.89 
(m, 6H), 5.00-5.16 (m, 6H), 5.20-5.35 (m, 7H), 6.69-6.93 (m, 12H, aromatic), 7.17-
7.54 (m, 36H, aromatic) ppm; 13C NMR (75 MHz, CDCl3); δ, 14.3, 20.6, 20.7 (x3), 
20.8 (x5), 20.9, 21.1 (x2), 26.5, 31.0, 55.7, 56.4, 60.4, 62.4, 62.5, 62.4, 62.5, 65.8, 
66.0 (x3), 66.1, 66.7, 66.8, 68.5, 68.9, 69.0, 62.2, 69.5 (x2), 72.7, 73.4, 74.1, 74.4, 
74.5, 74.6, 74.8, 75.0, 75.1 (x2), 76.7, 77.8, 78.6, 82.1, 97.4, 97.5, 98.1, 99.7, 101.1, 
123.2, 123.5, 126.1, 127.1 (x2), 127.2 (x2), 127.3, 127.4 (x2), 127.5 (x4), 127.6, 
127.7 (x3), 127.8 (x3), 127.9 (x3), 128.0 (x10), 128.2 (x2), 128.3 (x3), 128.4 (x6), 
128.5 (x4), 128.7, 131.5, 131.9, 133.7, 134.0, 135.6, 136.9 (x2), 137.8, 137.9, 138.0, 
138.5, 138.7 (x2), 167.5, 168.4, 169.6, 169.7, 169.8, 170.0, 170.5, 170.7, 170.9 ppm; 
HR-FAB MS [M+Na]+ calcd 2352.8520 for C126H135N3O40Na found 2352.8545. 
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CDCl3 300 MHz 
Figure A-1: 1H NMR spectrum of Ethyl 2,4,6-tri-O-benzyl-3-O-picoloyl-1-thio-α-D-
mannopyranoside (2.1e) 
 
 
 
CDCl3 75 MHz 
Figure A-2: 13C NMR spectrum of Ethyl 2,4,6-tri-O-benzyl-3-O-picoloyl-1-thio-α-D-
mannopyranoside (2.1e) 
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CDCl3 300 MHz 
Figure A-3: 2-D NMR COSY spectrum of Ethyl 2,4,6-tri-O-benzyl-3-O-picoloyl-1-
thio-α-D-mannopyranoside (2.1e) 
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CDCl3 300 MHz 
Figure A-4: 1H NMR spectrum of Ethyl 2,4-di-O-benzyl-3,6-di-O-picoloyl-1-thio-α-
D-mannopyranoside (2.1f) 
 
 
CDCl3 75 MHz 
Figure A-5: 13C NMR spectrum of Ethyl 2,4-di-O-benzyl-3,6-di-O-picoloyl-1-thio-α-
D-mannopyranoside (2.1f) 
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CDCl3 300 MHz 
Figure A-6: 2-D NMR COSY spectrum of Ethyl 2,4-di-O-benzyl-3,6-di-O-picoloyl-
1-thio-α-D-mannopyranoside (2.1f) 
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CDCl3 300 MHz 
Figure A-7: 1H NMR spectrum of Ethyl 2-O-benzyl-4,6-O-benzylidene-3-O-
picoloyl-1-thio-α-D-mannopyranoside (2.1g) 
 
 
 
 
CDCl3 75 MHz 
Figure A-8: 13C NMR spectrum Ethyl 2-O-benzyl-4,6-O-benzylidene-3-O-picoloyl-
1-thio-α-D-mannopyranoside (2.1g) 
 
 
 
9.5 9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
3
.2
9
4
3
2
.0
3
5
6
1
.0
1
6
8
2
.0
7
2
0
2
.1
0
1
5
2
.0
9
6
8
0
.8
5
0
6
1
.0
5
8
3
2
.0
2
7
1
3
.1
0
3
8
5
.2
6
4
3
3
.2
7
0
6
1
.0
4
1
4
1
.0
2
8
2
1
.0
0
0
0
200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 ppm
Salvatore G. Pistorio| UMSL 2016 | Page 177 
 
 
 
 
CDCl3 300 MHz 
Figure A-9: 2-D NMR COSY spectrum Ethyl 2-O-benzyl-4,6-O-benzylidene-3-O-
picoloyl-1-thio-α-D-mannopyranoside (2.1g) 
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CDCl3 300 MHz 
Figure A-10: 1H NMR spectrum Ethyl 4,6-di-O-benzoyl-2-O-benzyl-3-O-picoloyl-1-
thio-α-D-mannopyranoside (2.1h). 
 
 
 
CDCl3 75 MHz 
Figure A-11: 13C NMR spectrum Ethyl 4,6-di-O-benzoyl-2-O-benzyl-3-O-picoloyl-
1-thio-α-D-mannopyranoside (2.1h). 
 
  
0.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.510.0 ppm
3
.4
8
6
4
2
.2
6
5
4
0
.8
2
1
2
1
.0
0
4
9
1
.1
1
4
8
2
.1
6
0
3
0
.7
6
0
2
1
.4
3
0
6
1
.0
0
0
0
1
.0
2
1
7
1
.0
3
2
8
8
.2
7
3
4
8
.3
2
0
9
1
.7
6
3
3
1
.1
5
1
5
3
.9
1
3
3
2
.2
0
4
6
1
.0
8
8
9
210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 ppm
Salvatore G. Pistorio| UMSL 2016 | Page 179 
 
 
 
CDCl3 300 MHz 
Figure A-12: 2-D NMR COSY spectrum of Ethyl 4,6-di-O-benzoyl-2-O-benzyl-3-O-
picoloyl-1-thio-α-D-mannopyranoside (2.1h). 
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CDCl3 300 MHz 
Figure A-13: 1H NMR spectrum of p-Tolyl 2-O-benzyl-4,6-O-benzylidene-3-O-
picoloyl-1-thio-α-D-mannopyranoside (2.16) 
 
 
CDCl3 75 MHz 
Figure A-14: 13C NMR spectrum of p-Tolyl 2-O-benzyl-4,6-O-benzylidene-3-O-
picoloyl-1-thio-α-D-mannopyranoside (2.16) 
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CDCl3 300 MHz 
Figure A-15: 2-D NMR COSY spectrum of p-Tolyl 2-O-benzyl-4,6-O-benzylidene-
3-O-picoloyl-1-thio-α-D-mannopyranoside (2.16) 
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CDCl3 300 MHz 
Figure A-16: 1H NMR spectrum of p-Tolyl 4,6-O-benzoyl-2-O-benzyl-3-O-picoloyl-
1-thio-α-D-mannopyranoside (2.4) 
 
 
 
 
CDCl3 75 MHz  
Figure A-17: 13C NMR spectrum of p-Tolyl 4,6-O-benzoyl-2-O-benzyl-3-O-picoloyl-
1-thio-α-D-mannopyranoside (2.4) 
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CDCl3 300 MHz 
Figure A-18: 2-D NMR COSY spectrum of p-Tolyl 4,6-O-benzoyl-2-O-benzyl-3-O-
picoloyl-1-thio-α-D-mannopyranoside (2.4) 
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CDCl3 300 MHz 
Figure A-19: 1H NMR spectrum of Phenyl 4,6-di-O-benzoyl-2-O-benzyl-3-O-
picoloyl-1-thio-α-D-mannopyranoside (2.5). 
 
 
 
 
CDCl3 75 MHz 
Figure A-20: 13C NMR spectrum of Phenyl 4,6-di-O-benzoyl-2-O-benzyl-3-O-
picoloyl-1-thio-α-D-mannopyranoside (2.5). 
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CDCl3 300 MHz 
Figure A-21: 2-D NMR COSY spectrum of Phenyl 4,6-di-O-benzoyl-2-O-benzyl-3-
O-picoloyl-1-thio-α-D-mannopyranoside (2.5). 
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CDCl3 300 MHz 
Figure A-22: 1H NMR spectrum of p-Tolyl 2-O-benzyl-4,6-O-benzylidene-3-O-
picoloyl-1-thio-α-D-mannopyranoside (2.16) 
 
 
CDCl3 75 MHz 
Figure A-23: 13C NMR spectrum of p-Tolyl 2-O-benzyl-4,6-O-benzylidene-3-O-
picoloyl-1-thio-α-D-mannopyranoside (2.16) 
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CDCl3 300 MHz 
Figure A-24: 2-D NMR COSY spectrum of p-Tolyl 2-O-benzyl-4,6-O-benzylidene-
3-O-picoloyl-1-thio-α-D-mannopyranoside (2.16) 
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CDCl3 300 MHz 
Figure A-25: 1H NMR spectrum of Phenyl 2-O-benzyl-4,6-O-benzylidene-3-O-
picoloyl-1-thio-α-D-mannopyranoside (2.17) 
 
 
 
CDCl3 75 MHz 
Figure A-26: 13C NMR spectrum of Phenyl 2-O-benzyl-4,6-O-benzylidene-3-O-
picoloyl-1-thio-α-D-mannopyranoside (2.17) 
 
1.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.5 ppm
1
.0
3
4
8
0
.9
3
4
8
1
.0
5
5
1
3
.0
2
1
2
0
.9
5
3
4
2
.8
4
4
8
2
.8
6
2
1
9
.9
9
3
3
5
.7
9
3
1
1
.0
8
0
2
1
.0
0
4
2
1
.0
0
0
0
190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 ppm
Salvatore G. Pistorio| UMSL 2016 | Page 189 
 
 
 
 
CDCl3 300 MHz 
Figure A-27: 2-D NMR COSY spectrum of Phenyl 2-O-benzyl-4,6-O-benzylidene-3-
O-picoloyl-1-thio-α-D-mannopyranoside (2.17) 
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CDCl3 300 MHz 
Figure A-28: 1H NMR spectrum of Methyl 2,3,4-tri-O-benzyl-6-O-(2,4,6-tri-O-
benzyl-3-O-picoloyl-α/β-D-mannopyranosyl)-α-D-glucopyranoside (2.3e). 
 
 
 
 
 
 
CDCl3 150 MHz 
Figure A-29: 13C NMR spectrum of Methyl 2,3,4-tri-O-benzyl-6-O-(2,4,6-tri-O-
benzyl-3-O-picoloyl-α/β-D-mannopyranosyl)-α-D-glucopyranoside (2.3e). 
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CDCl3 300 MHz 
Figure A-30: 2-D NMR COSY spectrum of Methyl 2,3,4-tri-O-benzyl-6-O-(2,4,6-tri-
O-benzyl-3-O-picoloyl-α/β-D-mannopyranosyl)-α-D-glucopyranoside (2.3e). 
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CDCl3 300 MHz 
Figure A-31: 1H NMR spectrum of Methyl 2,3,4-tri-O-benzyl-6-O-(2,4-di-O-benzyl-
3,6-di-O-picoloyl-α/β-D-mannopyranosyl)-α-D-glucopyranoside (2.3f). 
 
 
 
CDCl3 150 MHz 
Figure A-32: 13C NMR spectrum of Methyl 2,3,4-tri-O-benzyl-6-O-(2,4-di-O-benzyl-
3,6-di-O-picoloyl-α/β-D-mannopyranosyl)-α-D-glucopyranoside (2.3f). 
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CDCl3 300 MHz 
Figure A-33: 2-D NMR COSY spectrum of Methyl 2,3,4-tri-O-benzyl-6-O-(2,4-di-
O-benzyl-3,6-di-O-picoloyl-α/β-D-mannopyranosyl)-α-D-glucopyranoside (2.3f). 
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CDCl3 300 MHz 
Figure A-34: 1H NMR spectrum of Methyl 2,3,4-tri-O-benzyl-6-O-(2-O-benzyl-4,6-
benzylidene-3-O-picoloyl-α/β-D-mannopyranosyl)- α-D-glucopyranoside (2.3g). 
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Figure A-35: 13C NMR spectrum of Methyl 2,3,4-tri-O-benzyl-6-O-(2-O-benzyl-4,6-
benzylidene-3-O-picoloyl-α/β-D-mannopyranosyl)- α-D-glucopyranoside (2.3g). 
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CDCl3 300 MHz 
Figure A-36: 2-D NMR COSY spectrum of Methyl 2,3,4-tri-O-benzyl-6-O-(2-O-
benzyl-4,6-benzylidene-3-O-picoloyl-α/β-D-mannopyranosyl)- α-D-glucopyranoside 
(2.3g). 
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CDCl3 300 MHz 
Figure A-37: 1H NMR spectrum of Methyl 6-O-(4,6-di-O-benzoyl-2-O-benzyl-3-O-
picoloyl-α/β-D-mannopyranosyl)-2,3,4-tri-O-benzyl-α-D-glucopyranoside (2.3h). 
 
 
 
CDCl3 150 MHz 
Figure A-38: 13C NMR spectrum of Methyl 6-O-(4,6-di-O-benzoyl-2-O-benzyl-3-O-
picoloyl-α/β-D-mannopyranosyl)-2,3,4-tri-O-benzyl-α-D-glucopyranoside (2.3h). 
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CDCl3 300 MHz 
Figure A-36: 2-D NMR COSY spectrum of Methyl 6-O-(4,6-di-O-benzoyl-2-O-
benzyl-3-O-picoloyl-α/β-D-mannopyranosyl)-2,3,4-tri-O-benzyl-α-D-
glucopyranoside (2.3h). 
 
 
ppm
3.54.04.55.05.56.06.57.07.58.08.5 ppm
3.5
4.0
4.5
5.0
5.5
6.0
6.5
7.0
7.5
8.0
8.5
9.0
Salvatore G. Pistorio| UMSL 2016 | Page 198 
 
 
 
 
CDCl3 300 MHz 
Figure A-37: 1H NMR spectrum of Methyl 2,3,6-tri-O-benzyl-4-O-(2,4,6-tri-O-
benzyl-3-O-picoloyl-α/β-D-mannopyranosyl)-α-D-glucopyranoside (2.7). 
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Figure A-38: 13C NMR spectrum of Methyl 2,3,6-tri-O-benzyl-4-O-(2,4,6-tri-O-
benzyl-3-O-picoloyl-α/β-D-mannopyranosyl)-α-D-glucopyranoside (2.7). 
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CDCl3 300 MHz 
Figure A-39: 2-D NMR COSY spectrum of Methyl 2,3,6-tri-O-benzyl-4-O-(2,4,6-tri-
O-benzyl-3-O-picoloyl-α/β-D-mannopyranosyl)-α-D-glucopyranoside (2.7). 
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CDCl3 300 MHz 
Figure A-40: 1H NMR spectrum of Methyl 3,4,6-tri-O-benzyl-2-O-(2,4,6-tri-O-
benzyl-3-O-picoloyl-α/β-D-mannopyranosyl)-α-D-glucopyranoside (2.9). 
 
 
 
CDCl3 150 MHz 
Figure A-41: 13C NMR spectrum of Methyl 3,4,6-tri-O-benzyl-2-O-(2,4,6-tri-O-
benzyl-3-O-picoloyl-α/β-D-mannopyranosyl)-α-D-glucopyranoside (2.9). 
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CDCl3 300 MHz 
Figure A-42: 2-D NMR COSY spectrum of Methyl 3,4,6-tri-O-benzyl-2-O-(2,4,6-tri-
O-benzyl-3-O-picoloyl-α/β-D-mannopyranosyl)-α-D-glucopyranoside (2.9). 
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CDCl3 300 MHz 
Figure A-43: 1H NMR spectrum of Methyl 2,3,6-tri-O-benzyl-4-O-(2,4-di-O-benzyl-
3,6-di-O-picoloyl-α/β-D-mannopyranosyl)-α-D-glucopyranoside (2.10). 
 
 
CDCl3 150 MHz 
Figure A-43: 13C NMR spectrum of Methyl 2,3,6-tri-O-benzyl-4-O-(2,4-di-O-benzyl-
3,6-di-O-picoloyl-α/β-D-mannopyranosyl)-α-D-glucopyranoside (2.10). 
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CDCl3 300 MHz 
Figure A-44: 2-D NMR COSY spectrum of Methyl 2,3,6-tri-O-benzyl-4-O-(2,4-di-
O-benzyl-3,6-di-O-picoloyl-α/β-D-mannopyranosyl)-α-D-glucopyranoside (2.10). 
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CDCl3 300 MHz 
Figure A-45: 1H NMR spectrum of Methyl 4-O-(4,6-di-O-benzoyl-2-O-benzyl-3-O-
picoloyl-α/β-D-mannopyranosyl)-2,3,6-tri-O-benzyl-α-D-glucopyranoside (2.11). 
 
 
CDCl3 150 MHz 
Figure A-46: 13C NMR spectrum of Methyl 4-O-(4,6-di-O-benzoyl-2-O-benzyl-3-O-
picoloyl-α/β-D-mannopyranosyl)-2,3,6-tri-O-benzyl-α-D-glucopyranoside (2.11). 
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CDCl3 300 MHz 
Figure A-47: 2-D NMR COSY spectrum of Methyl 4-O-(4,6-di-O-benzoyl-2-O-
benzyl-3-O-picoloyl-α/β-D-mannopyranosyl)-2,3,6-tri-O-benzyl-α-D-
glucopyranoside (2.11). 
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CDCl3 300 MHz 
Figure A-48: 1H NMR spectrum of Methyl 2,3,6-tri-O-benzyl-4-O-(2-O-benzyl-4,6-
O-benzylidene-3-O-picoloyl-α/β-D-mannopyranosyl)-α-D-glucopyranoside (2.12).  
 
 
 
CDCl3 150 MHz 
Figure A-49: 13C NMR spectrum of Methyl 2,3,6-tri-O-benzyl-4-O-(2-O-benzyl-4,6-
O-benzylidene-3-O-picoloyl-α/β-D-mannopyranosyl)-α-D-glucopyranoside (2.12). 
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CDCl3 300 MHz 
Figure A-50: 2-D NMR COSY spectrum of Methyl 2,3,6-tri-O-benzyl-4-O-(2-O-
benzyl-4,6-O-benzylidene-3-O-picoloyl-α/β-D-mannopyranosyl)-α-D-
glucopyranoside (2.12). 
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CDCl3 300 MHz 
Figure A-51: 1H NMR spectrum of methyl 2,3,4-tri-O-benzyl-6-O-(4,6-di-O-
benzoyl-2-O-benzyl-β-D-mannopyranosyl)-α-D-glucopyranoside (2.18) 
 
  
CDCl3 75 MHz 
Figure A-52: 13C NMR spectrum of methyl 2,3,4-tri-O-benzyl-6-O-(4,6-di-O-
benzoyl-2-O-benzyl-β-D-mannopyranosyl)-α-D-glucopyranoside (2.18) 
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CDCl3 300 MHz 
Figure A-53: 2-D NMR COSY spectrum of methyl 2,3,4-tri-O-benzyl-6-O-(4,6-di-O-
benzoyl-2-O-benzyl-β-D-mannopyranosyl)-α-D-glucopyranoside (2.18) 
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CDCl3 300 MHz 
Figure A-54: 1H NMR spectrum of Methyl O-(2-O-benzyl-4,6-O-benzylidene-3-O-
picoloyl-β-D-mannopyranosyl)-(13)-O-(4,6-di-O-benzoyl-2-O-benzyl-β-D-
mannopyranosyl)-(16)-2,3,4-tri-O-benzyl-α-D-glucopyranoside (2.19).   
 
 
  
CDCl3 150 MHz 
Figure A-55: 13C NMR spectrum of Methyl O-(2-O-benzyl-4,6-O-benzylidene-3-O-
picoloyl-β-D-mannopyranosyl)-(13)-O-(4,6-di-O-benzoyl-2-O-benzyl-β-D-
mannopyranosyl)-(16)-2,3,4-tri-O-benzyl-α-D-glucopyranoside (2.19).    
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CDCl3 300 MHz 
Figure A-56: 2-D NMR COSY spectrum of Methyl O-(2-O-benzyl-4,6-O-
benzylidene-3-O-picoloyl-β-D-mannopyranosyl)-(13)-O-(4,6-di-O-benzoyl-2-O-
benzyl-β-D-mannopyranosyl)-(16)-2,3,4-tri-O-benzyl-α-D-glucopyranoside (2.19).   
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CDCl3 300 MHz 
Figure A-57: 1H NMR spectrum of 4-Azidobutyl O-(3,6-di-O-benzyl-2-deoxy-2-
phthalimido-β-D-glucopyranosyl)-(1→4)-3,6-O-benzyl-2-deoxy-2-phthalimido-β-D-
glucopyranoside (3.9).   
 
CDCl3 150 MHz 
Figure A-58: 13C NMR spectrum of 4-Azidobutyl O-(3,6-di-O-benzyl-2-deoxy-2-
phthalimido-β-D-glucopyranosyl)-(1→4)-3,6-O-benzyl-2-deoxy-2-phthalimido-β-D-
glucopyranoside (3.9).   
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CDCl3 300 MHz 
Figure A-59: 2-D NMR COSY spectrum of 4-Azidobutyl O-(3,6-di-O-benzyl-2-
deoxy-2-phthalimido-β-D-glucopyranosyl)-(1→4)-3,6-O-benzyl-2-deoxy-2-
phthalimido-β-D-glucopyranoside (3.9).   
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CDCl3 300 MHz 
Figure A-60: 1H NMR spectrum of 4-Azidobutyl O-(2-O-benzyl-4,6-O-benzylidene-
3-O-picoloyl-β-D-mannopyranosyl)-(1→4)-O-(3,6-di-O-benzyl-2-deoxy-2-
phthalimido-β-D-glucopyranosyl)-(1→4)-3,6-O-benzyl-2-deoxy-2-phthalimido-β-D-
glucopyranoside (3.11).   
 
 
CDCl3 150 MHz 
Figure A-61: 13C NMR spectrum of 4-Azidobutyl O-(2-O-benzyl-4,6-O-benzylidene-
3-O-picoloyl-β-D-mannopyranosyl)-(1→4)-O-(3,6-di-O-benzyl-2-deoxy-2-
phthalimido-β-D-glucopyranosyl)-(1→4)-3,6-O-benzyl-2-deoxy-2-phthalimido-β-D-
glucopyranoside (3.11).   
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CDCl3 300 MHz 
 
Figure A-62: 2-D NMR COSY spectrum of 4-Azidobutyl O-(2-O-benzyl-4,6-O-
benzylidene-3-O-picoloyl-β-D-mannopyranosyl)-(1→4)-O-(3,6-di-O-benzyl-2-
deoxy-2-phthalimido-β-D-glucopyranosyl)-(1→4)-3,6-O-benzyl-2-deoxy-2-
phthalimido-β-D-glucopyranoside (3.11).   
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CDCl3 300 MHz 
Figure A-63: 1H NMR spectrum of 4-Azidobutyl O-(2,3,4,6-tetra-O-benzoyl-α-D-
mannopyranosyl)-(1→3)-O-(2-O-benzyl-β-D-mannopyranosyl)-(1→4)-O-(3,6-di-O-
benzyl-2-deoxy-2-phthalimido-β-D-glucopyranosyl)-(1→4)-3,6-di-O-benzyl-2-
deoxy-2-phthalimido-β-D-glucopyranoside (3.14).   
 
CDCl3 150 MHz 
Figure A-64: 13C NMR spectrum of 4-Azidobutyl O-(2,3,4,6-tetra-O-benzoyl-α-D-
mannopyranosyl)-(1→3)-O-(2-O-benzyl-β-D-mannopyranosyl)-(1→4)-O-(3,6-di-O-
benzyl-2-deoxy-2-phthalimido-β-D-glucopyranosyl)-(1→4)-3,6-di-O-benzyl-2-
deoxy-2-phthalimido-β-D-glucopyranoside (3.14).   
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CDCl3 300 MHz 
Figure A-65: 2-D NMR COSY spectrum of 4-Azidobutyl O-(2,3,4,6-tetra-O-
benzoyl-α-D-mannopyranosyl)-(1→3)-O-(2-O-benzyl-β-D-mannopyranosyl)-(1→4)-
O-(3,6-di-O-benzyl-2-deoxy-2-phthalimido-β-D-glucopyranosyl)-(1→4)-3,6-di-O-
benzyl-2-deoxy-2-phthalimido-β-D-glucopyranoside (3.14).   
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CDCl3 300 MHz 
Figure A-66: 1H NMR spectrum of 4-Azidobutyl di-O-(2,3,4,6-tetra-O-benzoyl-α-D-
mannopyranosyl)-(1→3,1→6)-O-(2-O-benzyl-β-D-mannopyranosyl)-(1→4)-O-(3,6-
di-O-benzyl-2-deoxy-2-phthalimido-β-D-glucopyranosyl)-(1→4)-3,6-di-O-benzyl-2-
deoxy-2-phthalimido-β-D-glucopyranoside (3.15).   
CDCl3 150 MHz 
Figure A-67: 13C NMR spectrum of 4-Azidobutyl di-O-(2,3,4,6-tetra-O-benzoyl-α-D-
mannopyranosyl)-(1→3,1→6)-O-(2-O-benzyl-β-D-mannopyranosyl)-(1→4)-O-(3,6-
di-O-benzyl-2-deoxy-2-phthalimido-β-D-glucopyranosyl)-(1→4)-3,6-di-O-benzyl-2-
deoxy-2-phthalimido-β-D-glucopyranoside (3.15).   
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CDCl3 300 MHz 
Figure A-68: 2-D NMR COSY spectrum of 4-Azidobutyl di-O-(2,3,4,6-tetra-O-
benzoyl-α-D-mannopyranosyl)-(1→3,1→6)-O-(2-O-benzyl-β-D-mannopyranosyl)-
(1→4)-O-(3,6-di-O-benzyl-2-deoxy-2-phthalimido-β-D-glucopyranosyl)-(1→4)-3,6-
di-O-benzyl-2-deoxy-2-phthalimido-β-D-glucopyranoside (3.15).   
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CDCl3 300 MHz 
Figure A-69: 1H NMR spectrum of 4-Aminobutyl di-O-(α-D-mannopyranosyl)-
(1→3,1→6)-O-(β-D-mannopyranosyl)-(1→4)-O-(2-acetamido-2-deoxy-β-D-
glucopyranosyl)-(1→4)-2-acetamido-2-deoxy-β-D-glucopyranoside (3.1).   
 
CDCl3 150 MHz 
Figure A-70: 13C NMR spectrum of 4-Aminobutyl di-O-(α-D-mannopyranosyl)-
(1→3,1→6)-O-(β-D-mannopyranosyl)-(1→4)-O-(2-acetamido-2-deoxy-β-D-
glucopyranosyl)-(1→4)-2-acetamido-2-deoxy-β-D-glucopyranoside (3.1).   
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CDCl3 300 MHz 
 
Figure A-71: 2-D NMR COSY spectrum of 4-Aminobutyl di-O-(α-D-
mannopyranosyl)-(1→3,1→6)-O-(β-D-mannopyranosyl)-(1→4)-O-(2-acetamido-2-
deoxy-β-D-glucopyranosyl)-(1→4)-2-acetamido-2-deoxy-β-D-glucopyranoside (3.1).   
 
ppm
0.51.01.52.02.53.03.54.04.55.05.5 ppm
0.5
1.0
1.5
2.0
2.5
3.0
3.5
4.0
4.5
5.0
5.5
Salvatore G. Pistorio| UMSL 2016 | Page 222 
 
 
 
CDCl3 300 MHz 
Figure A-72: 1H NMR spectrum of 8-(3-Carboxypropanoyloxy)oct-1-yl 2,3,4-tri-O-
benzyl-6-O-triphenylmethyl-α-D-glucopyranoside (4.1).   
 
 
CDCl3 150 MHz 
Figure A-73: 13C NMR spectrum of 8-(3-Carboxypropanoyloxy)oct-1-yl 2,3,4-tri-O-
benzyl-6-O-triphenylmethyl-α-D-glucopyranoside (4.1).   
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CDCl3 300 MHz 
 
Figure A-74: 2-D NMR COSY spectrum of 8-(3-Carboxypropanoyloxy)oct-1-yl 
2,3,4-tri-O-benzyl-6-O-triphenylmethyl-α-D-glucopyranoside (4.1).   
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CDCl3 300 MHz 
Figure A-75: 1H NMR spectrum of 8-Acetyloxyoct-1-yl O-(2,3,4,6-tetra-O-acetyl-β-
D-glucopyranosyl)-(1→6)-2,3,4-tri-O-benzyl-α-D-glucopyranoside (4.11).   
 
CDCl3 150 MHz 
Figure A-76: 13C NMR spectrum of 8-Acetyloxyoct-1-yl O-(2,3,4,6-tetra-O-acetyl-β-
D-glucopyranosyl)-(1→6)-2,3,4-tri-O-benzyl-α-D-glucopyranoside (4.11).   
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CDCl3 300 MHz 
 
Figure A-77: 2-D NMR COSY spectrum of 8-Acetyloxyoct-1-yl O-(2,3,4,6-tetra-O-
acetyl-β-D-glucopyranosyl)-(1→6)-2,3,4-tri-O-benzyl-α-D-glucopyranoside (4.11).   
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CDCl3 300 MHz 
Figure A-78: 1H NMR spectrum of 8-Acetyloxyoct-1-yl-O-(2,3,4,6-tetra-O-acetyl-β-
D-glucopyranosyl)-(1→6)-O-(2,3,4-tri-O-acetyl-β-D-glucopyranosyl)-(1→6)-2,3,4-
tri-O-acetyl-α-D-glucopyranoside (4.12). 
 
 
CDCl3 150 MHz 
Figure A-79: 13C NMR spectrum of 8-Acetyloxyoct-1-yl-O-(2,3,4,6-tetra-O-acetyl-β-
D-glucopyranosyl)-(1→6)-O-(2,3,4-tri-O-acetyl-β-D-glucopyranosyl)-(1→6)-2,3,4-
tri-O-acetyl-α-D-glucopyranoside (4.12). 
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CDCl3 300 MHz 
 
Figure A-80: 2-D NMR COSY spectrum of 8-Acetyloxyoct-1-yl-O-(2,3,4,6-tetra-O-
acetyl-β-D-glucopyranosyl)-(1→6)-O-(2,3,4-tri-O-acetyl-β-D-glucopyranosyl)-
(1→6)-2,3,4-tri-O-acetyl-α-D-glucopyranoside (4.12). 
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CDCl3 300 MHz 
Figure A-81: 1H NMR spectrum of 8-Acetyloxyoct-1-yl O-(2,3,4,6-tetra-O-acetyl-β-
D-galactopyranosyl)-(1→4)-O-(2,3,6-tri-O-acetyl-β-D-glucopyranosyl)-(1→6)-O-
(2,3,4-tri-O-acetyl-β-D-glucopyranosyl)-(1→6)-O-(2,3,4-tri-O-acetyl-β-D-
glucopyranosyl)-(1→6)-2,3,4-tri-O-benzyl-α-D-glucopyranoside (4.14). 
CDCl3 150 MHz 
Figure A-82: 13C NMR spectrum of 8-Acetyloxyoct-1-yl O-(2,3,4,6-tetra-O-acetyl-β-
D-galactopyranosyl)-(1→4)-O-(2,3,6-tri-O-acetyl-β-D-glucopyranosyl)-(1→6)-O-
(2,3,4-tri-O-acetyl-β-D-glucopyranosyl)-(1→6)-O-(2,3,4-tri-O-acetyl-β-D 
glucopyranosyl)-(1→6)-2,3,4-tri-O-benzyl-α-D-glucopyranoside (4.14). 
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CDCl3 300 MHz 
 
Figure A-83: 2-D NMR COSY spectrum of 8-Acetyloxyoct-1-yl O-(2,3,4,6-tetra-O-
acetyl-β-D-galactopyranosyl)-(1→4)-O-(2,3,6-tri-O-acetyl-β-D-glucopyranosyl)-
(1→6)-O-(2,3,4-tri-O-acetyl-β-D-glucopyranosyl)-(1→6)-O-(2,3,4-tri-O-acetyl-β-D-
glucopyranosyl)-(1→6)-2,3,4-tri-O-benzyl-α-D-glucopyranoside (4.14). 
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CDCl3 300 MHz 
Figure A-84: 1H NMR spectrum of N-(p-Succinoyloxymethyl)benzyloxycarbonyl-4-
benzylaminobutyl 3,6-di-O-benzyl-2-deoxy-2-phthalimido-β-D-glucopyranoside 
(5.10) 
 
 
CDCl3 150 MHz 
Figure A-85: 13C NMR spectrum of N-(p-Succinoyloxymethyl)benzyloxycarbonyl-4-
benzylaminobutyl 3,6-di-O-benzyl-2-deoxy-2-phthalimido-β-D-glucopyranoside 
(5.10) 
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CDCl3 300 MHz 
Figure A-86: 2-D NMR COSY spectrum of N-(p-Succinoyloxymethyl) 
benzyloxycarbonyl-4-benzylaminobutyl 3,6-di-O-benzyl-2-deoxy-2-phthalimido-β-D-
glucopyranoside (5.10) 
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CDCl3 300 MHz 
Figure A-87: 1H NMR spectrum of tert-Butyldimethylsilyl O-(2-O-benzyl-4,6-O-
benzylidene-3-O-picoloyl-β-D-mannopyranosyl)-(1→4)-3,6-di-O-benzyl-2-deoxy-2-
phthalimido-β-D 
glucopyranoside (5.17).   
 
 
CDCl3 150 MHz 
Figure A-88: 13C NMR spectrum of tert-Butyldimethylsilyl O-(2-O-benzyl-4,6-O-
benzylidene-3-O-picoloyl-β-D-mannopyranosyl)-(1→4)-3,6-di-O-benzyl-2-deoxy-2-
phthalimido-β-D 
glucopyranoside (5.17).   
9.5 9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0.0 ppm
-0
.2
8
9
2
-0
.2
7
9
0
-0
.1
3
7
2
0
.4
6
2
6
1
.0
6
7
8
1
.0
9
1
6
1
.4
8
9
7
1
.8
5
4
8
3
.5
3
3
9
3
.9
1
8
4
3
.9
4
2
7
3
.9
5
3
3
3
.9
6
0
5
3
.9
7
2
4
3
.9
8
0
9
4
.0
6
2
5
4
.0
7
7
4
4
.3
1
3
4
4
.4
2
8
3
4
.5
2
2
9
4
.5
4
9
1
4
.5
8
9
5
4
.6
2
7
6
4
.6
5
6
3
4
.6
9
7
9
5
.1
4
3
7
5
.1
7
0
4
5
.3
1
1
7
6
.6
8
0
0
6
.6
8
5
1
6
.6
9
3
0
6
.7
0
1
2
6
.7
6
6
0
6
.7
7
8
0
6
.7
9
0
2
6
.7
9
7
6
6
.9
3
6
2
6
.9
4
5
0
6
.9
5
7
7
7
.0
6
8
8
7
.0
9
6
4
7
.1
0
4
5
7
.1
1
5
5
7
.1
1
9
2
7
.1
2
5
9
7
.1
3
3
1
7
.1
4
5
7
7
.1
5
3
8
7
.1
8
9
5
7
.2
0
4
9
7
.2
1
3
9
7
.2
2
4
4
7
.2
3
3
8
7
.2
6
5
2
7
.2
6
9
1
7
.2
8
1
5
7
.2
8
5
0
7
.2
9
0
8
7
.2
9
4
4
7
.4
8
5
2
7
.6
0
7
4
7
.6
1
3
1
7
.8
4
5
4
6
.6
1
1
0
9
.7
1
4
5
1
.2
6
2
0
1
.0
3
4
0
2
.1
8
9
4
1
.9
8
3
6
7
.3
8
8
3
1
.1
8
3
0
6
.5
7
4
6
0
.9
3
0
9
1
.0
8
7
7
1
.0
0
0
0
5
.2
6
9
1
3
.4
8
9
6
1
5
.6
7
3
0
5
.9
4
1
1
1
.1
8
5
0
1
.0
7
1
3
210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 ppm
Salvatore G. Pistorio| UMSL 2016 | Page 233 
 
 
CDCl3 300 MHz 
Figure A-89: 2-D NMR COSY spectrum of tert-Butyldimethylsilyl O-(2-O-benzyl-
4,6-O-benzylidene-3-O-picoloyl-β-D-mannopyranosyl)-(1→4)-3,6-di-O-benzyl-2-
deoxy-2-phthalimido-β-D 
glucopyranoside (5.17).   
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CDCl3 300 MHz 
Figure A-90: 1H NMR spectrum of O-(2,4-Di-O-benzyl-3,6-O-picoloyl-β-D-
mannopyranosyl)-(1→4)-3,6-di-O-benzyl-2-deoxy-2-phthalimido-β-D-glucopyranose 
(5.21) 
 
 
CDCl3 150 MHz 
Figure A-91: 13C NMR spectrum of O-(2,4-Di-O-benzyl-3,6-O-picoloyl-β-D-
mannopyranosyl)-(1→4)-3,6-di-O-benzyl-2-deoxy-2-phthalimido-β-D-glucopyranose 
(5.21) 
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CDCl3 300 MHz 
Figure A-92: 2-D NMR COSY spectrum of O-(2,4-Di-O-benzyl-3,6-O-picoloyl-β-D-
mannopyranosyl)-(1→4)-3,6-di-O-benzyl-2-deoxy-2-phthalimido-β-D-glucopyranose 
(5.21) 
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CDCl3 300 MHz 
Figure A-93: 1H NMR spectrum of O-(2,4-Di-O-benzyl-3,6-O-picoloyl-β-D-
mannopyranosyl)-(1→4)-3,6-O-benzyl-2-deoxy-2-phthalimido-β-D-glucopyranosyl 
trichloroacetimidate (5.6).   
 
 
 
CDCl3 150 MHz 
Figure A-94: 13C NMR spectrum of O-(2,4-Di-O-benzyl-3,6-O-picoloyl-β-D-
mannopyranosyl)-(1→4)-3,6-O-benzyl-2-deoxy-2-phthalimido-β-D-glucopyranosyl 
trichloroacetimidate (5.6).   
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CDCl3 300 MHz 
Figure A-95: 2-D NMR COSY spectrum of O-(2,4-Di-O-benzyl-3,6-O-picoloyl-β-D-
mannopyranosyl)-(1→4)-3,6-O-benzyl-2-deoxy-2-phthalimido-β-D-glucopyranosyl 
trichloroacetimidate (5.6).   
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 CDCl3 300 MHz 
Figure A-96: 1H NMR spectrum of N-(p-Acetoxymethyl)benzyloxycarbonyl-4-
benzylaminobutyl O-(4,6-di-O-acetyl- 2,3-O-benzyl-α/β-D-mannopyranosyl)-(1→4)-
3,6-di-O-benzyl-2-deoxy-2-phthalimido-β-D glucopyranoside (5.13).   
 
CDCl3 150 MHz 
Figure A-97: 13C NMR spectrum of N-(p-Acetoxymethyl)benzyloxycarbonyl-4-
benzylaminobutyl O-(4,6-di-O-acetyl- 2,3-O-benzyl-α/β-D-mannopyranosyl)-(1→4)-
3,6-di-O-benzyl-2-deoxy-2-phthalimido-β-D glucopyranoside (5.13).   
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CDCl3 300 MHz 
Figure A-98: 2-D NMR COSY spectrum of N-(p-
Acetoxymethyl)benzyloxycarbonyl-4-benzylaminobutyl O-(4,6-di-O-acetyl- 2,3-O-
benzyl-α/β-D-mannopyranosyl)-(1→4)-3,6-di-O-benzyl-2-deoxy-2-phthalimido-β-D 
glucopyranoside (5.13).   
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CDCl3 300 MHz 
 Figure A-99: 1H NMR spectrum of N-(p-Acetoxymethyl)benzyloxycarbonyl-4-
benzylaminobutyl di-O-(2,3,4,6-tetra-O-acetyl-α-D-mannopyranosyl)-(1→3,1→6)-O-
(2-O-benzyl-α/β-D mannopyranosyl)-(1→4)-O-(3,6-di-O-benzyl-2-deoxy-2-
phthalimido-β-D glucopyranosyl)-(1→4)-3,6-di-O-benzyl-2-deoxy-2-phthalimido-β-
D-glucopyranoside (5.2).  
 
CDCl3 150 MHz 
Figure A-100: 13C NMR spectrum of  N-(p-Acetoxymethyl)benzyloxycarbonyl-4-
benzylaminobutyl di-O-(2,3,4,6-tetra-O-acetyl-α-D-mannopyranosyl)-(1→3,1→6)-O-
(2-O-benzyl-α/β-D mannopyranosyl)-(1→4)-O-(3,6-di-O-benzyl-2-deoxy-2-
phthalimido-β-D glucopyranosyl)-(1→4)-3,6-di-O-benzyl-2-deoxy-2-phthalimido-β-
D-glucopyranoside (5.2).  
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CDCl3 300 MHz 
Figure A-101: 2-D NMR COSY spectrum of N-(p-
Acetoxymethyl)benzyloxycarbonyl-4-benzylaminobutyl di-O-(2,3,4,6-tetra-O-acetyl-
α-D-mannopyranosyl)-(1→3,1→6)-O-(2-O-benzyl-α/β-D mannopyranosyl)-(1→4)-
O-(3,6-di-O-benzyl-2-deoxy-2-phthalimido-β-D glucopyranosyl)-(1→4)-3,6-di-O-
benzyl-2-deoxy-2-phthalimido-β-D-glucopyranoside (5.2).  
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